‘Most’ Cases of Avian Influenza in USA Cattle Likely Undetected 01/05/2024 Zuzanna Stawiska Milking a cow in Texas. H5N1 Avian influenza is spreading among US cattle herds, most probably during the time of milking. Most H5N1 infections spreading through US dairy cattle and other animal populations are likely going undetected despite stepped up surveillance by the US Department of Agriculture, Michael Osterholm, director of the Centre for Infectious Disease Research and Policy (CIDRAP), told Health Policy Watch on Wednesday. Osterholm spoke as a growing number of infectious experts were sounding alarm bells about the expanding spread of the deadly virus to mammalian populations – and especially dairy cattle in the United States, where some 36 herds have so far been infected, according to the latest US Centers for Disease Control and Prevention (CDC) update April 30. Sanitation gaps and lax surveillance in industrial dairy operations are facilitating H5N1 transmission, experts now suggest. Total number of H5N1 cases in different animals in the US. Infection spread in dairy cattle, the newest ‘terrain’ for the virus, is causing the most concern. And “most” infections are likely going undetected due to farmer reluctance to have cattle and employees tested for avian flu, warned Osterholm, an internationally-known expert. “We need much more extensive follow up, serology studies and close monitoring of mixing vessel animal species, e.g. pigs,” Osterholm stressed in emailed remarks. He noted that pig infections, for example, constitute a “mixing vessel animal species” because they can become co-infected with both animal and human forms of avian influenza, increasing the risks of spread to humans of a virus that has a greater than 50% fatality rate. On the positive side, Osterholm added that it was “very unlikely” pasteurized milk could transmit the infection if pasteurization “is done properly.” Policymakers have taken their ‘eye off the ball’ of ‘One Health’ principles “Policymakers have again taken their eyes off the ball in efforts to protect humanity from new pandemics,” stated Dr Nigel Sizer, an Executive Director of the non-profit Preventing Pandemics at the Source (PPATS), as part of a stiff warning issued Tuesday by half a dozen international experts on the wave of H5N1 infections. “In this case, it is hard not to point the finger at lax monitoring and regulation of animal agriculture in the United States and elsewhere,” Sizer said. Colorized transmission electron micrograph of Avian influenza A H5N1 viruses (seen in gold) grown in MDCK cells (seen in green). The expanding outbreak takes place as WHO member states are in the throes of finalizing a draft Pandemic Accord agreement, where a commitment to stronger “One Health” measures for preventing spillovers of animal pathogens to humans remains a sticking point for some countries in the Global South. But in the case of the USA, a dearth of surveillance is also a hallmark of the rapidly expanding avian flu outbreak in the Global North, other experts also pointed out. “The situation with avian influenza across the United States exemplifies the inherent hypocrisy and vested economic interests around Pandemic Prevention, Preparedness, and Response,” said Dr. Christian Walzer, Executive Director of Health at the Wildlife Conservation Society, and a professor at the University of Veterinary Medicine in Vienna, Austria, in the PPATS statement of experts. “As one hundred ninety-four member states of the World Health Organization (WHO) are negotiating perceived responsibilities and equity around a new Pathogen Access and Benefits-Sharing [PABS] Mechanism – while the Global North is demanding transparent and rapid access to pathogen data from the Global South to develop diagnostics, vaccines, and therapeutics, it seems unwilling to share such information with the world,” Walzer said. Spread through milking machines Among dairy cows, H5N1 appears to be transmitting rapidly through their mammary glands via virus contaminated milking machines, Stat News reported on Tuesday. The milking equipment is typically not sanitized between sessions with individual animals, becoming an obvious transmission path to infection by more and more cows from the herd. Experts such as Jared Taylor, a professor of veterinary pathobiology at Oklahoma State University, noted that the H5N1 infections in cattle herds reported so far have been limited to lactating dairy cows. And the ones who produce most milk – and therefore spend more time on the milking machines – have the highest disease incidence. Even more worrisome is the potential presence of the virus in raw milk – which some consumers in the USA as well as in Europe prefer as a more ‘natural’ alternative. US states where H1N5 has been detected in cattle There also have been virus remnants found in pasteurised milk. “The role of pasteurization in inactivation of the virus […] is currently being investigated,” states a 23 April assessment by the WHO, issued jointly with the UN Food and Agriculture Organization (FAO) and the World Organisation for Animal Health (WOAH). Infection with H5N1 from pasteurised milk is, however, “very unlikely, if [the pasteurisation is] done properly,” Osterholm said. As compared with consumers, farm workers who have everyday contact with cattle are, however, at a far higher risk of infection. And the one case of human infection reported in March, does not reflect the scale of the disease spread to people, experts say because farmers have been reluctant to allow testing of cattle or employees, and such testing remains voluntary. That’s why “most” cases likely go undetected, Osterholm told Health Policy Watch. Avian influenza as symptom of world’s failure to apply ‘One Health’ measures Virus spillovers to more and more species are a direct effect of the poor animal management practices in the intensive livestock production conditions that are common throughout the developed world today, said Sizer in the statement on April 30. “Improved animal husbandry conditions, more rigorous inspection standards, as well as better reporting and sharing of animal health information could reduce the risk of these outbreaks as well as improve the welfare of the animals we consume,” he asserted. “We must question for how much longer consumers will have to worry that the price of a cheap sausage or steak is the risk of another global pandemic.” One Health principles recognize the interlinkages between ecosystems, animal and human health, and call for enhanced collaboration between sectors to prevent zoonotic spillover into human populations. “This outbreak highlights the need for One Health approaches for preventing spillovers and interventions to reduce risk of such threats ‘at source’,” argued Dr. Malik Peiris, Professor of Virology at the School of Public Health at The University of Hong Kong, and a leading H5N1 expert. Pigs are an important possible intermediary host for avian influenza. “There is still a widespread philosophy of aiming for maximum profit in meat production, when it should be about optimizing food security, food safety, animal welfare and ecological sustainability,” added Dr. Dirk Pfeiffer, Professor of One Health at City University of Hong Kong, in the same statement, adding: “Global investors who see opportunities in making money out of meat production should be aware that ‘growing cattle, pigs or chickens’ is not the same as making parts for mobile telephones.” WHO still ranks human health risks as low or low-to moderate In its 23 April assessment, WHO ranked avian influenza risks to humans as low generally insofar as human-to-human transmission has never been documented, and low-to-moderate for those “with exposure to infected birds or animals or contaminated environments.” Only one human case connected with the US outbreak has been reported, a cattle worker from Texas. Since 2003, WHO reported only rare instances of human infections all from close contact with animals. Even so, the mortality was “extraordinarily high,” according to WHO Chief Scientist Jeremy Farrar. He was referring to the 52% mortality rate registered amongst the 889 human cases of H5N1 reported to WHO between 2003 and 1 April 2024. Jeremy Farrar, WHO Chief Scientist, during a press briefing April 18 “Being one of the few people around the world who have actually treated patients with H5N1 […] this remains I think an enormous concern,” Farrar stressed at an April 18 media briefing in Geneva. From 1996 until 2013, Farrar was Director of the Oxford University Clinical Research Unit in Ho Chi Minh City, where he and a Vietnamese colleague identified the re-emergence of the deadly bird flu, or H5N1, in humans in 2004. What worries experts the most is the virus’s expanding host range. Naturally found in wild birds, avian influenza has developed a limited ability to infect other species, including mammals. The recent joint assessment by WHO, FAO and WOAH reports mentions the virus as the probable source of infection in sea mammals, multiple fur animal farms and ferret-to-ferret infections, according to some studies. The list of infected animals is getting longer: cats, dogs, goat kids or polar bears, already known to suffer from the disease were recently joined by a walrus, as The Guardian reported. “The great concern, of course, is […] that that virus now evolves and develops the ability to infect humans. And then critically, the ability to go from human-to-human transmission,” Farrar told the media briefing. Reassurance, but… Other WHO officials have still sought to issue a more reassuring note. Speaking at another WHO press briefing on April 24, Dr. Maria Van Kerkhove, a WHO epidemiologist, asserted that appropriate surveillance systems are working well. “We are concerned about this particular virus because we know influenza has the potential to cause epidemics that have the potential to cause pandemics,” she said. “And that’s why we have a global system in place to monitor, detect, and to rapidly do risk assessments to look at viruses that could potentially be used in vaccines as we go forward. There’s a lot of work in place right now,” she said. Since the beginning of 2021, 28 detections of H5N1 in humans have been reported to WHO, with all nine cases reported in Europe or North America being assymptomatic or mild cases, notes the WHO/FAO/WOAH joint assessment. Still the three agencies also recommended tougher monitoring – calling on national authorities to use “active case finding and serologic methods, as well as work with national agencies to understand the exposure and risk from milk and milk products.” Osterholm, like other experts doubts that US authorities have the situation under control. What’s needed is, among others, a “much more extensive follow up,” said Osterholm. He also advises a close monitoring of pigs, which have “influenza virus receptors for both avian and human influenza viruses. “If they get coinfected with both viruses simultaneously then viral reassortment can occur and a new human virus emerge, like what happened in 2009 with the new H1N1 [strain] that emerged in swine in Mexico.” With editing and reporting contributions by Elaine Ruth Fletcher Image Credits: Josh Kelahan, US CDC, CDC/ Courtesy of Cynthia Goldsmith, Flickr: Dutchairplaneshooter. Slow Progress at UN Plastic Pollution Talks as Countries Clash Over Production Limits 30/04/2024 Kerry Cullinan On the final day of INC-4, delegates held talks until the early hours of the morning trying to find a way forward The fourth session of the UN intergovernmental negotiating committee (INC) to develop an international legally binding instrument on plastic pollution ended in Ottawa on Tuesday with “an advanced draft text of the instrument and agreement on inter-sessional work ahead”, according to the UN Environment Programme (UNEP). Delegates engaged in text-based discussion on the revised draft for the first time, but there were major sticking points – especially on limiting plastic production. The European Union (EU) proposed extending the meeting but delegates failed to agree on the proposal, according to the Earth Negotiation Bulletin. The #INC4 session in Ottawa has wrapped, setting a clear path to an ambitious #PlasticsTreaty. With progress on negotiations & future intersessional work agreed, strides are being made towards a legally binding agreement to #BeatPlasticPollution. 🔗See: https://t.co/w1VKGBbvnj pic.twitter.com/Wz1YJmea3T — UN Environment Programme (@UNEP) April 30, 2024 Other issues on the table related to emissions and releases; product design; waste management; problematic and avoidable plastics; financing, and a just transition. The INC members agreement to hold inter-sessional work – expert meetings between the official INC sessions – to work on “convergence on key issues” ahead of the next negotiating session, INC5, will take place in Busan, Korea, in November. The inter-sessional groups will look at financing to achieve the objectives of the instrument and approaches to address plastic pollution and chemicals of concern in plastic products and product design, focusing on products that can be recycled and reused. Long road to agreement INC5 is supposed to adopt an agreement, but there is still a long road ahead as “meetings to discuss the technical elements of the text diverged on almost all points of discussion, from problematic and avoidable plastics to product design, composition and performance,” according to the Earth Negotiation Bulletin.. “We came to Ottawa to advance the text and with the hope that members would agree on the intersessional work required to make even greater progress ahead of INC-5. We leave Ottawa having achieved both goals and a clear path to landing an ambitious deal in Busan ahead of us,” said Inger Andersen, UNEP executive director. “The work, however, is far from over. The plastic pollution crisis continues to engulf the world and we have just a few months left before the end of year deadline agreed upon in 2022. I urge members to show continued commitment and flexibility to achieve maximum ambition.” However, several NGOs that attending as observers were unhappy with the influence of member states with significant fossil fuel industries. Most plastics are made from oil and gas derivatives. “Despite hearing people from polluted communities around the world give sensible proposals to curb the lifecycle harms of plastics, fossil fuel and petrochemical interests are still shamelessly blocking progress and focusing on utterly inadequate plastic waste management,” said Julie Teel Simmonds, a senior attorney at the Center for Biological Diversity (CBD). While Rwanda and Peru, part of the high-ambition coalition, proposed production reductions, a coalition of fossil fuel–aligned countries, including Russia, China, and Saudi Arabia, objected to treaty measures to address plastic production, according to the CBD. Not ‘if ‘but ‘how’ “Canada is committed to reaching a final agreement at INC-5 in the Republic of Korea before year end. We are no longer talking about ‘if’ we can get there, but ‘how.’ Together we can land one of the most significant environmental decisions since the Paris Agreement and the Kunming Montreal Global Biodiversity Framework,” said Steven Guilbeault, Canada’s Minister of Environment and Climate Change, who hosted INC4. “We are doing everything we can to raise the international profile of the plastic pollution crisis so that the agreement gets the global attention it deserves to cross the finish line.” INC chairperson Ambassador Luis Vayas said that “some common ground” had been found and “I firmly believe that we can carry this same spirit forth to Busan to deliver on our mandate.” Delegates accepted Vayas’ proposal for a legal drafting group to ensure legal clarity in the text of the future agreement. Jyoti Mathur-Filipp, executive secretary of the INC secretariat, said that “compromise and commitment remains strong at this advanced stage of the negotiations”. “Members should arrive in Busan ready to deliver on their mandate and agree a final text of the instrument. This is more than a process – it is the fulfilment of your commitment to saving future generations from the global scourge of plastic pollution.” Image Credits: Kiara Worth/IISD. More African Countries Roll Out Malaria Vaccine, While Babies Get New Treatment Formulation 30/04/2024 Zuzanna Stawiska A rollout of malaria vaccine in Western African countries with a special focus on immunising children is an important step towards eliminating the disease Rollout of malaria vaccines are starting in Benin, Sierra Leone and Liberia, and the West African countries plan to deliver more than 800 000 doses of the RTS,S or R21 vaccines, according to WHO. The new vaccine will be added to their immunisation programmes for children, and are expected to protect over 200,000 children from the life-threatening disease. The RTS.S vaccine can be administered to children as young as five months old. In another promising development against malaria, a new formulation of a malaria treatment, Coartem, has proven to be safe and efficacious for babies under five kilograms, a previously overlooked group of patients. Pharmaceutical company Novartis and Medicines for Malaria Venture (MMV), a leading product development partnership, announced that their product has good efficacy and safety and is appropriate for babies in the wake of the successful CALINA study. The trial data have been submitted for regulatory review, they informed during the Multilateral Initiative on Malaria conference. “Infants below five kilograms make up a critical neglected group, and developing antimalarials specifically suited to their needs is essential to malaria control efforts,” said Wiweka Kaszubska, MMV vice president. The new formulation, known as Coartem <5 kg Baby, uses a new ratio and dose of artemether-lumefantrine to account for metabolic differences in babies under 5kg to minimise the risk of overdose and toxicity. “Infants under five kg can be affected by placental malaria, leading to poor birth outcomes, or contract malaria from the bite of an infected mosquito. The prevalence of the disease in this age and weight group is poorly understood, and it is therefore often misdiagnosed,” according to a company media release. Current antimalarials have not been developed small babies, who are usually treated with tablets meant for children above 5 kg adjusted by weight – yet, these tiny patients handle drugs differently due to the immaturity of their metabolising organs. Decreasing the burden Malaria is a life-threatening infectious disease with an estimated 249 million cases and 608 000 deaths in 2022, according to the World Malaria Report 2023. It is present in 85 countries, with 95% of cases in the African region. Most of the fatalities in the region – four out of five – are children under the age of five. “With the new, safe and efficacious malaria vaccine, we now have an additional tool to fight this disease. In combination with insecticide-treated nets, effective diagnosis and treatment, and indoor spraying, no child should die from malaria infection,” said Dr Austin Demby, the Minister of Health of Sierra Leone. The emerging interventions will likely decrease the burden of malaria substantially. In the recent years, (2019-2023), a pilot malaria vaccine programme in Ghana, Kenya and Malawi reached over two million children, showing a significant reduction in malaria illness. It also reached a 13% drop in overall child mortality and a reduction in hospitalisations. Benin, Liberia and Sierra Leone joined five other African countries that have already implemented the rollout of the newly developed malaria vaccines. Image Credits: WHO. Africa Wants Debt Swaps to Support Countries’ Defences Against Pandemics 29/04/2024 Kerry Cullinan African leaders who attended at the high level meeting in Addis Ababa on Saturday. African leaders want “explicit commitments” to debt relief and debt restructuring mechanisms, including debt swaps to support country-level pandemic prevention, preparedness and response (PPPR) in the pandemic agreement. This is one of the continent’s demands, made on the eve of the World Health Organization’s (WHO) pandemic agreement talks, following a high-level meeting of African health ministers and diplomats on Saturday. At the meeting, a key African Union (AU) leader warned against postponing the adoption of a pandemic agreement, saying it might never be passed. The pandemic agreement negotiations entered their final two-week phase in Geneva on Monday with 10 May as the deadline for what observers are describing as an “instrument of essentials” – a basic text that will be fleshed out by further talks in the next couple of years, as reported recently by Health Policy Watch. The first communique from the African leaders’ Saturday meeting was withdrawn a few hours after its release. The new statement released on Monday was identical except it removed a reference to the Pandemic Fund in its call for “an international financing mechanism” to support countries’ pandemic-proofing efforts. It also wants the accelerated “operationalisation of the financing of the African Epidemic Fund”. Support for PABS The continent supports a “multilateral pathogen access and benefit sharing system (PABS)” that provides legal certainty to users and providers and ensures improved access to pandemic-related health products and technologies. The draft agreement proposes a WHO-coordinated PABS system but for the operational details of this contested proposal are to be finalised by May 2026. Africa also wants “measures to establish regionally-distributed production of pandemic-related health products” and “commitments to organise and resource technical support” on all equity-related provisions. Pandemic prevention, preparedness, and response (PPPR) demands relate largely to national and regional responsibilities, with measures such as the enactment of “domestic laws providing for broad exemptions and limitations to intellectual property to address public health emergencies”, and supply chain diversification and logistics streamlining throughout the continent. Africa also wants the various WHO-coordinated mechanisms in the agreement – such as on research and development and technology transfer – to be operationalised and accountable to the Conference of Parties, a multi-country structure which is set to govern the agreement. “Africa stands ready to play its part and comments to engage actively in the ongoing negotiations and finalisation of the draft pandemic agreement,” the statement concludes. AU warns against postponement “I don’t think postponing an agreement is going to be in our interest because we may postpone forever. I look forward to us consolidating our common position today, consolidating our negotiating positions and ensuring that Africa’s interests are represented in the global pandemic agreement negotiations,” said AU deputy chairperson, Dr Monique Nsanzabaganwa, during the opening of the ministerial meeting. AU deputy chairperson Dr Monique Nsanzabaganwa warns against delaying the agreement. She also urged pragmatism when addressing the meeting on Saturday, explaining that several African demands – such as a seat at the G20 – had taken years to achieve. “In some situations, we don’t have even a choice because we need to continue being pragmatic as we look for all conditions that can allow us some equity and some flexibilities and conducive conditions for us to do what we’ll have to do for ourselves,” she said. She also warned of the likelihood of another COVID-like pandemic in the not so distant future, adding that it is “crucial that we work together to strengthen our collective preparedness and ensure that Africa’s voice is heard in global health discussions”. While Africa’s negotiators wanted a win-win situation, in negotiations “there is always give and take”, said Nsanzabaganwa, who hails from Rwanda. “We have also the duty to continue pressing for multilateralism to work.” Meanwhile, Zambia’s health minister, Sylvia Masebo, who chairs the Africa CDC board, called on the African negotiators to ensure “equitable access to pandemic-related health products” and “increased access to vaccines, diagnostics and therapeutics, ensuring that no one is left behind”. Africa CDC Director-General Dr Jean Kaseya said that unity and a common African position in the negotiations was key. Food Insecurity Affects 282 Million People in 2023 29/04/2024 Disha Shetty Food insecurity increased in 2023 due to a combination of conflicts, economic shocks and extreme weather events. In 2023, nearly 282 million people – 21.5% of the analysed population across 59 countries and territories – faced high levels of acute food insecurity, according to the Global Report on Food Crises (GRFC) 2024. This is 24 million more people than 2022. The rise was due to the report’s increased coverage of food crisis contexts and a sharp deterioration in food security, especially Gaza and Sudan. “The Gaza Strip became the most severe food crisis in our reporting history. Conflict and insecurity, along with extreme weather, events and economic shocks, are the key drivers of food insecurity and nutrition crisis,” said Dominique Burgeon, Director of the Food and Agriculture Organization (FAO) Liaison Office in Geneva. The current situation in the Gaza Strip accounts for 80% of those facing imminent famine, along with South Sudan, Burkina Faso, Somalia and Mali. For four consecutive years, the proportion of people facing acute food insecurity has remained persistently high at almost 22% of those assessed, significantly exceeding pre-COVID-19 levels. “This crisis demands an urgent response. Using the data in this report to transform food systems and address the underlying causes of food insecurity and malnutrition will be vital,” said António Guterres, UN Secretary-General. Number of people facing high levels of acute food insecurity in 59 countries and territories in 2023.(GRFC 2024) The report brings focuses on the enormity of the challenge of achieving the end of hunger by 2030 – a key UN Sustainable Development Goal. Improvements in food security in some countries was outweighed by deteriorating conditions in others. Over 26 million people are one step away from famine, while the total population in catastrophe was “more than four times higher than in 2016,” said Burgeon.The report was produced by the Global Network Against Food Crises (GNAFC), a multi-stakeholder initiative that is working to address the food crises. Protracted hunger Acute malnutrition worsened in 2023, particularly among people displaced because of conflict and disasters. Children and women are at the forefront of these hunger crises, with over 36 million children under five years of age acutely malnourished across 32 countries, the report showed. “The report also tells us that 60% of children experiencing acute malnutrition live in the ten countries facing the highest level of acute food insecurity,” said Burgeon of FAO. Thirty six countries have consistently featured in the GRFC analyses since 2016, reflecting continuing years of acute hunger, and currently representing 80% of the world’s most hungry. One million people more people face emergency levels of acute food insecurity across 39 countries and territories. In 2023, more than 705,000 people were at the catastrophe level of food insecurity and at risk of starvation – the highest number in the GRFC’s reporting history and up fourfold since 2016. The share of the analysed population facing high levels of acute food insecurity increased sharply from 14 percent in 2018 to more than 20 percent each year since 2020. Key drivers: Conflicts and extreme weather Conflict remained the primary driver of hunger, affecting 20 countries and forcing 135 million people into acute food insecurity – almost half of the global number. Sudan faced the largest deterioration due to conflict, with 8.6 million more people facing high levels of acute food insecurity as compared with 2022. “Sudan is a major concern for, the nutrition component because primarily of the major caseload, the number of people is staggering and also for the difficulty of reaching these people. In many areas, there is impossible access and or inconsistent access,” said Stefano Fedele, Global Nutrition Cluster Coordinator for UNICEF Geneva. Extreme weather events were the primary drivers in 18 countries where over 77 million people faced high levels of acute food insecurity, up from 12 countries with 57 million people in 2022. The impacts of economic shocks affected 21 countries where around 75 million people were facing high levels of acute food insecurity, due to their high dependency on imported food and agricultural inputs, persisting macroeconomic challenges, including currency depreciation, high prices and high debt levels. The drivers of food insecurity are interlinked and mutually reinforcing Breaking the cycle Tackling persistent food crises requires urgent long-term national and international investment to transform food systems and boost agricultural and rural development, according to the report. It also advocates for peace and prevention of conflict to become an integral part of the longer-term food systems transformation. Since 2023, needs have outpaced available resources and many humanitarian operations now overstretched, with many being forced to scale-down and further cut support to the most vulnerable. “This is truly a global challenge. There are far too many people waking up in the morning not knowing where their next meal will come from, not knowing how to feed their children, and having to make really truly impossible decisions throughout the course of their day to ensure that their most fundamental needs are being met,” said Courtney Blake, Senior Humanitarian Advisor for the US Mission in Geneva. Image Credits: Unsplash, Global Report on Food Security 2024. Final Pandemic Agreement Talks Start Amid Gamble on Process and African Show of Unity 28/04/2024 Kerry Cullinan The Africa CDC convened a high-level meeting in Addis Ababa on Saturday to discuss the continent’s position on the draft pandemic agreement. The World Health Organization’s (WHO) pandemic agreement negotiations begin their final two-week stretch on Monday (28 April) amid a gamble with the process, a show of unity from African member states – and more suggestions for the draft text. This final intergovernmental negotiating body (INB) meeting will focus on finding “common ground and consensus”, according to a decision taken at the last fractious meeting. The programme of work sets down 12-hour days, with the first week (29 April-3 May) focusing on finalising the substantive negotiations on the draft text. A “stock take” of progress will be held on Friday 3 May, and the second week (6-10 May) will look at outstanding articles, along with the draft resolution for the World Health Assembly at the end of May. The INB Bureau has also undertaken to provide daily briefing to relevant stakeholders on progress. ‘Take it or leave it’ After the previous session at which member states expressed frustration with one another and the INB Bureau, the INB co-chairs have taken a gamble with the process this time – and member states may not play along. The multitude of bracketed contested text has been purged from the new draft, and the co-chairs want the meeting to focus on saying “yes”, rather than being bogged down by disagreements. The meeting will go through the 23-page draft paragraph by paragraph, and member states that don’t agree with the text will be invited to have informal sessions, the co-chairs told a recent stakeholder briefing. But the draft will be considered as the default text where there is no consensus, which the co-chairs described as a “take it or leave it” approach. “The Bureau is of the opinion that the text as presented in the proposal for a WHO Pandemic Agreement is consensus ready,” it explained in a briefing document sent to stakeholders on Friday (26 April). “It was drafted on the basis of our many rounds of negotiations. The co-chairs will open the different articles and will ask the member states if the article is ready for approval. If not, delegations will be invited to explain what their issue with the article is. “Where possible the co-chairs will immediately propose a way forward. If the issue at hand is more fundamental, either a small informal meeting between a few member states can be proposed, or – if more member states want to be involved – a working group session can be proposed.” These working groups would be led by a member of the Bureau and the plan would be found them to return to the drafting group with a solution. At the recent stakeholder briefing, the European Union indicated that not all the text was consensus-based while Bangladesh, a key player in the Group of Equity negotiating bloc, criticised the approach of grabbing “low-hanging fruit for the sake of consensus”. 🇧🇩Bangladesh doubted finishing by May 2024, criticized agreeing to “low-hanging fruit for the sake of consensus,” proposed one IGWG on all remaining topics (not separate), and opposed parallel discussions during #INB9. 🇬🇧The UK asked about civil society engagement (thank you!). pic.twitter.com/TXcGsFnCkl — Nina Schwalbe (@nschwalbe) April 19, 2024 Africa asserts unity Meanwhile, African leaders urged continental unity and pragmatism at a high-level meeting on the pandemic negotiations convened on Saturday by the Africa Centre for Disease Control and Prevention (Africa CDC). Dr Monique Nsanzabaganwa, Deputy Chairperson of the African Union, urged pragmatism and realism at the meeting, attended by health ministers, diplomats and UN agency officials. Dr Monique Nsanzabaganwa, Deputy Chairperson of the African Union “At the time of COVID, multilateralism collapsed completely and then Africa was shut [out of] accessing all the things we needed at the time, the PPE and the vaccines,” she said, adding that the pandemic negotiations were an attempt to revive multilateralism. “In some situations, we don’t have a choice because we need to continue being pragmatic as we look for all conditions that can allow us some equity and some flexibilities and conducive conditions for us to do what we’ll have to do for ourselves,” she added. Africa CDC Director General Dr Jean Kaseya told the meeting, which was also briefed by INB co-chair Precious Matsoso, that “what matters most is for the continent to speak with one voice”. He stressed that Africa’s priorities, as contained in its New Public Order, are “to boost manufacturing capacities, expanded manufacturing capabilities, tech transfer, resilient supply chains, and robust regulatory frameworks”. At the high-level strategic meeting for #INB Negotiations today, I underlined Africa's #NewPublicHealthOrder priorities which are to boost manufacturing capacities, expanded manufacturing capabilities, tech transfer, resilient supply chains, and robust regulatory frameworks.… pic.twitter.com/XUoK6Oa0Ro — Jean Kaseya (@JeanKaseya2) April 27, 2024 Kaseya said member states had three options: to reject the agreement, to accept it, or to bring “strategic thinking” to the Geneva negotiations, which was “not yes or no”. Whatever happened, he urged that the continent speak with “one voice” during the “tough” upcoming negotiations. A communique released after the meeting identified Africa’s three bottom lines, which related to equity, pandemic prevention, preparedness and response (PPPR) and predictable, sustainable governing and financing. However, Africa CDC withdrew the communique a few hours later and claimed another would be following shortly . However, no replacement had been sent by late Sunday night, indicating some disagreement between parties about how to express the outcome of the meeting – not exactly an auspicious start for negotiations. One of Africa’s bottom lines has been in relation to PABS, where continental leaders have insisted that they need to be compensated for sharing information about pathogens. The current draft agreement proposes that details of a mutually beneficial PABS system – one of the biggest areas of disagreement – will only be finalised by mid-2026. However, the continent stressed its leaders were ready to engage actively in finalising the agreement. Ethiopia’s Ambassador to Geneva, Tsegab Kebebew Daka, told a recent event in Geneva that “the differences in the text are not huge”. “They are mainly differences of ideas and they’re not that many. So we can come to an agreement,” Daka, a key negotiator for the Africa group, told the event at the Geneva Graduate Institute’s Global Health Centre. While Daka acknowledged that there were still sticking points, he appealed to member states to take a “holistic view on the entire pandemic agreement” rather than dwelling on “specific articles where we have differences” – thereby endorsing the Bureau’s approach. WHO Group is ‘Very Close’ But Fails to Agree on Changes to International Health Regulations 26/04/2024 Kerry Cullinan An exhausted looking WGIHR co-chair Ashley Bloomfield reports back on the process The World Health Organization’s (WHO) working group has failed to meet its deadline of Friday (26 April) for amending the rules governing global disease outbreaks – the International Health Regulations (IHR) – and will reconvene. This emerged late afternoon on Friday (26 April) at a briefing after the week-long Working Group of Amendments to the IHR (WGIHR), when drawn co-chair Dr Ashley Bloomfield announced that the group would reconvene on 16 and 17 May for a final two days’ negotiation. “The mood in the room has been outstanding, and we have worked really hard to make amazing progress. We’re not quite cracking the bottles of champagne and sparkling grape juice, but we were getting very close and I have every sense that you are all committed to finishing the job,” said Bloomfield. WHO Deputy Director General Dr Mike Ryan commended the group, saying he was “very confident” that the IHR would be “a clearer, better instrument for your efforts, something that we can apply better on your behalf and on behalf of the people that you serve”. The WGIHR has asked member states to submit written inputs, particularly on the articles that the meeting failed to reach agreement on or did not discuss, by 6 May and it will reconvene for a further two days after that. The Articles that still need agreement relate to technology transfer, financing and governance. However, many of the WGIHR members are also part of the pandemic agreement talks, which start on Monday 29 April under the intergovernmental negotiating body (INB). The programme of work for the INB envisages 12-hour days, so there will be no space for IHR talks until after 10 May. However, the two processes are closer linked and the definitions adopted by the IHR, including all the phases that led up to the WHP Director General declaring a public health emergency of international concern (PHEIC), will be used in the pandemic agreement. The World Health Assembly, which is due to ratify the amendments, begins on 27 May, so time is very tight. The WGIHR will submit an updated proposed text to member states by 10 May. While No Human-to-Human Transmission Yet, Scientists Are Concerned About Rapid Spread of Avian Flu 26/04/2024 Zuzanna Stawiska The ongoing global spread of “bird flu” infections to mammals including humans is a significant public health concern While no cases of human-to-human transmission have been recorded in the current H5N1 avian outbreak, scientists are concerned about its transmission speed in mammals and whether this might result in a mutated pathogen that can infect people more easily. “H5N1 is (an) influenza infection, predominantly started in poultry and ducks and has spread effectively over the course of the last one or two years to become a global zoonotic – animal – pandemic,” said Dr Jeremy Farrar, the World Health Organization’s (WHO) Chief Scientist. “The great concern, of course, is that in doing so and infecting ducks and chickens – but now increasingly mammals – that that virus now evolves and develops the ability to infect humans. And then critically, the ability to go from human-to-human transmission,” Farrar told a media briefing in Geneva last week. At the WHO’s global media briefing on Wednesday, WHO epidemiologist Dr Maria Van Kerkhove that “we have not seen human-to-human transmission in the recent cases, and I think that’s really important because there’s a lot of news right now on influenza”. Spread in US dairy herds H5N1 has been detected in cattle in 33 dairy herds in eight US states, according to the latest US Centers for Disease Control and Prevention (CDC) report on 24 April. Remnants of the virus have also been detected in raw milk. US CDC described “this degree of spread outside of birds & poultry is unprecedented and concerning” and the US Department of Agriculture has restricted interstate cow transport to limit the spread of the disease. One human infection has been reported in a Texas, cattle farm worker in late March. Genomic sequencing from this patient found that each individual gene segment was “closely related to viruses detected in dairy cattle” in Texas, according to US CDC. “While minor changes were identified in the virus sequence from the patient specimen compared to the viral sequences from cattle, both cattle and human sequences maintain primarily avian genetic characteristics and, for the most part, lack changes that would make them better adapted to infect mammals,” it noted. “There are no markers known to be associated with influenza antiviral resistance found in the virus sequences from the patient’s specimen and the virus is very closely related to two existing candidate vaccine viruses that are already available to manufacturers, and which could be used to make vaccine if needed,” added. Overall, the genetic analysis “supports CDC’s conclusion that the human health risk currently remains low”. US public officials said that Tamiflu, an antiviral effective for treating influenza, is stockpiled for a potential emergency, NPR reported. Some candidate vaccines for H5N1 are also in development and there are some options for enhancing present supply. US states where H5N1 has been detected in cattle Historically, human cases of the H5N1 virus are so far very rare, with only 889 cases reported to the WHO since 2003, all involving people who came in contact with infected animals. But virus mortality reaches 52%, which is “extraordinary high”, said Farrar, who urged close monitoring and investigation of the outbreaks in US cattle by public health authorities “because it may evolve into transmitting in different ways”. “Do the milking structures of cows create aerosols? Is it the environment which they’re living in? Is it the transport system that is spreading this around the country?” he asked. “This is a huge concern and I think we have to … make sure that if H5N1 did come across to humans with human-to-human transmission that we were in a position to immediately respond with access equitably to vaccines, therapeutics and diagnostics.” Different strains, different severity Though avian influenza viruses naturally occur in wild water birds, some variants are also known to develop the ability to infect other animals. The virus has multiple variants of differing severity and transmission possibilities. A case of human infection with the much milder strain of avian influenza virus (H9N2) was confirmed in Viet Nam on 9 April by the International Health Regulations (IHR) National Focal Point, as WHO reported. The same virus strain was also detected in three patients in China,according to the Centre for Health Protection of Hong Kong. H9N2 usually results in mild infections of the upper respiratory tract, mostly affecting children. It is a low pathogenic avian influenza, usually showing only mild disease in chickens and other poultry, according to the US CDC. Systems in place to respond Maria van Kerkhove “We are concerned about this particular virus because we know influenza has the potential to cause epidemics,” said Van Kerkhove. “That’s why we have a global system in place to monitor detect, to rapidly do risk assessments to look at viruses that could potentially be used in vaccines as we go forward.” However, she expressed confidence that risks of an outbreak in human populations remain low and that existing WHO surveillance systems competent to monitor any developments. ”We have a global influenza surveillance and response system that’s been in place for 70 years. And within this systems, there are strong surveillance components, made up of labs around the world, made up of many partner agencies,” she assured the media briefing. Dr Michael Ryan, WHO’s Executive Director of the Health Emergencies Programme, backed Van Kerkhove: “We have a system that can measure and we have countermeasures ready to go should anything happen and that’s all we can do in public health.” “We can’t stop living because viruses threaten us. What we can do is be ready to respond,” he said,. The Pandemic Influenza Preparedness Framework “has been in place again for 20 years and has provided a framework for collaboration between WHO labs and industry for the sharing of material, for the sharing of vaccines”, added Ryan. Image Credits: Charlotte Kesl/ World Bank. ILO: Excessive Heat Linked to Climate Change Affects 70% of Workers 26/04/2024 Disha Shetty Outdoor workers are at a high potential health risk as climate change worsens heat. Over 70% of the world’s workforce faces potential health risks due to climate change, according to the latest report by the International Labour Organization (ILO) released earlier this week. Nearly 1.6 billion outdoor workers are also at risk from high levels of air pollution. “More than 70% of our workers are exposed to excessive heat at least one point in their working lives. That’s 2.4 billion workers globally out of a global workforce of 3.4 billion,” said Manal Azzi, Senior Specialist on Occupational Safety and Health (ILO) at the report launch at the United Nations in Geneva. The report, Ensuring safety and health at work in a changing climate, states that climate change is already having a serious impact on the safety and health of workers in all regions of the world. The share of global workers impacted by climate change hazards has increased by about from 65% in 2020 to 70% in 2024, the report said. Workers in the world’s most impoverished regions face heightened risks from scorching heatwaves, prolonged droughts, raging wildfires, and devastating hurricanes, according to the ILO. Did you know? 🌍🔥 Over 2.4 billion workers face excessive heat due to #ClimateChange. ⏳It's a race against time for safety and health. Learn more at our global event tomorrow: https://t.co/i3SlGiyisO#SafeDay2024 pic.twitter.com/LnofX5hKif — International Labour Organization (@ilo) April 24, 2024 Range of climate-linked health risks The report notes that numerous health conditions in workers have been linked to climate change, including cancer, cardiovascular disease, respiratory illnesses, kidney dysfunction and mental health conditions. The impact includes the 1.6 billion workers exposed to UV radiation, with more than 18,960 work-related deaths annually from non-melanoma skin cancer. “More than 22 million workers are suffering from sicknesses and injuries related to exposure to excessive heat and these can range from injuries in transport, in traffic accidents due to bad night of sleep because it was excessively hot, to construction accidents, injuries, slips and falls related to the exposure to heat,” Azzi said. Many deaths are also directly related to the impact of climate change. “Nearly 20,000 workers are dying yearly because of these injuries in the workplace related to rising temperatures and to exposure to excessive heat, indoor and outdoor heat, and losing millions – over two million disability-adjusted years – are lost because of injuries and deaths related to heat,” said Azzi, who is the ILO’s specialist on occupational safety and health. A traditional brick factory in Tozeur, southern Tunisia. In Africa and South Asia brick making and waste burning are major sources of air pollution. High levels of air pollution causing harm The report also said that nearly 1.6 billion outdoor workers are at risk of health impacts due to worsening air pollution, particularly those working in the transport sector and firefighters. Around 860,000 work-related deaths have been attributed to air pollution for outdoor workers annually. The report noted that modified weather patterns due to climate change have influenced levels of outdoor air pollutants, such as ground-level ozone, fine (PM2.5) and course (PM10) particulate matter, nitrogen dioxide (NO2), and sulphur dioxide (SO2). Rise in vector-borne diseases With increasing temperatures and higher humidity, more pesticides are also being used in the agriculture sector. According to the report, there are more than 870 million workers in agriculture that are likely to be exposed to pesticides, with more than 300,000 deaths attributed to pesticide poisoning annually. Azzi notes that “15,000 people die due to parasitic and vector-borne diseases exposed to in the workplace”. “Obviously, these include a lot of diseases like dengue, rabies and various diseases that are increasing in regions that we never used to see them before. Malaria has even increased and we’re seeing it’s shown in countries that it never used to be before.” The ILO has planned a meeting in 2025 with government, employer and worker representatives to provide policy guidance on climate hazards. Image Credits: Unsplash, WHO/Diego Rodriguez. Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan HIV medicine dolutegravir. The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of the World Health Organization (WHO). Dolutegravir has fewer side effects and a lower risk of developing resistance. UNAIDS has described the move as an “important breakthrough in public health measures” that breaks “the monopoly”, and could mean that the price of the life-saving medicine is reduced by as much as 80%. “When the power to produce health technologies is held by a few companies, the result all too often is that countries can’t afford the high prices and people who need newer products cannot access them,” said Luisa Cabal, UNAIDS Regional Director for Latin America and the Caribbean. “This decision provides the government with the legal conditions to manufacture or purchase more affordable versions of this essential first-line antiretroviral treatment for all people living with HIV in Colombia, including Venezuelan migrants”, said Ms Cabal. “We are confident that this decision will have an impact across the whole region and beyond, as many middle-income countries are struggling to access generic markets of key health products to prevent and treat HIV infection.” Prohibitive costs This move has also been welcomed by Médecins Sans Frontières (MSF), Public Citizen and Global Humanitarian Progress Corporation Colombia. ⚡️⚡️⚡️Breaking News: Colombia issues its first compulsory license (CL) for the HIV drug dolutegravir bringing the price down from US$1,224 per patient per year by ViiV to $44 through generics. This proves the power of generic competition!!! https://t.co/yPSpAFzJyJ — Shailly Gupta (@Shaillytweeting) April 25, 2024 “Colombia’s decision to issue a compulsory license for dolutegravir is great news because, until now, we have not been able to introduce dolutegravir in our medical operations, as the costs have been prohibitive,” said Dr Carmenza Gálvez, MSF’s medical coordinator for Colombia and Panama. Although generic versions of dolutegravir are available internationally for a fraction of ViiV’s price through voluntary licenses with the Medicines Patent Pool (MPP), ViiV excluded Colombia and many middle-income countries from being able to benefit from its license with MPP, allowing ViiV to maintain its monopoly and continue to charge high prices in Colombia and other countries excluded from the license. The Global Fund buys generic dolutegravir for $22.80 per patient per year, while Pan-American Health Organization (PAHO) can procure it for $44 – but Colombia cannot access these prices. According to the Colombian government, the estimated cost of dolutegravir sold by ViiV under the brand name, Tivicay, is around $1,224 per patient per year in 2023. If Colombia can procure the generics for $44, it will be able to treat 27 people for what it is paying for one person at present. According to UNAIDS, Colombia hosts the largest number of Venezuelan migrants in the world (2.9 million as of October 2022), and “recent studies have shown a 0.9% HIV prevalence among this migrant population, almost double the 0.5% HIV prevalence among the country’s adult population”. Compulsory licensing is a provision in the World Trade Organization (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement). It enables governments to supply its citizens with generic versions of patented treatments either through domestic production or imports, ensuring health products’ prices are affordable. The 2001 WTO Declaration on the TRIPS agreement and public health reaffirmed the rights of member states to make use of all flexibilities in the TRIPS agreement to protect public health, including compulsory licenses. More recently, in the 2021 Political Declaration on HIV/AIDS, countries committed to make use of TRIPS flexibilities, specifically geared to promoting access to medicines. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Slow Progress at UN Plastic Pollution Talks as Countries Clash Over Production Limits 30/04/2024 Kerry Cullinan On the final day of INC-4, delegates held talks until the early hours of the morning trying to find a way forward The fourth session of the UN intergovernmental negotiating committee (INC) to develop an international legally binding instrument on plastic pollution ended in Ottawa on Tuesday with “an advanced draft text of the instrument and agreement on inter-sessional work ahead”, according to the UN Environment Programme (UNEP). Delegates engaged in text-based discussion on the revised draft for the first time, but there were major sticking points – especially on limiting plastic production. The European Union (EU) proposed extending the meeting but delegates failed to agree on the proposal, according to the Earth Negotiation Bulletin. The #INC4 session in Ottawa has wrapped, setting a clear path to an ambitious #PlasticsTreaty. With progress on negotiations & future intersessional work agreed, strides are being made towards a legally binding agreement to #BeatPlasticPollution. 🔗See: https://t.co/w1VKGBbvnj pic.twitter.com/Wz1YJmea3T — UN Environment Programme (@UNEP) April 30, 2024 Other issues on the table related to emissions and releases; product design; waste management; problematic and avoidable plastics; financing, and a just transition. The INC members agreement to hold inter-sessional work – expert meetings between the official INC sessions – to work on “convergence on key issues” ahead of the next negotiating session, INC5, will take place in Busan, Korea, in November. The inter-sessional groups will look at financing to achieve the objectives of the instrument and approaches to address plastic pollution and chemicals of concern in plastic products and product design, focusing on products that can be recycled and reused. Long road to agreement INC5 is supposed to adopt an agreement, but there is still a long road ahead as “meetings to discuss the technical elements of the text diverged on almost all points of discussion, from problematic and avoidable plastics to product design, composition and performance,” according to the Earth Negotiation Bulletin.. “We came to Ottawa to advance the text and with the hope that members would agree on the intersessional work required to make even greater progress ahead of INC-5. We leave Ottawa having achieved both goals and a clear path to landing an ambitious deal in Busan ahead of us,” said Inger Andersen, UNEP executive director. “The work, however, is far from over. The plastic pollution crisis continues to engulf the world and we have just a few months left before the end of year deadline agreed upon in 2022. I urge members to show continued commitment and flexibility to achieve maximum ambition.” However, several NGOs that attending as observers were unhappy with the influence of member states with significant fossil fuel industries. Most plastics are made from oil and gas derivatives. “Despite hearing people from polluted communities around the world give sensible proposals to curb the lifecycle harms of plastics, fossil fuel and petrochemical interests are still shamelessly blocking progress and focusing on utterly inadequate plastic waste management,” said Julie Teel Simmonds, a senior attorney at the Center for Biological Diversity (CBD). While Rwanda and Peru, part of the high-ambition coalition, proposed production reductions, a coalition of fossil fuel–aligned countries, including Russia, China, and Saudi Arabia, objected to treaty measures to address plastic production, according to the CBD. Not ‘if ‘but ‘how’ “Canada is committed to reaching a final agreement at INC-5 in the Republic of Korea before year end. We are no longer talking about ‘if’ we can get there, but ‘how.’ Together we can land one of the most significant environmental decisions since the Paris Agreement and the Kunming Montreal Global Biodiversity Framework,” said Steven Guilbeault, Canada’s Minister of Environment and Climate Change, who hosted INC4. “We are doing everything we can to raise the international profile of the plastic pollution crisis so that the agreement gets the global attention it deserves to cross the finish line.” INC chairperson Ambassador Luis Vayas said that “some common ground” had been found and “I firmly believe that we can carry this same spirit forth to Busan to deliver on our mandate.” Delegates accepted Vayas’ proposal for a legal drafting group to ensure legal clarity in the text of the future agreement. Jyoti Mathur-Filipp, executive secretary of the INC secretariat, said that “compromise and commitment remains strong at this advanced stage of the negotiations”. “Members should arrive in Busan ready to deliver on their mandate and agree a final text of the instrument. This is more than a process – it is the fulfilment of your commitment to saving future generations from the global scourge of plastic pollution.” Image Credits: Kiara Worth/IISD. More African Countries Roll Out Malaria Vaccine, While Babies Get New Treatment Formulation 30/04/2024 Zuzanna Stawiska A rollout of malaria vaccine in Western African countries with a special focus on immunising children is an important step towards eliminating the disease Rollout of malaria vaccines are starting in Benin, Sierra Leone and Liberia, and the West African countries plan to deliver more than 800 000 doses of the RTS,S or R21 vaccines, according to WHO. The new vaccine will be added to their immunisation programmes for children, and are expected to protect over 200,000 children from the life-threatening disease. The RTS.S vaccine can be administered to children as young as five months old. In another promising development against malaria, a new formulation of a malaria treatment, Coartem, has proven to be safe and efficacious for babies under five kilograms, a previously overlooked group of patients. Pharmaceutical company Novartis and Medicines for Malaria Venture (MMV), a leading product development partnership, announced that their product has good efficacy and safety and is appropriate for babies in the wake of the successful CALINA study. The trial data have been submitted for regulatory review, they informed during the Multilateral Initiative on Malaria conference. “Infants below five kilograms make up a critical neglected group, and developing antimalarials specifically suited to their needs is essential to malaria control efforts,” said Wiweka Kaszubska, MMV vice president. The new formulation, known as Coartem <5 kg Baby, uses a new ratio and dose of artemether-lumefantrine to account for metabolic differences in babies under 5kg to minimise the risk of overdose and toxicity. “Infants under five kg can be affected by placental malaria, leading to poor birth outcomes, or contract malaria from the bite of an infected mosquito. The prevalence of the disease in this age and weight group is poorly understood, and it is therefore often misdiagnosed,” according to a company media release. Current antimalarials have not been developed small babies, who are usually treated with tablets meant for children above 5 kg adjusted by weight – yet, these tiny patients handle drugs differently due to the immaturity of their metabolising organs. Decreasing the burden Malaria is a life-threatening infectious disease with an estimated 249 million cases and 608 000 deaths in 2022, according to the World Malaria Report 2023. It is present in 85 countries, with 95% of cases in the African region. Most of the fatalities in the region – four out of five – are children under the age of five. “With the new, safe and efficacious malaria vaccine, we now have an additional tool to fight this disease. In combination with insecticide-treated nets, effective diagnosis and treatment, and indoor spraying, no child should die from malaria infection,” said Dr Austin Demby, the Minister of Health of Sierra Leone. The emerging interventions will likely decrease the burden of malaria substantially. In the recent years, (2019-2023), a pilot malaria vaccine programme in Ghana, Kenya and Malawi reached over two million children, showing a significant reduction in malaria illness. It also reached a 13% drop in overall child mortality and a reduction in hospitalisations. Benin, Liberia and Sierra Leone joined five other African countries that have already implemented the rollout of the newly developed malaria vaccines. Image Credits: WHO. Africa Wants Debt Swaps to Support Countries’ Defences Against Pandemics 29/04/2024 Kerry Cullinan African leaders who attended at the high level meeting in Addis Ababa on Saturday. African leaders want “explicit commitments” to debt relief and debt restructuring mechanisms, including debt swaps to support country-level pandemic prevention, preparedness and response (PPPR) in the pandemic agreement. This is one of the continent’s demands, made on the eve of the World Health Organization’s (WHO) pandemic agreement talks, following a high-level meeting of African health ministers and diplomats on Saturday. At the meeting, a key African Union (AU) leader warned against postponing the adoption of a pandemic agreement, saying it might never be passed. The pandemic agreement negotiations entered their final two-week phase in Geneva on Monday with 10 May as the deadline for what observers are describing as an “instrument of essentials” – a basic text that will be fleshed out by further talks in the next couple of years, as reported recently by Health Policy Watch. The first communique from the African leaders’ Saturday meeting was withdrawn a few hours after its release. The new statement released on Monday was identical except it removed a reference to the Pandemic Fund in its call for “an international financing mechanism” to support countries’ pandemic-proofing efforts. It also wants the accelerated “operationalisation of the financing of the African Epidemic Fund”. Support for PABS The continent supports a “multilateral pathogen access and benefit sharing system (PABS)” that provides legal certainty to users and providers and ensures improved access to pandemic-related health products and technologies. The draft agreement proposes a WHO-coordinated PABS system but for the operational details of this contested proposal are to be finalised by May 2026. Africa also wants “measures to establish regionally-distributed production of pandemic-related health products” and “commitments to organise and resource technical support” on all equity-related provisions. Pandemic prevention, preparedness, and response (PPPR) demands relate largely to national and regional responsibilities, with measures such as the enactment of “domestic laws providing for broad exemptions and limitations to intellectual property to address public health emergencies”, and supply chain diversification and logistics streamlining throughout the continent. Africa also wants the various WHO-coordinated mechanisms in the agreement – such as on research and development and technology transfer – to be operationalised and accountable to the Conference of Parties, a multi-country structure which is set to govern the agreement. “Africa stands ready to play its part and comments to engage actively in the ongoing negotiations and finalisation of the draft pandemic agreement,” the statement concludes. AU warns against postponement “I don’t think postponing an agreement is going to be in our interest because we may postpone forever. I look forward to us consolidating our common position today, consolidating our negotiating positions and ensuring that Africa’s interests are represented in the global pandemic agreement negotiations,” said AU deputy chairperson, Dr Monique Nsanzabaganwa, during the opening of the ministerial meeting. AU deputy chairperson Dr Monique Nsanzabaganwa warns against delaying the agreement. She also urged pragmatism when addressing the meeting on Saturday, explaining that several African demands – such as a seat at the G20 – had taken years to achieve. “In some situations, we don’t have even a choice because we need to continue being pragmatic as we look for all conditions that can allow us some equity and some flexibilities and conducive conditions for us to do what we’ll have to do for ourselves,” she said. She also warned of the likelihood of another COVID-like pandemic in the not so distant future, adding that it is “crucial that we work together to strengthen our collective preparedness and ensure that Africa’s voice is heard in global health discussions”. While Africa’s negotiators wanted a win-win situation, in negotiations “there is always give and take”, said Nsanzabaganwa, who hails from Rwanda. “We have also the duty to continue pressing for multilateralism to work.” Meanwhile, Zambia’s health minister, Sylvia Masebo, who chairs the Africa CDC board, called on the African negotiators to ensure “equitable access to pandemic-related health products” and “increased access to vaccines, diagnostics and therapeutics, ensuring that no one is left behind”. Africa CDC Director-General Dr Jean Kaseya said that unity and a common African position in the negotiations was key. Food Insecurity Affects 282 Million People in 2023 29/04/2024 Disha Shetty Food insecurity increased in 2023 due to a combination of conflicts, economic shocks and extreme weather events. In 2023, nearly 282 million people – 21.5% of the analysed population across 59 countries and territories – faced high levels of acute food insecurity, according to the Global Report on Food Crises (GRFC) 2024. This is 24 million more people than 2022. The rise was due to the report’s increased coverage of food crisis contexts and a sharp deterioration in food security, especially Gaza and Sudan. “The Gaza Strip became the most severe food crisis in our reporting history. Conflict and insecurity, along with extreme weather, events and economic shocks, are the key drivers of food insecurity and nutrition crisis,” said Dominique Burgeon, Director of the Food and Agriculture Organization (FAO) Liaison Office in Geneva. The current situation in the Gaza Strip accounts for 80% of those facing imminent famine, along with South Sudan, Burkina Faso, Somalia and Mali. For four consecutive years, the proportion of people facing acute food insecurity has remained persistently high at almost 22% of those assessed, significantly exceeding pre-COVID-19 levels. “This crisis demands an urgent response. Using the data in this report to transform food systems and address the underlying causes of food insecurity and malnutrition will be vital,” said António Guterres, UN Secretary-General. Number of people facing high levels of acute food insecurity in 59 countries and territories in 2023.(GRFC 2024) The report brings focuses on the enormity of the challenge of achieving the end of hunger by 2030 – a key UN Sustainable Development Goal. Improvements in food security in some countries was outweighed by deteriorating conditions in others. Over 26 million people are one step away from famine, while the total population in catastrophe was “more than four times higher than in 2016,” said Burgeon.The report was produced by the Global Network Against Food Crises (GNAFC), a multi-stakeholder initiative that is working to address the food crises. Protracted hunger Acute malnutrition worsened in 2023, particularly among people displaced because of conflict and disasters. Children and women are at the forefront of these hunger crises, with over 36 million children under five years of age acutely malnourished across 32 countries, the report showed. “The report also tells us that 60% of children experiencing acute malnutrition live in the ten countries facing the highest level of acute food insecurity,” said Burgeon of FAO. Thirty six countries have consistently featured in the GRFC analyses since 2016, reflecting continuing years of acute hunger, and currently representing 80% of the world’s most hungry. One million people more people face emergency levels of acute food insecurity across 39 countries and territories. In 2023, more than 705,000 people were at the catastrophe level of food insecurity and at risk of starvation – the highest number in the GRFC’s reporting history and up fourfold since 2016. The share of the analysed population facing high levels of acute food insecurity increased sharply from 14 percent in 2018 to more than 20 percent each year since 2020. Key drivers: Conflicts and extreme weather Conflict remained the primary driver of hunger, affecting 20 countries and forcing 135 million people into acute food insecurity – almost half of the global number. Sudan faced the largest deterioration due to conflict, with 8.6 million more people facing high levels of acute food insecurity as compared with 2022. “Sudan is a major concern for, the nutrition component because primarily of the major caseload, the number of people is staggering and also for the difficulty of reaching these people. In many areas, there is impossible access and or inconsistent access,” said Stefano Fedele, Global Nutrition Cluster Coordinator for UNICEF Geneva. Extreme weather events were the primary drivers in 18 countries where over 77 million people faced high levels of acute food insecurity, up from 12 countries with 57 million people in 2022. The impacts of economic shocks affected 21 countries where around 75 million people were facing high levels of acute food insecurity, due to their high dependency on imported food and agricultural inputs, persisting macroeconomic challenges, including currency depreciation, high prices and high debt levels. The drivers of food insecurity are interlinked and mutually reinforcing Breaking the cycle Tackling persistent food crises requires urgent long-term national and international investment to transform food systems and boost agricultural and rural development, according to the report. It also advocates for peace and prevention of conflict to become an integral part of the longer-term food systems transformation. Since 2023, needs have outpaced available resources and many humanitarian operations now overstretched, with many being forced to scale-down and further cut support to the most vulnerable. “This is truly a global challenge. There are far too many people waking up in the morning not knowing where their next meal will come from, not knowing how to feed their children, and having to make really truly impossible decisions throughout the course of their day to ensure that their most fundamental needs are being met,” said Courtney Blake, Senior Humanitarian Advisor for the US Mission in Geneva. Image Credits: Unsplash, Global Report on Food Security 2024. Final Pandemic Agreement Talks Start Amid Gamble on Process and African Show of Unity 28/04/2024 Kerry Cullinan The Africa CDC convened a high-level meeting in Addis Ababa on Saturday to discuss the continent’s position on the draft pandemic agreement. The World Health Organization’s (WHO) pandemic agreement negotiations begin their final two-week stretch on Monday (28 April) amid a gamble with the process, a show of unity from African member states – and more suggestions for the draft text. This final intergovernmental negotiating body (INB) meeting will focus on finding “common ground and consensus”, according to a decision taken at the last fractious meeting. The programme of work sets down 12-hour days, with the first week (29 April-3 May) focusing on finalising the substantive negotiations on the draft text. A “stock take” of progress will be held on Friday 3 May, and the second week (6-10 May) will look at outstanding articles, along with the draft resolution for the World Health Assembly at the end of May. The INB Bureau has also undertaken to provide daily briefing to relevant stakeholders on progress. ‘Take it or leave it’ After the previous session at which member states expressed frustration with one another and the INB Bureau, the INB co-chairs have taken a gamble with the process this time – and member states may not play along. The multitude of bracketed contested text has been purged from the new draft, and the co-chairs want the meeting to focus on saying “yes”, rather than being bogged down by disagreements. The meeting will go through the 23-page draft paragraph by paragraph, and member states that don’t agree with the text will be invited to have informal sessions, the co-chairs told a recent stakeholder briefing. But the draft will be considered as the default text where there is no consensus, which the co-chairs described as a “take it or leave it” approach. “The Bureau is of the opinion that the text as presented in the proposal for a WHO Pandemic Agreement is consensus ready,” it explained in a briefing document sent to stakeholders on Friday (26 April). “It was drafted on the basis of our many rounds of negotiations. The co-chairs will open the different articles and will ask the member states if the article is ready for approval. If not, delegations will be invited to explain what their issue with the article is. “Where possible the co-chairs will immediately propose a way forward. If the issue at hand is more fundamental, either a small informal meeting between a few member states can be proposed, or – if more member states want to be involved – a working group session can be proposed.” These working groups would be led by a member of the Bureau and the plan would be found them to return to the drafting group with a solution. At the recent stakeholder briefing, the European Union indicated that not all the text was consensus-based while Bangladesh, a key player in the Group of Equity negotiating bloc, criticised the approach of grabbing “low-hanging fruit for the sake of consensus”. 🇧🇩Bangladesh doubted finishing by May 2024, criticized agreeing to “low-hanging fruit for the sake of consensus,” proposed one IGWG on all remaining topics (not separate), and opposed parallel discussions during #INB9. 🇬🇧The UK asked about civil society engagement (thank you!). pic.twitter.com/TXcGsFnCkl — Nina Schwalbe (@nschwalbe) April 19, 2024 Africa asserts unity Meanwhile, African leaders urged continental unity and pragmatism at a high-level meeting on the pandemic negotiations convened on Saturday by the Africa Centre for Disease Control and Prevention (Africa CDC). Dr Monique Nsanzabaganwa, Deputy Chairperson of the African Union, urged pragmatism and realism at the meeting, attended by health ministers, diplomats and UN agency officials. Dr Monique Nsanzabaganwa, Deputy Chairperson of the African Union “At the time of COVID, multilateralism collapsed completely and then Africa was shut [out of] accessing all the things we needed at the time, the PPE and the vaccines,” she said, adding that the pandemic negotiations were an attempt to revive multilateralism. “In some situations, we don’t have a choice because we need to continue being pragmatic as we look for all conditions that can allow us some equity and some flexibilities and conducive conditions for us to do what we’ll have to do for ourselves,” she added. Africa CDC Director General Dr Jean Kaseya told the meeting, which was also briefed by INB co-chair Precious Matsoso, that “what matters most is for the continent to speak with one voice”. He stressed that Africa’s priorities, as contained in its New Public Order, are “to boost manufacturing capacities, expanded manufacturing capabilities, tech transfer, resilient supply chains, and robust regulatory frameworks”. At the high-level strategic meeting for #INB Negotiations today, I underlined Africa's #NewPublicHealthOrder priorities which are to boost manufacturing capacities, expanded manufacturing capabilities, tech transfer, resilient supply chains, and robust regulatory frameworks.… pic.twitter.com/XUoK6Oa0Ro — Jean Kaseya (@JeanKaseya2) April 27, 2024 Kaseya said member states had three options: to reject the agreement, to accept it, or to bring “strategic thinking” to the Geneva negotiations, which was “not yes or no”. Whatever happened, he urged that the continent speak with “one voice” during the “tough” upcoming negotiations. A communique released after the meeting identified Africa’s three bottom lines, which related to equity, pandemic prevention, preparedness and response (PPPR) and predictable, sustainable governing and financing. However, Africa CDC withdrew the communique a few hours later and claimed another would be following shortly . However, no replacement had been sent by late Sunday night, indicating some disagreement between parties about how to express the outcome of the meeting – not exactly an auspicious start for negotiations. One of Africa’s bottom lines has been in relation to PABS, where continental leaders have insisted that they need to be compensated for sharing information about pathogens. The current draft agreement proposes that details of a mutually beneficial PABS system – one of the biggest areas of disagreement – will only be finalised by mid-2026. However, the continent stressed its leaders were ready to engage actively in finalising the agreement. Ethiopia’s Ambassador to Geneva, Tsegab Kebebew Daka, told a recent event in Geneva that “the differences in the text are not huge”. “They are mainly differences of ideas and they’re not that many. So we can come to an agreement,” Daka, a key negotiator for the Africa group, told the event at the Geneva Graduate Institute’s Global Health Centre. While Daka acknowledged that there were still sticking points, he appealed to member states to take a “holistic view on the entire pandemic agreement” rather than dwelling on “specific articles where we have differences” – thereby endorsing the Bureau’s approach. WHO Group is ‘Very Close’ But Fails to Agree on Changes to International Health Regulations 26/04/2024 Kerry Cullinan An exhausted looking WGIHR co-chair Ashley Bloomfield reports back on the process The World Health Organization’s (WHO) working group has failed to meet its deadline of Friday (26 April) for amending the rules governing global disease outbreaks – the International Health Regulations (IHR) – and will reconvene. This emerged late afternoon on Friday (26 April) at a briefing after the week-long Working Group of Amendments to the IHR (WGIHR), when drawn co-chair Dr Ashley Bloomfield announced that the group would reconvene on 16 and 17 May for a final two days’ negotiation. “The mood in the room has been outstanding, and we have worked really hard to make amazing progress. We’re not quite cracking the bottles of champagne and sparkling grape juice, but we were getting very close and I have every sense that you are all committed to finishing the job,” said Bloomfield. WHO Deputy Director General Dr Mike Ryan commended the group, saying he was “very confident” that the IHR would be “a clearer, better instrument for your efforts, something that we can apply better on your behalf and on behalf of the people that you serve”. The WGIHR has asked member states to submit written inputs, particularly on the articles that the meeting failed to reach agreement on or did not discuss, by 6 May and it will reconvene for a further two days after that. The Articles that still need agreement relate to technology transfer, financing and governance. However, many of the WGIHR members are also part of the pandemic agreement talks, which start on Monday 29 April under the intergovernmental negotiating body (INB). The programme of work for the INB envisages 12-hour days, so there will be no space for IHR talks until after 10 May. However, the two processes are closer linked and the definitions adopted by the IHR, including all the phases that led up to the WHP Director General declaring a public health emergency of international concern (PHEIC), will be used in the pandemic agreement. The World Health Assembly, which is due to ratify the amendments, begins on 27 May, so time is very tight. The WGIHR will submit an updated proposed text to member states by 10 May. While No Human-to-Human Transmission Yet, Scientists Are Concerned About Rapid Spread of Avian Flu 26/04/2024 Zuzanna Stawiska The ongoing global spread of “bird flu” infections to mammals including humans is a significant public health concern While no cases of human-to-human transmission have been recorded in the current H5N1 avian outbreak, scientists are concerned about its transmission speed in mammals and whether this might result in a mutated pathogen that can infect people more easily. “H5N1 is (an) influenza infection, predominantly started in poultry and ducks and has spread effectively over the course of the last one or two years to become a global zoonotic – animal – pandemic,” said Dr Jeremy Farrar, the World Health Organization’s (WHO) Chief Scientist. “The great concern, of course, is that in doing so and infecting ducks and chickens – but now increasingly mammals – that that virus now evolves and develops the ability to infect humans. And then critically, the ability to go from human-to-human transmission,” Farrar told a media briefing in Geneva last week. At the WHO’s global media briefing on Wednesday, WHO epidemiologist Dr Maria Van Kerkhove that “we have not seen human-to-human transmission in the recent cases, and I think that’s really important because there’s a lot of news right now on influenza”. Spread in US dairy herds H5N1 has been detected in cattle in 33 dairy herds in eight US states, according to the latest US Centers for Disease Control and Prevention (CDC) report on 24 April. Remnants of the virus have also been detected in raw milk. US CDC described “this degree of spread outside of birds & poultry is unprecedented and concerning” and the US Department of Agriculture has restricted interstate cow transport to limit the spread of the disease. One human infection has been reported in a Texas, cattle farm worker in late March. Genomic sequencing from this patient found that each individual gene segment was “closely related to viruses detected in dairy cattle” in Texas, according to US CDC. “While minor changes were identified in the virus sequence from the patient specimen compared to the viral sequences from cattle, both cattle and human sequences maintain primarily avian genetic characteristics and, for the most part, lack changes that would make them better adapted to infect mammals,” it noted. “There are no markers known to be associated with influenza antiviral resistance found in the virus sequences from the patient’s specimen and the virus is very closely related to two existing candidate vaccine viruses that are already available to manufacturers, and which could be used to make vaccine if needed,” added. Overall, the genetic analysis “supports CDC’s conclusion that the human health risk currently remains low”. US public officials said that Tamiflu, an antiviral effective for treating influenza, is stockpiled for a potential emergency, NPR reported. Some candidate vaccines for H5N1 are also in development and there are some options for enhancing present supply. US states where H5N1 has been detected in cattle Historically, human cases of the H5N1 virus are so far very rare, with only 889 cases reported to the WHO since 2003, all involving people who came in contact with infected animals. But virus mortality reaches 52%, which is “extraordinary high”, said Farrar, who urged close monitoring and investigation of the outbreaks in US cattle by public health authorities “because it may evolve into transmitting in different ways”. “Do the milking structures of cows create aerosols? Is it the environment which they’re living in? Is it the transport system that is spreading this around the country?” he asked. “This is a huge concern and I think we have to … make sure that if H5N1 did come across to humans with human-to-human transmission that we were in a position to immediately respond with access equitably to vaccines, therapeutics and diagnostics.” Different strains, different severity Though avian influenza viruses naturally occur in wild water birds, some variants are also known to develop the ability to infect other animals. The virus has multiple variants of differing severity and transmission possibilities. A case of human infection with the much milder strain of avian influenza virus (H9N2) was confirmed in Viet Nam on 9 April by the International Health Regulations (IHR) National Focal Point, as WHO reported. The same virus strain was also detected in three patients in China,according to the Centre for Health Protection of Hong Kong. H9N2 usually results in mild infections of the upper respiratory tract, mostly affecting children. It is a low pathogenic avian influenza, usually showing only mild disease in chickens and other poultry, according to the US CDC. Systems in place to respond Maria van Kerkhove “We are concerned about this particular virus because we know influenza has the potential to cause epidemics,” said Van Kerkhove. “That’s why we have a global system in place to monitor detect, to rapidly do risk assessments to look at viruses that could potentially be used in vaccines as we go forward.” However, she expressed confidence that risks of an outbreak in human populations remain low and that existing WHO surveillance systems competent to monitor any developments. ”We have a global influenza surveillance and response system that’s been in place for 70 years. And within this systems, there are strong surveillance components, made up of labs around the world, made up of many partner agencies,” she assured the media briefing. Dr Michael Ryan, WHO’s Executive Director of the Health Emergencies Programme, backed Van Kerkhove: “We have a system that can measure and we have countermeasures ready to go should anything happen and that’s all we can do in public health.” “We can’t stop living because viruses threaten us. What we can do is be ready to respond,” he said,. The Pandemic Influenza Preparedness Framework “has been in place again for 20 years and has provided a framework for collaboration between WHO labs and industry for the sharing of material, for the sharing of vaccines”, added Ryan. Image Credits: Charlotte Kesl/ World Bank. ILO: Excessive Heat Linked to Climate Change Affects 70% of Workers 26/04/2024 Disha Shetty Outdoor workers are at a high potential health risk as climate change worsens heat. Over 70% of the world’s workforce faces potential health risks due to climate change, according to the latest report by the International Labour Organization (ILO) released earlier this week. Nearly 1.6 billion outdoor workers are also at risk from high levels of air pollution. “More than 70% of our workers are exposed to excessive heat at least one point in their working lives. That’s 2.4 billion workers globally out of a global workforce of 3.4 billion,” said Manal Azzi, Senior Specialist on Occupational Safety and Health (ILO) at the report launch at the United Nations in Geneva. The report, Ensuring safety and health at work in a changing climate, states that climate change is already having a serious impact on the safety and health of workers in all regions of the world. The share of global workers impacted by climate change hazards has increased by about from 65% in 2020 to 70% in 2024, the report said. Workers in the world’s most impoverished regions face heightened risks from scorching heatwaves, prolonged droughts, raging wildfires, and devastating hurricanes, according to the ILO. Did you know? 🌍🔥 Over 2.4 billion workers face excessive heat due to #ClimateChange. ⏳It's a race against time for safety and health. Learn more at our global event tomorrow: https://t.co/i3SlGiyisO#SafeDay2024 pic.twitter.com/LnofX5hKif — International Labour Organization (@ilo) April 24, 2024 Range of climate-linked health risks The report notes that numerous health conditions in workers have been linked to climate change, including cancer, cardiovascular disease, respiratory illnesses, kidney dysfunction and mental health conditions. The impact includes the 1.6 billion workers exposed to UV radiation, with more than 18,960 work-related deaths annually from non-melanoma skin cancer. “More than 22 million workers are suffering from sicknesses and injuries related to exposure to excessive heat and these can range from injuries in transport, in traffic accidents due to bad night of sleep because it was excessively hot, to construction accidents, injuries, slips and falls related to the exposure to heat,” Azzi said. Many deaths are also directly related to the impact of climate change. “Nearly 20,000 workers are dying yearly because of these injuries in the workplace related to rising temperatures and to exposure to excessive heat, indoor and outdoor heat, and losing millions – over two million disability-adjusted years – are lost because of injuries and deaths related to heat,” said Azzi, who is the ILO’s specialist on occupational safety and health. A traditional brick factory in Tozeur, southern Tunisia. In Africa and South Asia brick making and waste burning are major sources of air pollution. High levels of air pollution causing harm The report also said that nearly 1.6 billion outdoor workers are at risk of health impacts due to worsening air pollution, particularly those working in the transport sector and firefighters. Around 860,000 work-related deaths have been attributed to air pollution for outdoor workers annually. The report noted that modified weather patterns due to climate change have influenced levels of outdoor air pollutants, such as ground-level ozone, fine (PM2.5) and course (PM10) particulate matter, nitrogen dioxide (NO2), and sulphur dioxide (SO2). Rise in vector-borne diseases With increasing temperatures and higher humidity, more pesticides are also being used in the agriculture sector. According to the report, there are more than 870 million workers in agriculture that are likely to be exposed to pesticides, with more than 300,000 deaths attributed to pesticide poisoning annually. Azzi notes that “15,000 people die due to parasitic and vector-borne diseases exposed to in the workplace”. “Obviously, these include a lot of diseases like dengue, rabies and various diseases that are increasing in regions that we never used to see them before. Malaria has even increased and we’re seeing it’s shown in countries that it never used to be before.” The ILO has planned a meeting in 2025 with government, employer and worker representatives to provide policy guidance on climate hazards. Image Credits: Unsplash, WHO/Diego Rodriguez. Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan HIV medicine dolutegravir. The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of the World Health Organization (WHO). Dolutegravir has fewer side effects and a lower risk of developing resistance. UNAIDS has described the move as an “important breakthrough in public health measures” that breaks “the monopoly”, and could mean that the price of the life-saving medicine is reduced by as much as 80%. “When the power to produce health technologies is held by a few companies, the result all too often is that countries can’t afford the high prices and people who need newer products cannot access them,” said Luisa Cabal, UNAIDS Regional Director for Latin America and the Caribbean. “This decision provides the government with the legal conditions to manufacture or purchase more affordable versions of this essential first-line antiretroviral treatment for all people living with HIV in Colombia, including Venezuelan migrants”, said Ms Cabal. “We are confident that this decision will have an impact across the whole region and beyond, as many middle-income countries are struggling to access generic markets of key health products to prevent and treat HIV infection.” Prohibitive costs This move has also been welcomed by Médecins Sans Frontières (MSF), Public Citizen and Global Humanitarian Progress Corporation Colombia. ⚡️⚡️⚡️Breaking News: Colombia issues its first compulsory license (CL) for the HIV drug dolutegravir bringing the price down from US$1,224 per patient per year by ViiV to $44 through generics. This proves the power of generic competition!!! https://t.co/yPSpAFzJyJ — Shailly Gupta (@Shaillytweeting) April 25, 2024 “Colombia’s decision to issue a compulsory license for dolutegravir is great news because, until now, we have not been able to introduce dolutegravir in our medical operations, as the costs have been prohibitive,” said Dr Carmenza Gálvez, MSF’s medical coordinator for Colombia and Panama. Although generic versions of dolutegravir are available internationally for a fraction of ViiV’s price through voluntary licenses with the Medicines Patent Pool (MPP), ViiV excluded Colombia and many middle-income countries from being able to benefit from its license with MPP, allowing ViiV to maintain its monopoly and continue to charge high prices in Colombia and other countries excluded from the license. The Global Fund buys generic dolutegravir for $22.80 per patient per year, while Pan-American Health Organization (PAHO) can procure it for $44 – but Colombia cannot access these prices. According to the Colombian government, the estimated cost of dolutegravir sold by ViiV under the brand name, Tivicay, is around $1,224 per patient per year in 2023. If Colombia can procure the generics for $44, it will be able to treat 27 people for what it is paying for one person at present. According to UNAIDS, Colombia hosts the largest number of Venezuelan migrants in the world (2.9 million as of October 2022), and “recent studies have shown a 0.9% HIV prevalence among this migrant population, almost double the 0.5% HIV prevalence among the country’s adult population”. Compulsory licensing is a provision in the World Trade Organization (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement). It enables governments to supply its citizens with generic versions of patented treatments either through domestic production or imports, ensuring health products’ prices are affordable. The 2001 WTO Declaration on the TRIPS agreement and public health reaffirmed the rights of member states to make use of all flexibilities in the TRIPS agreement to protect public health, including compulsory licenses. More recently, in the 2021 Political Declaration on HIV/AIDS, countries committed to make use of TRIPS flexibilities, specifically geared to promoting access to medicines. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More African Countries Roll Out Malaria Vaccine, While Babies Get New Treatment Formulation 30/04/2024 Zuzanna Stawiska A rollout of malaria vaccine in Western African countries with a special focus on immunising children is an important step towards eliminating the disease Rollout of malaria vaccines are starting in Benin, Sierra Leone and Liberia, and the West African countries plan to deliver more than 800 000 doses of the RTS,S or R21 vaccines, according to WHO. The new vaccine will be added to their immunisation programmes for children, and are expected to protect over 200,000 children from the life-threatening disease. The RTS.S vaccine can be administered to children as young as five months old. In another promising development against malaria, a new formulation of a malaria treatment, Coartem, has proven to be safe and efficacious for babies under five kilograms, a previously overlooked group of patients. Pharmaceutical company Novartis and Medicines for Malaria Venture (MMV), a leading product development partnership, announced that their product has good efficacy and safety and is appropriate for babies in the wake of the successful CALINA study. The trial data have been submitted for regulatory review, they informed during the Multilateral Initiative on Malaria conference. “Infants below five kilograms make up a critical neglected group, and developing antimalarials specifically suited to their needs is essential to malaria control efforts,” said Wiweka Kaszubska, MMV vice president. The new formulation, known as Coartem <5 kg Baby, uses a new ratio and dose of artemether-lumefantrine to account for metabolic differences in babies under 5kg to minimise the risk of overdose and toxicity. “Infants under five kg can be affected by placental malaria, leading to poor birth outcomes, or contract malaria from the bite of an infected mosquito. The prevalence of the disease in this age and weight group is poorly understood, and it is therefore often misdiagnosed,” according to a company media release. Current antimalarials have not been developed small babies, who are usually treated with tablets meant for children above 5 kg adjusted by weight – yet, these tiny patients handle drugs differently due to the immaturity of their metabolising organs. Decreasing the burden Malaria is a life-threatening infectious disease with an estimated 249 million cases and 608 000 deaths in 2022, according to the World Malaria Report 2023. It is present in 85 countries, with 95% of cases in the African region. Most of the fatalities in the region – four out of five – are children under the age of five. “With the new, safe and efficacious malaria vaccine, we now have an additional tool to fight this disease. In combination with insecticide-treated nets, effective diagnosis and treatment, and indoor spraying, no child should die from malaria infection,” said Dr Austin Demby, the Minister of Health of Sierra Leone. The emerging interventions will likely decrease the burden of malaria substantially. In the recent years, (2019-2023), a pilot malaria vaccine programme in Ghana, Kenya and Malawi reached over two million children, showing a significant reduction in malaria illness. It also reached a 13% drop in overall child mortality and a reduction in hospitalisations. Benin, Liberia and Sierra Leone joined five other African countries that have already implemented the rollout of the newly developed malaria vaccines. Image Credits: WHO. Africa Wants Debt Swaps to Support Countries’ Defences Against Pandemics 29/04/2024 Kerry Cullinan African leaders who attended at the high level meeting in Addis Ababa on Saturday. African leaders want “explicit commitments” to debt relief and debt restructuring mechanisms, including debt swaps to support country-level pandemic prevention, preparedness and response (PPPR) in the pandemic agreement. This is one of the continent’s demands, made on the eve of the World Health Organization’s (WHO) pandemic agreement talks, following a high-level meeting of African health ministers and diplomats on Saturday. At the meeting, a key African Union (AU) leader warned against postponing the adoption of a pandemic agreement, saying it might never be passed. The pandemic agreement negotiations entered their final two-week phase in Geneva on Monday with 10 May as the deadline for what observers are describing as an “instrument of essentials” – a basic text that will be fleshed out by further talks in the next couple of years, as reported recently by Health Policy Watch. The first communique from the African leaders’ Saturday meeting was withdrawn a few hours after its release. The new statement released on Monday was identical except it removed a reference to the Pandemic Fund in its call for “an international financing mechanism” to support countries’ pandemic-proofing efforts. It also wants the accelerated “operationalisation of the financing of the African Epidemic Fund”. Support for PABS The continent supports a “multilateral pathogen access and benefit sharing system (PABS)” that provides legal certainty to users and providers and ensures improved access to pandemic-related health products and technologies. The draft agreement proposes a WHO-coordinated PABS system but for the operational details of this contested proposal are to be finalised by May 2026. Africa also wants “measures to establish regionally-distributed production of pandemic-related health products” and “commitments to organise and resource technical support” on all equity-related provisions. Pandemic prevention, preparedness, and response (PPPR) demands relate largely to national and regional responsibilities, with measures such as the enactment of “domestic laws providing for broad exemptions and limitations to intellectual property to address public health emergencies”, and supply chain diversification and logistics streamlining throughout the continent. Africa also wants the various WHO-coordinated mechanisms in the agreement – such as on research and development and technology transfer – to be operationalised and accountable to the Conference of Parties, a multi-country structure which is set to govern the agreement. “Africa stands ready to play its part and comments to engage actively in the ongoing negotiations and finalisation of the draft pandemic agreement,” the statement concludes. AU warns against postponement “I don’t think postponing an agreement is going to be in our interest because we may postpone forever. I look forward to us consolidating our common position today, consolidating our negotiating positions and ensuring that Africa’s interests are represented in the global pandemic agreement negotiations,” said AU deputy chairperson, Dr Monique Nsanzabaganwa, during the opening of the ministerial meeting. AU deputy chairperson Dr Monique Nsanzabaganwa warns against delaying the agreement. She also urged pragmatism when addressing the meeting on Saturday, explaining that several African demands – such as a seat at the G20 – had taken years to achieve. “In some situations, we don’t have even a choice because we need to continue being pragmatic as we look for all conditions that can allow us some equity and some flexibilities and conducive conditions for us to do what we’ll have to do for ourselves,” she said. She also warned of the likelihood of another COVID-like pandemic in the not so distant future, adding that it is “crucial that we work together to strengthen our collective preparedness and ensure that Africa’s voice is heard in global health discussions”. While Africa’s negotiators wanted a win-win situation, in negotiations “there is always give and take”, said Nsanzabaganwa, who hails from Rwanda. “We have also the duty to continue pressing for multilateralism to work.” Meanwhile, Zambia’s health minister, Sylvia Masebo, who chairs the Africa CDC board, called on the African negotiators to ensure “equitable access to pandemic-related health products” and “increased access to vaccines, diagnostics and therapeutics, ensuring that no one is left behind”. Africa CDC Director-General Dr Jean Kaseya said that unity and a common African position in the negotiations was key. Food Insecurity Affects 282 Million People in 2023 29/04/2024 Disha Shetty Food insecurity increased in 2023 due to a combination of conflicts, economic shocks and extreme weather events. In 2023, nearly 282 million people – 21.5% of the analysed population across 59 countries and territories – faced high levels of acute food insecurity, according to the Global Report on Food Crises (GRFC) 2024. This is 24 million more people than 2022. The rise was due to the report’s increased coverage of food crisis contexts and a sharp deterioration in food security, especially Gaza and Sudan. “The Gaza Strip became the most severe food crisis in our reporting history. Conflict and insecurity, along with extreme weather, events and economic shocks, are the key drivers of food insecurity and nutrition crisis,” said Dominique Burgeon, Director of the Food and Agriculture Organization (FAO) Liaison Office in Geneva. The current situation in the Gaza Strip accounts for 80% of those facing imminent famine, along with South Sudan, Burkina Faso, Somalia and Mali. For four consecutive years, the proportion of people facing acute food insecurity has remained persistently high at almost 22% of those assessed, significantly exceeding pre-COVID-19 levels. “This crisis demands an urgent response. Using the data in this report to transform food systems and address the underlying causes of food insecurity and malnutrition will be vital,” said António Guterres, UN Secretary-General. Number of people facing high levels of acute food insecurity in 59 countries and territories in 2023.(GRFC 2024) The report brings focuses on the enormity of the challenge of achieving the end of hunger by 2030 – a key UN Sustainable Development Goal. Improvements in food security in some countries was outweighed by deteriorating conditions in others. Over 26 million people are one step away from famine, while the total population in catastrophe was “more than four times higher than in 2016,” said Burgeon.The report was produced by the Global Network Against Food Crises (GNAFC), a multi-stakeholder initiative that is working to address the food crises. Protracted hunger Acute malnutrition worsened in 2023, particularly among people displaced because of conflict and disasters. Children and women are at the forefront of these hunger crises, with over 36 million children under five years of age acutely malnourished across 32 countries, the report showed. “The report also tells us that 60% of children experiencing acute malnutrition live in the ten countries facing the highest level of acute food insecurity,” said Burgeon of FAO. Thirty six countries have consistently featured in the GRFC analyses since 2016, reflecting continuing years of acute hunger, and currently representing 80% of the world’s most hungry. One million people more people face emergency levels of acute food insecurity across 39 countries and territories. In 2023, more than 705,000 people were at the catastrophe level of food insecurity and at risk of starvation – the highest number in the GRFC’s reporting history and up fourfold since 2016. The share of the analysed population facing high levels of acute food insecurity increased sharply from 14 percent in 2018 to more than 20 percent each year since 2020. Key drivers: Conflicts and extreme weather Conflict remained the primary driver of hunger, affecting 20 countries and forcing 135 million people into acute food insecurity – almost half of the global number. Sudan faced the largest deterioration due to conflict, with 8.6 million more people facing high levels of acute food insecurity as compared with 2022. “Sudan is a major concern for, the nutrition component because primarily of the major caseload, the number of people is staggering and also for the difficulty of reaching these people. In many areas, there is impossible access and or inconsistent access,” said Stefano Fedele, Global Nutrition Cluster Coordinator for UNICEF Geneva. Extreme weather events were the primary drivers in 18 countries where over 77 million people faced high levels of acute food insecurity, up from 12 countries with 57 million people in 2022. The impacts of economic shocks affected 21 countries where around 75 million people were facing high levels of acute food insecurity, due to their high dependency on imported food and agricultural inputs, persisting macroeconomic challenges, including currency depreciation, high prices and high debt levels. The drivers of food insecurity are interlinked and mutually reinforcing Breaking the cycle Tackling persistent food crises requires urgent long-term national and international investment to transform food systems and boost agricultural and rural development, according to the report. It also advocates for peace and prevention of conflict to become an integral part of the longer-term food systems transformation. Since 2023, needs have outpaced available resources and many humanitarian operations now overstretched, with many being forced to scale-down and further cut support to the most vulnerable. “This is truly a global challenge. There are far too many people waking up in the morning not knowing where their next meal will come from, not knowing how to feed their children, and having to make really truly impossible decisions throughout the course of their day to ensure that their most fundamental needs are being met,” said Courtney Blake, Senior Humanitarian Advisor for the US Mission in Geneva. Image Credits: Unsplash, Global Report on Food Security 2024. Final Pandemic Agreement Talks Start Amid Gamble on Process and African Show of Unity 28/04/2024 Kerry Cullinan The Africa CDC convened a high-level meeting in Addis Ababa on Saturday to discuss the continent’s position on the draft pandemic agreement. The World Health Organization’s (WHO) pandemic agreement negotiations begin their final two-week stretch on Monday (28 April) amid a gamble with the process, a show of unity from African member states – and more suggestions for the draft text. This final intergovernmental negotiating body (INB) meeting will focus on finding “common ground and consensus”, according to a decision taken at the last fractious meeting. The programme of work sets down 12-hour days, with the first week (29 April-3 May) focusing on finalising the substantive negotiations on the draft text. A “stock take” of progress will be held on Friday 3 May, and the second week (6-10 May) will look at outstanding articles, along with the draft resolution for the World Health Assembly at the end of May. The INB Bureau has also undertaken to provide daily briefing to relevant stakeholders on progress. ‘Take it or leave it’ After the previous session at which member states expressed frustration with one another and the INB Bureau, the INB co-chairs have taken a gamble with the process this time – and member states may not play along. The multitude of bracketed contested text has been purged from the new draft, and the co-chairs want the meeting to focus on saying “yes”, rather than being bogged down by disagreements. The meeting will go through the 23-page draft paragraph by paragraph, and member states that don’t agree with the text will be invited to have informal sessions, the co-chairs told a recent stakeholder briefing. But the draft will be considered as the default text where there is no consensus, which the co-chairs described as a “take it or leave it” approach. “The Bureau is of the opinion that the text as presented in the proposal for a WHO Pandemic Agreement is consensus ready,” it explained in a briefing document sent to stakeholders on Friday (26 April). “It was drafted on the basis of our many rounds of negotiations. The co-chairs will open the different articles and will ask the member states if the article is ready for approval. If not, delegations will be invited to explain what their issue with the article is. “Where possible the co-chairs will immediately propose a way forward. If the issue at hand is more fundamental, either a small informal meeting between a few member states can be proposed, or – if more member states want to be involved – a working group session can be proposed.” These working groups would be led by a member of the Bureau and the plan would be found them to return to the drafting group with a solution. At the recent stakeholder briefing, the European Union indicated that not all the text was consensus-based while Bangladesh, a key player in the Group of Equity negotiating bloc, criticised the approach of grabbing “low-hanging fruit for the sake of consensus”. 🇧🇩Bangladesh doubted finishing by May 2024, criticized agreeing to “low-hanging fruit for the sake of consensus,” proposed one IGWG on all remaining topics (not separate), and opposed parallel discussions during #INB9. 🇬🇧The UK asked about civil society engagement (thank you!). pic.twitter.com/TXcGsFnCkl — Nina Schwalbe (@nschwalbe) April 19, 2024 Africa asserts unity Meanwhile, African leaders urged continental unity and pragmatism at a high-level meeting on the pandemic negotiations convened on Saturday by the Africa Centre for Disease Control and Prevention (Africa CDC). Dr Monique Nsanzabaganwa, Deputy Chairperson of the African Union, urged pragmatism and realism at the meeting, attended by health ministers, diplomats and UN agency officials. Dr Monique Nsanzabaganwa, Deputy Chairperson of the African Union “At the time of COVID, multilateralism collapsed completely and then Africa was shut [out of] accessing all the things we needed at the time, the PPE and the vaccines,” she said, adding that the pandemic negotiations were an attempt to revive multilateralism. “In some situations, we don’t have a choice because we need to continue being pragmatic as we look for all conditions that can allow us some equity and some flexibilities and conducive conditions for us to do what we’ll have to do for ourselves,” she added. Africa CDC Director General Dr Jean Kaseya told the meeting, which was also briefed by INB co-chair Precious Matsoso, that “what matters most is for the continent to speak with one voice”. He stressed that Africa’s priorities, as contained in its New Public Order, are “to boost manufacturing capacities, expanded manufacturing capabilities, tech transfer, resilient supply chains, and robust regulatory frameworks”. At the high-level strategic meeting for #INB Negotiations today, I underlined Africa's #NewPublicHealthOrder priorities which are to boost manufacturing capacities, expanded manufacturing capabilities, tech transfer, resilient supply chains, and robust regulatory frameworks.… pic.twitter.com/XUoK6Oa0Ro — Jean Kaseya (@JeanKaseya2) April 27, 2024 Kaseya said member states had three options: to reject the agreement, to accept it, or to bring “strategic thinking” to the Geneva negotiations, which was “not yes or no”. Whatever happened, he urged that the continent speak with “one voice” during the “tough” upcoming negotiations. A communique released after the meeting identified Africa’s three bottom lines, which related to equity, pandemic prevention, preparedness and response (PPPR) and predictable, sustainable governing and financing. However, Africa CDC withdrew the communique a few hours later and claimed another would be following shortly . However, no replacement had been sent by late Sunday night, indicating some disagreement between parties about how to express the outcome of the meeting – not exactly an auspicious start for negotiations. One of Africa’s bottom lines has been in relation to PABS, where continental leaders have insisted that they need to be compensated for sharing information about pathogens. The current draft agreement proposes that details of a mutually beneficial PABS system – one of the biggest areas of disagreement – will only be finalised by mid-2026. However, the continent stressed its leaders were ready to engage actively in finalising the agreement. Ethiopia’s Ambassador to Geneva, Tsegab Kebebew Daka, told a recent event in Geneva that “the differences in the text are not huge”. “They are mainly differences of ideas and they’re not that many. So we can come to an agreement,” Daka, a key negotiator for the Africa group, told the event at the Geneva Graduate Institute’s Global Health Centre. While Daka acknowledged that there were still sticking points, he appealed to member states to take a “holistic view on the entire pandemic agreement” rather than dwelling on “specific articles where we have differences” – thereby endorsing the Bureau’s approach. WHO Group is ‘Very Close’ But Fails to Agree on Changes to International Health Regulations 26/04/2024 Kerry Cullinan An exhausted looking WGIHR co-chair Ashley Bloomfield reports back on the process The World Health Organization’s (WHO) working group has failed to meet its deadline of Friday (26 April) for amending the rules governing global disease outbreaks – the International Health Regulations (IHR) – and will reconvene. This emerged late afternoon on Friday (26 April) at a briefing after the week-long Working Group of Amendments to the IHR (WGIHR), when drawn co-chair Dr Ashley Bloomfield announced that the group would reconvene on 16 and 17 May for a final two days’ negotiation. “The mood in the room has been outstanding, and we have worked really hard to make amazing progress. We’re not quite cracking the bottles of champagne and sparkling grape juice, but we were getting very close and I have every sense that you are all committed to finishing the job,” said Bloomfield. WHO Deputy Director General Dr Mike Ryan commended the group, saying he was “very confident” that the IHR would be “a clearer, better instrument for your efforts, something that we can apply better on your behalf and on behalf of the people that you serve”. The WGIHR has asked member states to submit written inputs, particularly on the articles that the meeting failed to reach agreement on or did not discuss, by 6 May and it will reconvene for a further two days after that. The Articles that still need agreement relate to technology transfer, financing and governance. However, many of the WGIHR members are also part of the pandemic agreement talks, which start on Monday 29 April under the intergovernmental negotiating body (INB). The programme of work for the INB envisages 12-hour days, so there will be no space for IHR talks until after 10 May. However, the two processes are closer linked and the definitions adopted by the IHR, including all the phases that led up to the WHP Director General declaring a public health emergency of international concern (PHEIC), will be used in the pandemic agreement. The World Health Assembly, which is due to ratify the amendments, begins on 27 May, so time is very tight. The WGIHR will submit an updated proposed text to member states by 10 May. While No Human-to-Human Transmission Yet, Scientists Are Concerned About Rapid Spread of Avian Flu 26/04/2024 Zuzanna Stawiska The ongoing global spread of “bird flu” infections to mammals including humans is a significant public health concern While no cases of human-to-human transmission have been recorded in the current H5N1 avian outbreak, scientists are concerned about its transmission speed in mammals and whether this might result in a mutated pathogen that can infect people more easily. “H5N1 is (an) influenza infection, predominantly started in poultry and ducks and has spread effectively over the course of the last one or two years to become a global zoonotic – animal – pandemic,” said Dr Jeremy Farrar, the World Health Organization’s (WHO) Chief Scientist. “The great concern, of course, is that in doing so and infecting ducks and chickens – but now increasingly mammals – that that virus now evolves and develops the ability to infect humans. And then critically, the ability to go from human-to-human transmission,” Farrar told a media briefing in Geneva last week. At the WHO’s global media briefing on Wednesday, WHO epidemiologist Dr Maria Van Kerkhove that “we have not seen human-to-human transmission in the recent cases, and I think that’s really important because there’s a lot of news right now on influenza”. Spread in US dairy herds H5N1 has been detected in cattle in 33 dairy herds in eight US states, according to the latest US Centers for Disease Control and Prevention (CDC) report on 24 April. Remnants of the virus have also been detected in raw milk. US CDC described “this degree of spread outside of birds & poultry is unprecedented and concerning” and the US Department of Agriculture has restricted interstate cow transport to limit the spread of the disease. One human infection has been reported in a Texas, cattle farm worker in late March. Genomic sequencing from this patient found that each individual gene segment was “closely related to viruses detected in dairy cattle” in Texas, according to US CDC. “While minor changes were identified in the virus sequence from the patient specimen compared to the viral sequences from cattle, both cattle and human sequences maintain primarily avian genetic characteristics and, for the most part, lack changes that would make them better adapted to infect mammals,” it noted. “There are no markers known to be associated with influenza antiviral resistance found in the virus sequences from the patient’s specimen and the virus is very closely related to two existing candidate vaccine viruses that are already available to manufacturers, and which could be used to make vaccine if needed,” added. Overall, the genetic analysis “supports CDC’s conclusion that the human health risk currently remains low”. US public officials said that Tamiflu, an antiviral effective for treating influenza, is stockpiled for a potential emergency, NPR reported. Some candidate vaccines for H5N1 are also in development and there are some options for enhancing present supply. US states where H5N1 has been detected in cattle Historically, human cases of the H5N1 virus are so far very rare, with only 889 cases reported to the WHO since 2003, all involving people who came in contact with infected animals. But virus mortality reaches 52%, which is “extraordinary high”, said Farrar, who urged close monitoring and investigation of the outbreaks in US cattle by public health authorities “because it may evolve into transmitting in different ways”. “Do the milking structures of cows create aerosols? Is it the environment which they’re living in? Is it the transport system that is spreading this around the country?” he asked. “This is a huge concern and I think we have to … make sure that if H5N1 did come across to humans with human-to-human transmission that we were in a position to immediately respond with access equitably to vaccines, therapeutics and diagnostics.” Different strains, different severity Though avian influenza viruses naturally occur in wild water birds, some variants are also known to develop the ability to infect other animals. The virus has multiple variants of differing severity and transmission possibilities. A case of human infection with the much milder strain of avian influenza virus (H9N2) was confirmed in Viet Nam on 9 April by the International Health Regulations (IHR) National Focal Point, as WHO reported. The same virus strain was also detected in three patients in China,according to the Centre for Health Protection of Hong Kong. H9N2 usually results in mild infections of the upper respiratory tract, mostly affecting children. It is a low pathogenic avian influenza, usually showing only mild disease in chickens and other poultry, according to the US CDC. Systems in place to respond Maria van Kerkhove “We are concerned about this particular virus because we know influenza has the potential to cause epidemics,” said Van Kerkhove. “That’s why we have a global system in place to monitor detect, to rapidly do risk assessments to look at viruses that could potentially be used in vaccines as we go forward.” However, she expressed confidence that risks of an outbreak in human populations remain low and that existing WHO surveillance systems competent to monitor any developments. ”We have a global influenza surveillance and response system that’s been in place for 70 years. And within this systems, there are strong surveillance components, made up of labs around the world, made up of many partner agencies,” she assured the media briefing. Dr Michael Ryan, WHO’s Executive Director of the Health Emergencies Programme, backed Van Kerkhove: “We have a system that can measure and we have countermeasures ready to go should anything happen and that’s all we can do in public health.” “We can’t stop living because viruses threaten us. What we can do is be ready to respond,” he said,. The Pandemic Influenza Preparedness Framework “has been in place again for 20 years and has provided a framework for collaboration between WHO labs and industry for the sharing of material, for the sharing of vaccines”, added Ryan. Image Credits: Charlotte Kesl/ World Bank. ILO: Excessive Heat Linked to Climate Change Affects 70% of Workers 26/04/2024 Disha Shetty Outdoor workers are at a high potential health risk as climate change worsens heat. Over 70% of the world’s workforce faces potential health risks due to climate change, according to the latest report by the International Labour Organization (ILO) released earlier this week. Nearly 1.6 billion outdoor workers are also at risk from high levels of air pollution. “More than 70% of our workers are exposed to excessive heat at least one point in their working lives. That’s 2.4 billion workers globally out of a global workforce of 3.4 billion,” said Manal Azzi, Senior Specialist on Occupational Safety and Health (ILO) at the report launch at the United Nations in Geneva. The report, Ensuring safety and health at work in a changing climate, states that climate change is already having a serious impact on the safety and health of workers in all regions of the world. The share of global workers impacted by climate change hazards has increased by about from 65% in 2020 to 70% in 2024, the report said. Workers in the world’s most impoverished regions face heightened risks from scorching heatwaves, prolonged droughts, raging wildfires, and devastating hurricanes, according to the ILO. Did you know? 🌍🔥 Over 2.4 billion workers face excessive heat due to #ClimateChange. ⏳It's a race against time for safety and health. Learn more at our global event tomorrow: https://t.co/i3SlGiyisO#SafeDay2024 pic.twitter.com/LnofX5hKif — International Labour Organization (@ilo) April 24, 2024 Range of climate-linked health risks The report notes that numerous health conditions in workers have been linked to climate change, including cancer, cardiovascular disease, respiratory illnesses, kidney dysfunction and mental health conditions. The impact includes the 1.6 billion workers exposed to UV radiation, with more than 18,960 work-related deaths annually from non-melanoma skin cancer. “More than 22 million workers are suffering from sicknesses and injuries related to exposure to excessive heat and these can range from injuries in transport, in traffic accidents due to bad night of sleep because it was excessively hot, to construction accidents, injuries, slips and falls related to the exposure to heat,” Azzi said. Many deaths are also directly related to the impact of climate change. “Nearly 20,000 workers are dying yearly because of these injuries in the workplace related to rising temperatures and to exposure to excessive heat, indoor and outdoor heat, and losing millions – over two million disability-adjusted years – are lost because of injuries and deaths related to heat,” said Azzi, who is the ILO’s specialist on occupational safety and health. A traditional brick factory in Tozeur, southern Tunisia. In Africa and South Asia brick making and waste burning are major sources of air pollution. High levels of air pollution causing harm The report also said that nearly 1.6 billion outdoor workers are at risk of health impacts due to worsening air pollution, particularly those working in the transport sector and firefighters. Around 860,000 work-related deaths have been attributed to air pollution for outdoor workers annually. The report noted that modified weather patterns due to climate change have influenced levels of outdoor air pollutants, such as ground-level ozone, fine (PM2.5) and course (PM10) particulate matter, nitrogen dioxide (NO2), and sulphur dioxide (SO2). Rise in vector-borne diseases With increasing temperatures and higher humidity, more pesticides are also being used in the agriculture sector. According to the report, there are more than 870 million workers in agriculture that are likely to be exposed to pesticides, with more than 300,000 deaths attributed to pesticide poisoning annually. Azzi notes that “15,000 people die due to parasitic and vector-borne diseases exposed to in the workplace”. “Obviously, these include a lot of diseases like dengue, rabies and various diseases that are increasing in regions that we never used to see them before. Malaria has even increased and we’re seeing it’s shown in countries that it never used to be before.” The ILO has planned a meeting in 2025 with government, employer and worker representatives to provide policy guidance on climate hazards. Image Credits: Unsplash, WHO/Diego Rodriguez. Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan HIV medicine dolutegravir. The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of the World Health Organization (WHO). Dolutegravir has fewer side effects and a lower risk of developing resistance. UNAIDS has described the move as an “important breakthrough in public health measures” that breaks “the monopoly”, and could mean that the price of the life-saving medicine is reduced by as much as 80%. “When the power to produce health technologies is held by a few companies, the result all too often is that countries can’t afford the high prices and people who need newer products cannot access them,” said Luisa Cabal, UNAIDS Regional Director for Latin America and the Caribbean. “This decision provides the government with the legal conditions to manufacture or purchase more affordable versions of this essential first-line antiretroviral treatment for all people living with HIV in Colombia, including Venezuelan migrants”, said Ms Cabal. “We are confident that this decision will have an impact across the whole region and beyond, as many middle-income countries are struggling to access generic markets of key health products to prevent and treat HIV infection.” Prohibitive costs This move has also been welcomed by Médecins Sans Frontières (MSF), Public Citizen and Global Humanitarian Progress Corporation Colombia. ⚡️⚡️⚡️Breaking News: Colombia issues its first compulsory license (CL) for the HIV drug dolutegravir bringing the price down from US$1,224 per patient per year by ViiV to $44 through generics. This proves the power of generic competition!!! https://t.co/yPSpAFzJyJ — Shailly Gupta (@Shaillytweeting) April 25, 2024 “Colombia’s decision to issue a compulsory license for dolutegravir is great news because, until now, we have not been able to introduce dolutegravir in our medical operations, as the costs have been prohibitive,” said Dr Carmenza Gálvez, MSF’s medical coordinator for Colombia and Panama. Although generic versions of dolutegravir are available internationally for a fraction of ViiV’s price through voluntary licenses with the Medicines Patent Pool (MPP), ViiV excluded Colombia and many middle-income countries from being able to benefit from its license with MPP, allowing ViiV to maintain its monopoly and continue to charge high prices in Colombia and other countries excluded from the license. The Global Fund buys generic dolutegravir for $22.80 per patient per year, while Pan-American Health Organization (PAHO) can procure it for $44 – but Colombia cannot access these prices. According to the Colombian government, the estimated cost of dolutegravir sold by ViiV under the brand name, Tivicay, is around $1,224 per patient per year in 2023. If Colombia can procure the generics for $44, it will be able to treat 27 people for what it is paying for one person at present. According to UNAIDS, Colombia hosts the largest number of Venezuelan migrants in the world (2.9 million as of October 2022), and “recent studies have shown a 0.9% HIV prevalence among this migrant population, almost double the 0.5% HIV prevalence among the country’s adult population”. Compulsory licensing is a provision in the World Trade Organization (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement). It enables governments to supply its citizens with generic versions of patented treatments either through domestic production or imports, ensuring health products’ prices are affordable. The 2001 WTO Declaration on the TRIPS agreement and public health reaffirmed the rights of member states to make use of all flexibilities in the TRIPS agreement to protect public health, including compulsory licenses. More recently, in the 2021 Political Declaration on HIV/AIDS, countries committed to make use of TRIPS flexibilities, specifically geared to promoting access to medicines. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa Wants Debt Swaps to Support Countries’ Defences Against Pandemics 29/04/2024 Kerry Cullinan African leaders who attended at the high level meeting in Addis Ababa on Saturday. African leaders want “explicit commitments” to debt relief and debt restructuring mechanisms, including debt swaps to support country-level pandemic prevention, preparedness and response (PPPR) in the pandemic agreement. This is one of the continent’s demands, made on the eve of the World Health Organization’s (WHO) pandemic agreement talks, following a high-level meeting of African health ministers and diplomats on Saturday. At the meeting, a key African Union (AU) leader warned against postponing the adoption of a pandemic agreement, saying it might never be passed. The pandemic agreement negotiations entered their final two-week phase in Geneva on Monday with 10 May as the deadline for what observers are describing as an “instrument of essentials” – a basic text that will be fleshed out by further talks in the next couple of years, as reported recently by Health Policy Watch. The first communique from the African leaders’ Saturday meeting was withdrawn a few hours after its release. The new statement released on Monday was identical except it removed a reference to the Pandemic Fund in its call for “an international financing mechanism” to support countries’ pandemic-proofing efforts. It also wants the accelerated “operationalisation of the financing of the African Epidemic Fund”. Support for PABS The continent supports a “multilateral pathogen access and benefit sharing system (PABS)” that provides legal certainty to users and providers and ensures improved access to pandemic-related health products and technologies. The draft agreement proposes a WHO-coordinated PABS system but for the operational details of this contested proposal are to be finalised by May 2026. Africa also wants “measures to establish regionally-distributed production of pandemic-related health products” and “commitments to organise and resource technical support” on all equity-related provisions. Pandemic prevention, preparedness, and response (PPPR) demands relate largely to national and regional responsibilities, with measures such as the enactment of “domestic laws providing for broad exemptions and limitations to intellectual property to address public health emergencies”, and supply chain diversification and logistics streamlining throughout the continent. Africa also wants the various WHO-coordinated mechanisms in the agreement – such as on research and development and technology transfer – to be operationalised and accountable to the Conference of Parties, a multi-country structure which is set to govern the agreement. “Africa stands ready to play its part and comments to engage actively in the ongoing negotiations and finalisation of the draft pandemic agreement,” the statement concludes. AU warns against postponement “I don’t think postponing an agreement is going to be in our interest because we may postpone forever. I look forward to us consolidating our common position today, consolidating our negotiating positions and ensuring that Africa’s interests are represented in the global pandemic agreement negotiations,” said AU deputy chairperson, Dr Monique Nsanzabaganwa, during the opening of the ministerial meeting. AU deputy chairperson Dr Monique Nsanzabaganwa warns against delaying the agreement. She also urged pragmatism when addressing the meeting on Saturday, explaining that several African demands – such as a seat at the G20 – had taken years to achieve. “In some situations, we don’t have even a choice because we need to continue being pragmatic as we look for all conditions that can allow us some equity and some flexibilities and conducive conditions for us to do what we’ll have to do for ourselves,” she said. She also warned of the likelihood of another COVID-like pandemic in the not so distant future, adding that it is “crucial that we work together to strengthen our collective preparedness and ensure that Africa’s voice is heard in global health discussions”. While Africa’s negotiators wanted a win-win situation, in negotiations “there is always give and take”, said Nsanzabaganwa, who hails from Rwanda. “We have also the duty to continue pressing for multilateralism to work.” Meanwhile, Zambia’s health minister, Sylvia Masebo, who chairs the Africa CDC board, called on the African negotiators to ensure “equitable access to pandemic-related health products” and “increased access to vaccines, diagnostics and therapeutics, ensuring that no one is left behind”. Africa CDC Director-General Dr Jean Kaseya said that unity and a common African position in the negotiations was key. Food Insecurity Affects 282 Million People in 2023 29/04/2024 Disha Shetty Food insecurity increased in 2023 due to a combination of conflicts, economic shocks and extreme weather events. In 2023, nearly 282 million people – 21.5% of the analysed population across 59 countries and territories – faced high levels of acute food insecurity, according to the Global Report on Food Crises (GRFC) 2024. This is 24 million more people than 2022. The rise was due to the report’s increased coverage of food crisis contexts and a sharp deterioration in food security, especially Gaza and Sudan. “The Gaza Strip became the most severe food crisis in our reporting history. Conflict and insecurity, along with extreme weather, events and economic shocks, are the key drivers of food insecurity and nutrition crisis,” said Dominique Burgeon, Director of the Food and Agriculture Organization (FAO) Liaison Office in Geneva. The current situation in the Gaza Strip accounts for 80% of those facing imminent famine, along with South Sudan, Burkina Faso, Somalia and Mali. For four consecutive years, the proportion of people facing acute food insecurity has remained persistently high at almost 22% of those assessed, significantly exceeding pre-COVID-19 levels. “This crisis demands an urgent response. Using the data in this report to transform food systems and address the underlying causes of food insecurity and malnutrition will be vital,” said António Guterres, UN Secretary-General. Number of people facing high levels of acute food insecurity in 59 countries and territories in 2023.(GRFC 2024) The report brings focuses on the enormity of the challenge of achieving the end of hunger by 2030 – a key UN Sustainable Development Goal. Improvements in food security in some countries was outweighed by deteriorating conditions in others. Over 26 million people are one step away from famine, while the total population in catastrophe was “more than four times higher than in 2016,” said Burgeon.The report was produced by the Global Network Against Food Crises (GNAFC), a multi-stakeholder initiative that is working to address the food crises. Protracted hunger Acute malnutrition worsened in 2023, particularly among people displaced because of conflict and disasters. Children and women are at the forefront of these hunger crises, with over 36 million children under five years of age acutely malnourished across 32 countries, the report showed. “The report also tells us that 60% of children experiencing acute malnutrition live in the ten countries facing the highest level of acute food insecurity,” said Burgeon of FAO. Thirty six countries have consistently featured in the GRFC analyses since 2016, reflecting continuing years of acute hunger, and currently representing 80% of the world’s most hungry. One million people more people face emergency levels of acute food insecurity across 39 countries and territories. In 2023, more than 705,000 people were at the catastrophe level of food insecurity and at risk of starvation – the highest number in the GRFC’s reporting history and up fourfold since 2016. The share of the analysed population facing high levels of acute food insecurity increased sharply from 14 percent in 2018 to more than 20 percent each year since 2020. Key drivers: Conflicts and extreme weather Conflict remained the primary driver of hunger, affecting 20 countries and forcing 135 million people into acute food insecurity – almost half of the global number. Sudan faced the largest deterioration due to conflict, with 8.6 million more people facing high levels of acute food insecurity as compared with 2022. “Sudan is a major concern for, the nutrition component because primarily of the major caseload, the number of people is staggering and also for the difficulty of reaching these people. In many areas, there is impossible access and or inconsistent access,” said Stefano Fedele, Global Nutrition Cluster Coordinator for UNICEF Geneva. Extreme weather events were the primary drivers in 18 countries where over 77 million people faced high levels of acute food insecurity, up from 12 countries with 57 million people in 2022. The impacts of economic shocks affected 21 countries where around 75 million people were facing high levels of acute food insecurity, due to their high dependency on imported food and agricultural inputs, persisting macroeconomic challenges, including currency depreciation, high prices and high debt levels. The drivers of food insecurity are interlinked and mutually reinforcing Breaking the cycle Tackling persistent food crises requires urgent long-term national and international investment to transform food systems and boost agricultural and rural development, according to the report. It also advocates for peace and prevention of conflict to become an integral part of the longer-term food systems transformation. Since 2023, needs have outpaced available resources and many humanitarian operations now overstretched, with many being forced to scale-down and further cut support to the most vulnerable. “This is truly a global challenge. There are far too many people waking up in the morning not knowing where their next meal will come from, not knowing how to feed their children, and having to make really truly impossible decisions throughout the course of their day to ensure that their most fundamental needs are being met,” said Courtney Blake, Senior Humanitarian Advisor for the US Mission in Geneva. Image Credits: Unsplash, Global Report on Food Security 2024. Final Pandemic Agreement Talks Start Amid Gamble on Process and African Show of Unity 28/04/2024 Kerry Cullinan The Africa CDC convened a high-level meeting in Addis Ababa on Saturday to discuss the continent’s position on the draft pandemic agreement. The World Health Organization’s (WHO) pandemic agreement negotiations begin their final two-week stretch on Monday (28 April) amid a gamble with the process, a show of unity from African member states – and more suggestions for the draft text. This final intergovernmental negotiating body (INB) meeting will focus on finding “common ground and consensus”, according to a decision taken at the last fractious meeting. The programme of work sets down 12-hour days, with the first week (29 April-3 May) focusing on finalising the substantive negotiations on the draft text. A “stock take” of progress will be held on Friday 3 May, and the second week (6-10 May) will look at outstanding articles, along with the draft resolution for the World Health Assembly at the end of May. The INB Bureau has also undertaken to provide daily briefing to relevant stakeholders on progress. ‘Take it or leave it’ After the previous session at which member states expressed frustration with one another and the INB Bureau, the INB co-chairs have taken a gamble with the process this time – and member states may not play along. The multitude of bracketed contested text has been purged from the new draft, and the co-chairs want the meeting to focus on saying “yes”, rather than being bogged down by disagreements. The meeting will go through the 23-page draft paragraph by paragraph, and member states that don’t agree with the text will be invited to have informal sessions, the co-chairs told a recent stakeholder briefing. But the draft will be considered as the default text where there is no consensus, which the co-chairs described as a “take it or leave it” approach. “The Bureau is of the opinion that the text as presented in the proposal for a WHO Pandemic Agreement is consensus ready,” it explained in a briefing document sent to stakeholders on Friday (26 April). “It was drafted on the basis of our many rounds of negotiations. The co-chairs will open the different articles and will ask the member states if the article is ready for approval. If not, delegations will be invited to explain what their issue with the article is. “Where possible the co-chairs will immediately propose a way forward. If the issue at hand is more fundamental, either a small informal meeting between a few member states can be proposed, or – if more member states want to be involved – a working group session can be proposed.” These working groups would be led by a member of the Bureau and the plan would be found them to return to the drafting group with a solution. At the recent stakeholder briefing, the European Union indicated that not all the text was consensus-based while Bangladesh, a key player in the Group of Equity negotiating bloc, criticised the approach of grabbing “low-hanging fruit for the sake of consensus”. 🇧🇩Bangladesh doubted finishing by May 2024, criticized agreeing to “low-hanging fruit for the sake of consensus,” proposed one IGWG on all remaining topics (not separate), and opposed parallel discussions during #INB9. 🇬🇧The UK asked about civil society engagement (thank you!). pic.twitter.com/TXcGsFnCkl — Nina Schwalbe (@nschwalbe) April 19, 2024 Africa asserts unity Meanwhile, African leaders urged continental unity and pragmatism at a high-level meeting on the pandemic negotiations convened on Saturday by the Africa Centre for Disease Control and Prevention (Africa CDC). Dr Monique Nsanzabaganwa, Deputy Chairperson of the African Union, urged pragmatism and realism at the meeting, attended by health ministers, diplomats and UN agency officials. Dr Monique Nsanzabaganwa, Deputy Chairperson of the African Union “At the time of COVID, multilateralism collapsed completely and then Africa was shut [out of] accessing all the things we needed at the time, the PPE and the vaccines,” she said, adding that the pandemic negotiations were an attempt to revive multilateralism. “In some situations, we don’t have a choice because we need to continue being pragmatic as we look for all conditions that can allow us some equity and some flexibilities and conducive conditions for us to do what we’ll have to do for ourselves,” she added. Africa CDC Director General Dr Jean Kaseya told the meeting, which was also briefed by INB co-chair Precious Matsoso, that “what matters most is for the continent to speak with one voice”. He stressed that Africa’s priorities, as contained in its New Public Order, are “to boost manufacturing capacities, expanded manufacturing capabilities, tech transfer, resilient supply chains, and robust regulatory frameworks”. At the high-level strategic meeting for #INB Negotiations today, I underlined Africa's #NewPublicHealthOrder priorities which are to boost manufacturing capacities, expanded manufacturing capabilities, tech transfer, resilient supply chains, and robust regulatory frameworks.… pic.twitter.com/XUoK6Oa0Ro — Jean Kaseya (@JeanKaseya2) April 27, 2024 Kaseya said member states had three options: to reject the agreement, to accept it, or to bring “strategic thinking” to the Geneva negotiations, which was “not yes or no”. Whatever happened, he urged that the continent speak with “one voice” during the “tough” upcoming negotiations. A communique released after the meeting identified Africa’s three bottom lines, which related to equity, pandemic prevention, preparedness and response (PPPR) and predictable, sustainable governing and financing. However, Africa CDC withdrew the communique a few hours later and claimed another would be following shortly . However, no replacement had been sent by late Sunday night, indicating some disagreement between parties about how to express the outcome of the meeting – not exactly an auspicious start for negotiations. One of Africa’s bottom lines has been in relation to PABS, where continental leaders have insisted that they need to be compensated for sharing information about pathogens. The current draft agreement proposes that details of a mutually beneficial PABS system – one of the biggest areas of disagreement – will only be finalised by mid-2026. However, the continent stressed its leaders were ready to engage actively in finalising the agreement. Ethiopia’s Ambassador to Geneva, Tsegab Kebebew Daka, told a recent event in Geneva that “the differences in the text are not huge”. “They are mainly differences of ideas and they’re not that many. So we can come to an agreement,” Daka, a key negotiator for the Africa group, told the event at the Geneva Graduate Institute’s Global Health Centre. While Daka acknowledged that there were still sticking points, he appealed to member states to take a “holistic view on the entire pandemic agreement” rather than dwelling on “specific articles where we have differences” – thereby endorsing the Bureau’s approach. WHO Group is ‘Very Close’ But Fails to Agree on Changes to International Health Regulations 26/04/2024 Kerry Cullinan An exhausted looking WGIHR co-chair Ashley Bloomfield reports back on the process The World Health Organization’s (WHO) working group has failed to meet its deadline of Friday (26 April) for amending the rules governing global disease outbreaks – the International Health Regulations (IHR) – and will reconvene. This emerged late afternoon on Friday (26 April) at a briefing after the week-long Working Group of Amendments to the IHR (WGIHR), when drawn co-chair Dr Ashley Bloomfield announced that the group would reconvene on 16 and 17 May for a final two days’ negotiation. “The mood in the room has been outstanding, and we have worked really hard to make amazing progress. We’re not quite cracking the bottles of champagne and sparkling grape juice, but we were getting very close and I have every sense that you are all committed to finishing the job,” said Bloomfield. WHO Deputy Director General Dr Mike Ryan commended the group, saying he was “very confident” that the IHR would be “a clearer, better instrument for your efforts, something that we can apply better on your behalf and on behalf of the people that you serve”. The WGIHR has asked member states to submit written inputs, particularly on the articles that the meeting failed to reach agreement on or did not discuss, by 6 May and it will reconvene for a further two days after that. The Articles that still need agreement relate to technology transfer, financing and governance. However, many of the WGIHR members are also part of the pandemic agreement talks, which start on Monday 29 April under the intergovernmental negotiating body (INB). The programme of work for the INB envisages 12-hour days, so there will be no space for IHR talks until after 10 May. However, the two processes are closer linked and the definitions adopted by the IHR, including all the phases that led up to the WHP Director General declaring a public health emergency of international concern (PHEIC), will be used in the pandemic agreement. The World Health Assembly, which is due to ratify the amendments, begins on 27 May, so time is very tight. The WGIHR will submit an updated proposed text to member states by 10 May. While No Human-to-Human Transmission Yet, Scientists Are Concerned About Rapid Spread of Avian Flu 26/04/2024 Zuzanna Stawiska The ongoing global spread of “bird flu” infections to mammals including humans is a significant public health concern While no cases of human-to-human transmission have been recorded in the current H5N1 avian outbreak, scientists are concerned about its transmission speed in mammals and whether this might result in a mutated pathogen that can infect people more easily. “H5N1 is (an) influenza infection, predominantly started in poultry and ducks and has spread effectively over the course of the last one or two years to become a global zoonotic – animal – pandemic,” said Dr Jeremy Farrar, the World Health Organization’s (WHO) Chief Scientist. “The great concern, of course, is that in doing so and infecting ducks and chickens – but now increasingly mammals – that that virus now evolves and develops the ability to infect humans. And then critically, the ability to go from human-to-human transmission,” Farrar told a media briefing in Geneva last week. At the WHO’s global media briefing on Wednesday, WHO epidemiologist Dr Maria Van Kerkhove that “we have not seen human-to-human transmission in the recent cases, and I think that’s really important because there’s a lot of news right now on influenza”. Spread in US dairy herds H5N1 has been detected in cattle in 33 dairy herds in eight US states, according to the latest US Centers for Disease Control and Prevention (CDC) report on 24 April. Remnants of the virus have also been detected in raw milk. US CDC described “this degree of spread outside of birds & poultry is unprecedented and concerning” and the US Department of Agriculture has restricted interstate cow transport to limit the spread of the disease. One human infection has been reported in a Texas, cattle farm worker in late March. Genomic sequencing from this patient found that each individual gene segment was “closely related to viruses detected in dairy cattle” in Texas, according to US CDC. “While minor changes were identified in the virus sequence from the patient specimen compared to the viral sequences from cattle, both cattle and human sequences maintain primarily avian genetic characteristics and, for the most part, lack changes that would make them better adapted to infect mammals,” it noted. “There are no markers known to be associated with influenza antiviral resistance found in the virus sequences from the patient’s specimen and the virus is very closely related to two existing candidate vaccine viruses that are already available to manufacturers, and which could be used to make vaccine if needed,” added. Overall, the genetic analysis “supports CDC’s conclusion that the human health risk currently remains low”. US public officials said that Tamiflu, an antiviral effective for treating influenza, is stockpiled for a potential emergency, NPR reported. Some candidate vaccines for H5N1 are also in development and there are some options for enhancing present supply. US states where H5N1 has been detected in cattle Historically, human cases of the H5N1 virus are so far very rare, with only 889 cases reported to the WHO since 2003, all involving people who came in contact with infected animals. But virus mortality reaches 52%, which is “extraordinary high”, said Farrar, who urged close monitoring and investigation of the outbreaks in US cattle by public health authorities “because it may evolve into transmitting in different ways”. “Do the milking structures of cows create aerosols? Is it the environment which they’re living in? Is it the transport system that is spreading this around the country?” he asked. “This is a huge concern and I think we have to … make sure that if H5N1 did come across to humans with human-to-human transmission that we were in a position to immediately respond with access equitably to vaccines, therapeutics and diagnostics.” Different strains, different severity Though avian influenza viruses naturally occur in wild water birds, some variants are also known to develop the ability to infect other animals. The virus has multiple variants of differing severity and transmission possibilities. A case of human infection with the much milder strain of avian influenza virus (H9N2) was confirmed in Viet Nam on 9 April by the International Health Regulations (IHR) National Focal Point, as WHO reported. The same virus strain was also detected in three patients in China,according to the Centre for Health Protection of Hong Kong. H9N2 usually results in mild infections of the upper respiratory tract, mostly affecting children. It is a low pathogenic avian influenza, usually showing only mild disease in chickens and other poultry, according to the US CDC. Systems in place to respond Maria van Kerkhove “We are concerned about this particular virus because we know influenza has the potential to cause epidemics,” said Van Kerkhove. “That’s why we have a global system in place to monitor detect, to rapidly do risk assessments to look at viruses that could potentially be used in vaccines as we go forward.” However, she expressed confidence that risks of an outbreak in human populations remain low and that existing WHO surveillance systems competent to monitor any developments. ”We have a global influenza surveillance and response system that’s been in place for 70 years. And within this systems, there are strong surveillance components, made up of labs around the world, made up of many partner agencies,” she assured the media briefing. Dr Michael Ryan, WHO’s Executive Director of the Health Emergencies Programme, backed Van Kerkhove: “We have a system that can measure and we have countermeasures ready to go should anything happen and that’s all we can do in public health.” “We can’t stop living because viruses threaten us. What we can do is be ready to respond,” he said,. The Pandemic Influenza Preparedness Framework “has been in place again for 20 years and has provided a framework for collaboration between WHO labs and industry for the sharing of material, for the sharing of vaccines”, added Ryan. Image Credits: Charlotte Kesl/ World Bank. ILO: Excessive Heat Linked to Climate Change Affects 70% of Workers 26/04/2024 Disha Shetty Outdoor workers are at a high potential health risk as climate change worsens heat. Over 70% of the world’s workforce faces potential health risks due to climate change, according to the latest report by the International Labour Organization (ILO) released earlier this week. Nearly 1.6 billion outdoor workers are also at risk from high levels of air pollution. “More than 70% of our workers are exposed to excessive heat at least one point in their working lives. That’s 2.4 billion workers globally out of a global workforce of 3.4 billion,” said Manal Azzi, Senior Specialist on Occupational Safety and Health (ILO) at the report launch at the United Nations in Geneva. The report, Ensuring safety and health at work in a changing climate, states that climate change is already having a serious impact on the safety and health of workers in all regions of the world. The share of global workers impacted by climate change hazards has increased by about from 65% in 2020 to 70% in 2024, the report said. Workers in the world’s most impoverished regions face heightened risks from scorching heatwaves, prolonged droughts, raging wildfires, and devastating hurricanes, according to the ILO. Did you know? 🌍🔥 Over 2.4 billion workers face excessive heat due to #ClimateChange. ⏳It's a race against time for safety and health. Learn more at our global event tomorrow: https://t.co/i3SlGiyisO#SafeDay2024 pic.twitter.com/LnofX5hKif — International Labour Organization (@ilo) April 24, 2024 Range of climate-linked health risks The report notes that numerous health conditions in workers have been linked to climate change, including cancer, cardiovascular disease, respiratory illnesses, kidney dysfunction and mental health conditions. The impact includes the 1.6 billion workers exposed to UV radiation, with more than 18,960 work-related deaths annually from non-melanoma skin cancer. “More than 22 million workers are suffering from sicknesses and injuries related to exposure to excessive heat and these can range from injuries in transport, in traffic accidents due to bad night of sleep because it was excessively hot, to construction accidents, injuries, slips and falls related to the exposure to heat,” Azzi said. Many deaths are also directly related to the impact of climate change. “Nearly 20,000 workers are dying yearly because of these injuries in the workplace related to rising temperatures and to exposure to excessive heat, indoor and outdoor heat, and losing millions – over two million disability-adjusted years – are lost because of injuries and deaths related to heat,” said Azzi, who is the ILO’s specialist on occupational safety and health. A traditional brick factory in Tozeur, southern Tunisia. In Africa and South Asia brick making and waste burning are major sources of air pollution. High levels of air pollution causing harm The report also said that nearly 1.6 billion outdoor workers are at risk of health impacts due to worsening air pollution, particularly those working in the transport sector and firefighters. Around 860,000 work-related deaths have been attributed to air pollution for outdoor workers annually. The report noted that modified weather patterns due to climate change have influenced levels of outdoor air pollutants, such as ground-level ozone, fine (PM2.5) and course (PM10) particulate matter, nitrogen dioxide (NO2), and sulphur dioxide (SO2). Rise in vector-borne diseases With increasing temperatures and higher humidity, more pesticides are also being used in the agriculture sector. According to the report, there are more than 870 million workers in agriculture that are likely to be exposed to pesticides, with more than 300,000 deaths attributed to pesticide poisoning annually. Azzi notes that “15,000 people die due to parasitic and vector-borne diseases exposed to in the workplace”. “Obviously, these include a lot of diseases like dengue, rabies and various diseases that are increasing in regions that we never used to see them before. Malaria has even increased and we’re seeing it’s shown in countries that it never used to be before.” The ILO has planned a meeting in 2025 with government, employer and worker representatives to provide policy guidance on climate hazards. Image Credits: Unsplash, WHO/Diego Rodriguez. Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan HIV medicine dolutegravir. The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of the World Health Organization (WHO). Dolutegravir has fewer side effects and a lower risk of developing resistance. UNAIDS has described the move as an “important breakthrough in public health measures” that breaks “the monopoly”, and could mean that the price of the life-saving medicine is reduced by as much as 80%. “When the power to produce health technologies is held by a few companies, the result all too often is that countries can’t afford the high prices and people who need newer products cannot access them,” said Luisa Cabal, UNAIDS Regional Director for Latin America and the Caribbean. “This decision provides the government with the legal conditions to manufacture or purchase more affordable versions of this essential first-line antiretroviral treatment for all people living with HIV in Colombia, including Venezuelan migrants”, said Ms Cabal. “We are confident that this decision will have an impact across the whole region and beyond, as many middle-income countries are struggling to access generic markets of key health products to prevent and treat HIV infection.” Prohibitive costs This move has also been welcomed by Médecins Sans Frontières (MSF), Public Citizen and Global Humanitarian Progress Corporation Colombia. ⚡️⚡️⚡️Breaking News: Colombia issues its first compulsory license (CL) for the HIV drug dolutegravir bringing the price down from US$1,224 per patient per year by ViiV to $44 through generics. This proves the power of generic competition!!! https://t.co/yPSpAFzJyJ — Shailly Gupta (@Shaillytweeting) April 25, 2024 “Colombia’s decision to issue a compulsory license for dolutegravir is great news because, until now, we have not been able to introduce dolutegravir in our medical operations, as the costs have been prohibitive,” said Dr Carmenza Gálvez, MSF’s medical coordinator for Colombia and Panama. Although generic versions of dolutegravir are available internationally for a fraction of ViiV’s price through voluntary licenses with the Medicines Patent Pool (MPP), ViiV excluded Colombia and many middle-income countries from being able to benefit from its license with MPP, allowing ViiV to maintain its monopoly and continue to charge high prices in Colombia and other countries excluded from the license. The Global Fund buys generic dolutegravir for $22.80 per patient per year, while Pan-American Health Organization (PAHO) can procure it for $44 – but Colombia cannot access these prices. According to the Colombian government, the estimated cost of dolutegravir sold by ViiV under the brand name, Tivicay, is around $1,224 per patient per year in 2023. If Colombia can procure the generics for $44, it will be able to treat 27 people for what it is paying for one person at present. According to UNAIDS, Colombia hosts the largest number of Venezuelan migrants in the world (2.9 million as of October 2022), and “recent studies have shown a 0.9% HIV prevalence among this migrant population, almost double the 0.5% HIV prevalence among the country’s adult population”. Compulsory licensing is a provision in the World Trade Organization (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement). It enables governments to supply its citizens with generic versions of patented treatments either through domestic production or imports, ensuring health products’ prices are affordable. The 2001 WTO Declaration on the TRIPS agreement and public health reaffirmed the rights of member states to make use of all flexibilities in the TRIPS agreement to protect public health, including compulsory licenses. More recently, in the 2021 Political Declaration on HIV/AIDS, countries committed to make use of TRIPS flexibilities, specifically geared to promoting access to medicines. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Food Insecurity Affects 282 Million People in 2023 29/04/2024 Disha Shetty Food insecurity increased in 2023 due to a combination of conflicts, economic shocks and extreme weather events. In 2023, nearly 282 million people – 21.5% of the analysed population across 59 countries and territories – faced high levels of acute food insecurity, according to the Global Report on Food Crises (GRFC) 2024. This is 24 million more people than 2022. The rise was due to the report’s increased coverage of food crisis contexts and a sharp deterioration in food security, especially Gaza and Sudan. “The Gaza Strip became the most severe food crisis in our reporting history. Conflict and insecurity, along with extreme weather, events and economic shocks, are the key drivers of food insecurity and nutrition crisis,” said Dominique Burgeon, Director of the Food and Agriculture Organization (FAO) Liaison Office in Geneva. The current situation in the Gaza Strip accounts for 80% of those facing imminent famine, along with South Sudan, Burkina Faso, Somalia and Mali. For four consecutive years, the proportion of people facing acute food insecurity has remained persistently high at almost 22% of those assessed, significantly exceeding pre-COVID-19 levels. “This crisis demands an urgent response. Using the data in this report to transform food systems and address the underlying causes of food insecurity and malnutrition will be vital,” said António Guterres, UN Secretary-General. Number of people facing high levels of acute food insecurity in 59 countries and territories in 2023.(GRFC 2024) The report brings focuses on the enormity of the challenge of achieving the end of hunger by 2030 – a key UN Sustainable Development Goal. Improvements in food security in some countries was outweighed by deteriorating conditions in others. Over 26 million people are one step away from famine, while the total population in catastrophe was “more than four times higher than in 2016,” said Burgeon.The report was produced by the Global Network Against Food Crises (GNAFC), a multi-stakeholder initiative that is working to address the food crises. Protracted hunger Acute malnutrition worsened in 2023, particularly among people displaced because of conflict and disasters. Children and women are at the forefront of these hunger crises, with over 36 million children under five years of age acutely malnourished across 32 countries, the report showed. “The report also tells us that 60% of children experiencing acute malnutrition live in the ten countries facing the highest level of acute food insecurity,” said Burgeon of FAO. Thirty six countries have consistently featured in the GRFC analyses since 2016, reflecting continuing years of acute hunger, and currently representing 80% of the world’s most hungry. One million people more people face emergency levels of acute food insecurity across 39 countries and territories. In 2023, more than 705,000 people were at the catastrophe level of food insecurity and at risk of starvation – the highest number in the GRFC’s reporting history and up fourfold since 2016. The share of the analysed population facing high levels of acute food insecurity increased sharply from 14 percent in 2018 to more than 20 percent each year since 2020. Key drivers: Conflicts and extreme weather Conflict remained the primary driver of hunger, affecting 20 countries and forcing 135 million people into acute food insecurity – almost half of the global number. Sudan faced the largest deterioration due to conflict, with 8.6 million more people facing high levels of acute food insecurity as compared with 2022. “Sudan is a major concern for, the nutrition component because primarily of the major caseload, the number of people is staggering and also for the difficulty of reaching these people. In many areas, there is impossible access and or inconsistent access,” said Stefano Fedele, Global Nutrition Cluster Coordinator for UNICEF Geneva. Extreme weather events were the primary drivers in 18 countries where over 77 million people faced high levels of acute food insecurity, up from 12 countries with 57 million people in 2022. The impacts of economic shocks affected 21 countries where around 75 million people were facing high levels of acute food insecurity, due to their high dependency on imported food and agricultural inputs, persisting macroeconomic challenges, including currency depreciation, high prices and high debt levels. The drivers of food insecurity are interlinked and mutually reinforcing Breaking the cycle Tackling persistent food crises requires urgent long-term national and international investment to transform food systems and boost agricultural and rural development, according to the report. It also advocates for peace and prevention of conflict to become an integral part of the longer-term food systems transformation. Since 2023, needs have outpaced available resources and many humanitarian operations now overstretched, with many being forced to scale-down and further cut support to the most vulnerable. “This is truly a global challenge. There are far too many people waking up in the morning not knowing where their next meal will come from, not knowing how to feed their children, and having to make really truly impossible decisions throughout the course of their day to ensure that their most fundamental needs are being met,” said Courtney Blake, Senior Humanitarian Advisor for the US Mission in Geneva. Image Credits: Unsplash, Global Report on Food Security 2024. Final Pandemic Agreement Talks Start Amid Gamble on Process and African Show of Unity 28/04/2024 Kerry Cullinan The Africa CDC convened a high-level meeting in Addis Ababa on Saturday to discuss the continent’s position on the draft pandemic agreement. The World Health Organization’s (WHO) pandemic agreement negotiations begin their final two-week stretch on Monday (28 April) amid a gamble with the process, a show of unity from African member states – and more suggestions for the draft text. This final intergovernmental negotiating body (INB) meeting will focus on finding “common ground and consensus”, according to a decision taken at the last fractious meeting. The programme of work sets down 12-hour days, with the first week (29 April-3 May) focusing on finalising the substantive negotiations on the draft text. A “stock take” of progress will be held on Friday 3 May, and the second week (6-10 May) will look at outstanding articles, along with the draft resolution for the World Health Assembly at the end of May. The INB Bureau has also undertaken to provide daily briefing to relevant stakeholders on progress. ‘Take it or leave it’ After the previous session at which member states expressed frustration with one another and the INB Bureau, the INB co-chairs have taken a gamble with the process this time – and member states may not play along. The multitude of bracketed contested text has been purged from the new draft, and the co-chairs want the meeting to focus on saying “yes”, rather than being bogged down by disagreements. The meeting will go through the 23-page draft paragraph by paragraph, and member states that don’t agree with the text will be invited to have informal sessions, the co-chairs told a recent stakeholder briefing. But the draft will be considered as the default text where there is no consensus, which the co-chairs described as a “take it or leave it” approach. “The Bureau is of the opinion that the text as presented in the proposal for a WHO Pandemic Agreement is consensus ready,” it explained in a briefing document sent to stakeholders on Friday (26 April). “It was drafted on the basis of our many rounds of negotiations. The co-chairs will open the different articles and will ask the member states if the article is ready for approval. If not, delegations will be invited to explain what their issue with the article is. “Where possible the co-chairs will immediately propose a way forward. If the issue at hand is more fundamental, either a small informal meeting between a few member states can be proposed, or – if more member states want to be involved – a working group session can be proposed.” These working groups would be led by a member of the Bureau and the plan would be found them to return to the drafting group with a solution. At the recent stakeholder briefing, the European Union indicated that not all the text was consensus-based while Bangladesh, a key player in the Group of Equity negotiating bloc, criticised the approach of grabbing “low-hanging fruit for the sake of consensus”. 🇧🇩Bangladesh doubted finishing by May 2024, criticized agreeing to “low-hanging fruit for the sake of consensus,” proposed one IGWG on all remaining topics (not separate), and opposed parallel discussions during #INB9. 🇬🇧The UK asked about civil society engagement (thank you!). pic.twitter.com/TXcGsFnCkl — Nina Schwalbe (@nschwalbe) April 19, 2024 Africa asserts unity Meanwhile, African leaders urged continental unity and pragmatism at a high-level meeting on the pandemic negotiations convened on Saturday by the Africa Centre for Disease Control and Prevention (Africa CDC). Dr Monique Nsanzabaganwa, Deputy Chairperson of the African Union, urged pragmatism and realism at the meeting, attended by health ministers, diplomats and UN agency officials. Dr Monique Nsanzabaganwa, Deputy Chairperson of the African Union “At the time of COVID, multilateralism collapsed completely and then Africa was shut [out of] accessing all the things we needed at the time, the PPE and the vaccines,” she said, adding that the pandemic negotiations were an attempt to revive multilateralism. “In some situations, we don’t have a choice because we need to continue being pragmatic as we look for all conditions that can allow us some equity and some flexibilities and conducive conditions for us to do what we’ll have to do for ourselves,” she added. Africa CDC Director General Dr Jean Kaseya told the meeting, which was also briefed by INB co-chair Precious Matsoso, that “what matters most is for the continent to speak with one voice”. He stressed that Africa’s priorities, as contained in its New Public Order, are “to boost manufacturing capacities, expanded manufacturing capabilities, tech transfer, resilient supply chains, and robust regulatory frameworks”. At the high-level strategic meeting for #INB Negotiations today, I underlined Africa's #NewPublicHealthOrder priorities which are to boost manufacturing capacities, expanded manufacturing capabilities, tech transfer, resilient supply chains, and robust regulatory frameworks.… pic.twitter.com/XUoK6Oa0Ro — Jean Kaseya (@JeanKaseya2) April 27, 2024 Kaseya said member states had three options: to reject the agreement, to accept it, or to bring “strategic thinking” to the Geneva negotiations, which was “not yes or no”. Whatever happened, he urged that the continent speak with “one voice” during the “tough” upcoming negotiations. A communique released after the meeting identified Africa’s three bottom lines, which related to equity, pandemic prevention, preparedness and response (PPPR) and predictable, sustainable governing and financing. However, Africa CDC withdrew the communique a few hours later and claimed another would be following shortly . However, no replacement had been sent by late Sunday night, indicating some disagreement between parties about how to express the outcome of the meeting – not exactly an auspicious start for negotiations. One of Africa’s bottom lines has been in relation to PABS, where continental leaders have insisted that they need to be compensated for sharing information about pathogens. The current draft agreement proposes that details of a mutually beneficial PABS system – one of the biggest areas of disagreement – will only be finalised by mid-2026. However, the continent stressed its leaders were ready to engage actively in finalising the agreement. Ethiopia’s Ambassador to Geneva, Tsegab Kebebew Daka, told a recent event in Geneva that “the differences in the text are not huge”. “They are mainly differences of ideas and they’re not that many. So we can come to an agreement,” Daka, a key negotiator for the Africa group, told the event at the Geneva Graduate Institute’s Global Health Centre. While Daka acknowledged that there were still sticking points, he appealed to member states to take a “holistic view on the entire pandemic agreement” rather than dwelling on “specific articles where we have differences” – thereby endorsing the Bureau’s approach. WHO Group is ‘Very Close’ But Fails to Agree on Changes to International Health Regulations 26/04/2024 Kerry Cullinan An exhausted looking WGIHR co-chair Ashley Bloomfield reports back on the process The World Health Organization’s (WHO) working group has failed to meet its deadline of Friday (26 April) for amending the rules governing global disease outbreaks – the International Health Regulations (IHR) – and will reconvene. This emerged late afternoon on Friday (26 April) at a briefing after the week-long Working Group of Amendments to the IHR (WGIHR), when drawn co-chair Dr Ashley Bloomfield announced that the group would reconvene on 16 and 17 May for a final two days’ negotiation. “The mood in the room has been outstanding, and we have worked really hard to make amazing progress. We’re not quite cracking the bottles of champagne and sparkling grape juice, but we were getting very close and I have every sense that you are all committed to finishing the job,” said Bloomfield. WHO Deputy Director General Dr Mike Ryan commended the group, saying he was “very confident” that the IHR would be “a clearer, better instrument for your efforts, something that we can apply better on your behalf and on behalf of the people that you serve”. The WGIHR has asked member states to submit written inputs, particularly on the articles that the meeting failed to reach agreement on or did not discuss, by 6 May and it will reconvene for a further two days after that. The Articles that still need agreement relate to technology transfer, financing and governance. However, many of the WGIHR members are also part of the pandemic agreement talks, which start on Monday 29 April under the intergovernmental negotiating body (INB). The programme of work for the INB envisages 12-hour days, so there will be no space for IHR talks until after 10 May. However, the two processes are closer linked and the definitions adopted by the IHR, including all the phases that led up to the WHP Director General declaring a public health emergency of international concern (PHEIC), will be used in the pandemic agreement. The World Health Assembly, which is due to ratify the amendments, begins on 27 May, so time is very tight. The WGIHR will submit an updated proposed text to member states by 10 May. While No Human-to-Human Transmission Yet, Scientists Are Concerned About Rapid Spread of Avian Flu 26/04/2024 Zuzanna Stawiska The ongoing global spread of “bird flu” infections to mammals including humans is a significant public health concern While no cases of human-to-human transmission have been recorded in the current H5N1 avian outbreak, scientists are concerned about its transmission speed in mammals and whether this might result in a mutated pathogen that can infect people more easily. “H5N1 is (an) influenza infection, predominantly started in poultry and ducks and has spread effectively over the course of the last one or two years to become a global zoonotic – animal – pandemic,” said Dr Jeremy Farrar, the World Health Organization’s (WHO) Chief Scientist. “The great concern, of course, is that in doing so and infecting ducks and chickens – but now increasingly mammals – that that virus now evolves and develops the ability to infect humans. And then critically, the ability to go from human-to-human transmission,” Farrar told a media briefing in Geneva last week. At the WHO’s global media briefing on Wednesday, WHO epidemiologist Dr Maria Van Kerkhove that “we have not seen human-to-human transmission in the recent cases, and I think that’s really important because there’s a lot of news right now on influenza”. Spread in US dairy herds H5N1 has been detected in cattle in 33 dairy herds in eight US states, according to the latest US Centers for Disease Control and Prevention (CDC) report on 24 April. Remnants of the virus have also been detected in raw milk. US CDC described “this degree of spread outside of birds & poultry is unprecedented and concerning” and the US Department of Agriculture has restricted interstate cow transport to limit the spread of the disease. One human infection has been reported in a Texas, cattle farm worker in late March. Genomic sequencing from this patient found that each individual gene segment was “closely related to viruses detected in dairy cattle” in Texas, according to US CDC. “While minor changes were identified in the virus sequence from the patient specimen compared to the viral sequences from cattle, both cattle and human sequences maintain primarily avian genetic characteristics and, for the most part, lack changes that would make them better adapted to infect mammals,” it noted. “There are no markers known to be associated with influenza antiviral resistance found in the virus sequences from the patient’s specimen and the virus is very closely related to two existing candidate vaccine viruses that are already available to manufacturers, and which could be used to make vaccine if needed,” added. Overall, the genetic analysis “supports CDC’s conclusion that the human health risk currently remains low”. US public officials said that Tamiflu, an antiviral effective for treating influenza, is stockpiled for a potential emergency, NPR reported. Some candidate vaccines for H5N1 are also in development and there are some options for enhancing present supply. US states where H5N1 has been detected in cattle Historically, human cases of the H5N1 virus are so far very rare, with only 889 cases reported to the WHO since 2003, all involving people who came in contact with infected animals. But virus mortality reaches 52%, which is “extraordinary high”, said Farrar, who urged close monitoring and investigation of the outbreaks in US cattle by public health authorities “because it may evolve into transmitting in different ways”. “Do the milking structures of cows create aerosols? Is it the environment which they’re living in? Is it the transport system that is spreading this around the country?” he asked. “This is a huge concern and I think we have to … make sure that if H5N1 did come across to humans with human-to-human transmission that we were in a position to immediately respond with access equitably to vaccines, therapeutics and diagnostics.” Different strains, different severity Though avian influenza viruses naturally occur in wild water birds, some variants are also known to develop the ability to infect other animals. The virus has multiple variants of differing severity and transmission possibilities. A case of human infection with the much milder strain of avian influenza virus (H9N2) was confirmed in Viet Nam on 9 April by the International Health Regulations (IHR) National Focal Point, as WHO reported. The same virus strain was also detected in three patients in China,according to the Centre for Health Protection of Hong Kong. H9N2 usually results in mild infections of the upper respiratory tract, mostly affecting children. It is a low pathogenic avian influenza, usually showing only mild disease in chickens and other poultry, according to the US CDC. Systems in place to respond Maria van Kerkhove “We are concerned about this particular virus because we know influenza has the potential to cause epidemics,” said Van Kerkhove. “That’s why we have a global system in place to monitor detect, to rapidly do risk assessments to look at viruses that could potentially be used in vaccines as we go forward.” However, she expressed confidence that risks of an outbreak in human populations remain low and that existing WHO surveillance systems competent to monitor any developments. ”We have a global influenza surveillance and response system that’s been in place for 70 years. And within this systems, there are strong surveillance components, made up of labs around the world, made up of many partner agencies,” she assured the media briefing. Dr Michael Ryan, WHO’s Executive Director of the Health Emergencies Programme, backed Van Kerkhove: “We have a system that can measure and we have countermeasures ready to go should anything happen and that’s all we can do in public health.” “We can’t stop living because viruses threaten us. What we can do is be ready to respond,” he said,. The Pandemic Influenza Preparedness Framework “has been in place again for 20 years and has provided a framework for collaboration between WHO labs and industry for the sharing of material, for the sharing of vaccines”, added Ryan. Image Credits: Charlotte Kesl/ World Bank. ILO: Excessive Heat Linked to Climate Change Affects 70% of Workers 26/04/2024 Disha Shetty Outdoor workers are at a high potential health risk as climate change worsens heat. Over 70% of the world’s workforce faces potential health risks due to climate change, according to the latest report by the International Labour Organization (ILO) released earlier this week. Nearly 1.6 billion outdoor workers are also at risk from high levels of air pollution. “More than 70% of our workers are exposed to excessive heat at least one point in their working lives. That’s 2.4 billion workers globally out of a global workforce of 3.4 billion,” said Manal Azzi, Senior Specialist on Occupational Safety and Health (ILO) at the report launch at the United Nations in Geneva. The report, Ensuring safety and health at work in a changing climate, states that climate change is already having a serious impact on the safety and health of workers in all regions of the world. The share of global workers impacted by climate change hazards has increased by about from 65% in 2020 to 70% in 2024, the report said. Workers in the world’s most impoverished regions face heightened risks from scorching heatwaves, prolonged droughts, raging wildfires, and devastating hurricanes, according to the ILO. Did you know? 🌍🔥 Over 2.4 billion workers face excessive heat due to #ClimateChange. ⏳It's a race against time for safety and health. Learn more at our global event tomorrow: https://t.co/i3SlGiyisO#SafeDay2024 pic.twitter.com/LnofX5hKif — International Labour Organization (@ilo) April 24, 2024 Range of climate-linked health risks The report notes that numerous health conditions in workers have been linked to climate change, including cancer, cardiovascular disease, respiratory illnesses, kidney dysfunction and mental health conditions. The impact includes the 1.6 billion workers exposed to UV radiation, with more than 18,960 work-related deaths annually from non-melanoma skin cancer. “More than 22 million workers are suffering from sicknesses and injuries related to exposure to excessive heat and these can range from injuries in transport, in traffic accidents due to bad night of sleep because it was excessively hot, to construction accidents, injuries, slips and falls related to the exposure to heat,” Azzi said. Many deaths are also directly related to the impact of climate change. “Nearly 20,000 workers are dying yearly because of these injuries in the workplace related to rising temperatures and to exposure to excessive heat, indoor and outdoor heat, and losing millions – over two million disability-adjusted years – are lost because of injuries and deaths related to heat,” said Azzi, who is the ILO’s specialist on occupational safety and health. A traditional brick factory in Tozeur, southern Tunisia. In Africa and South Asia brick making and waste burning are major sources of air pollution. High levels of air pollution causing harm The report also said that nearly 1.6 billion outdoor workers are at risk of health impacts due to worsening air pollution, particularly those working in the transport sector and firefighters. Around 860,000 work-related deaths have been attributed to air pollution for outdoor workers annually. The report noted that modified weather patterns due to climate change have influenced levels of outdoor air pollutants, such as ground-level ozone, fine (PM2.5) and course (PM10) particulate matter, nitrogen dioxide (NO2), and sulphur dioxide (SO2). Rise in vector-borne diseases With increasing temperatures and higher humidity, more pesticides are also being used in the agriculture sector. According to the report, there are more than 870 million workers in agriculture that are likely to be exposed to pesticides, with more than 300,000 deaths attributed to pesticide poisoning annually. Azzi notes that “15,000 people die due to parasitic and vector-borne diseases exposed to in the workplace”. “Obviously, these include a lot of diseases like dengue, rabies and various diseases that are increasing in regions that we never used to see them before. Malaria has even increased and we’re seeing it’s shown in countries that it never used to be before.” The ILO has planned a meeting in 2025 with government, employer and worker representatives to provide policy guidance on climate hazards. Image Credits: Unsplash, WHO/Diego Rodriguez. Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan HIV medicine dolutegravir. The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of the World Health Organization (WHO). Dolutegravir has fewer side effects and a lower risk of developing resistance. UNAIDS has described the move as an “important breakthrough in public health measures” that breaks “the monopoly”, and could mean that the price of the life-saving medicine is reduced by as much as 80%. “When the power to produce health technologies is held by a few companies, the result all too often is that countries can’t afford the high prices and people who need newer products cannot access them,” said Luisa Cabal, UNAIDS Regional Director for Latin America and the Caribbean. “This decision provides the government with the legal conditions to manufacture or purchase more affordable versions of this essential first-line antiretroviral treatment for all people living with HIV in Colombia, including Venezuelan migrants”, said Ms Cabal. “We are confident that this decision will have an impact across the whole region and beyond, as many middle-income countries are struggling to access generic markets of key health products to prevent and treat HIV infection.” Prohibitive costs This move has also been welcomed by Médecins Sans Frontières (MSF), Public Citizen and Global Humanitarian Progress Corporation Colombia. ⚡️⚡️⚡️Breaking News: Colombia issues its first compulsory license (CL) for the HIV drug dolutegravir bringing the price down from US$1,224 per patient per year by ViiV to $44 through generics. This proves the power of generic competition!!! https://t.co/yPSpAFzJyJ — Shailly Gupta (@Shaillytweeting) April 25, 2024 “Colombia’s decision to issue a compulsory license for dolutegravir is great news because, until now, we have not been able to introduce dolutegravir in our medical operations, as the costs have been prohibitive,” said Dr Carmenza Gálvez, MSF’s medical coordinator for Colombia and Panama. Although generic versions of dolutegravir are available internationally for a fraction of ViiV’s price through voluntary licenses with the Medicines Patent Pool (MPP), ViiV excluded Colombia and many middle-income countries from being able to benefit from its license with MPP, allowing ViiV to maintain its monopoly and continue to charge high prices in Colombia and other countries excluded from the license. The Global Fund buys generic dolutegravir for $22.80 per patient per year, while Pan-American Health Organization (PAHO) can procure it for $44 – but Colombia cannot access these prices. According to the Colombian government, the estimated cost of dolutegravir sold by ViiV under the brand name, Tivicay, is around $1,224 per patient per year in 2023. If Colombia can procure the generics for $44, it will be able to treat 27 people for what it is paying for one person at present. According to UNAIDS, Colombia hosts the largest number of Venezuelan migrants in the world (2.9 million as of October 2022), and “recent studies have shown a 0.9% HIV prevalence among this migrant population, almost double the 0.5% HIV prevalence among the country’s adult population”. Compulsory licensing is a provision in the World Trade Organization (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement). It enables governments to supply its citizens with generic versions of patented treatments either through domestic production or imports, ensuring health products’ prices are affordable. The 2001 WTO Declaration on the TRIPS agreement and public health reaffirmed the rights of member states to make use of all flexibilities in the TRIPS agreement to protect public health, including compulsory licenses. More recently, in the 2021 Political Declaration on HIV/AIDS, countries committed to make use of TRIPS flexibilities, specifically geared to promoting access to medicines. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Final Pandemic Agreement Talks Start Amid Gamble on Process and African Show of Unity 28/04/2024 Kerry Cullinan The Africa CDC convened a high-level meeting in Addis Ababa on Saturday to discuss the continent’s position on the draft pandemic agreement. The World Health Organization’s (WHO) pandemic agreement negotiations begin their final two-week stretch on Monday (28 April) amid a gamble with the process, a show of unity from African member states – and more suggestions for the draft text. This final intergovernmental negotiating body (INB) meeting will focus on finding “common ground and consensus”, according to a decision taken at the last fractious meeting. The programme of work sets down 12-hour days, with the first week (29 April-3 May) focusing on finalising the substantive negotiations on the draft text. A “stock take” of progress will be held on Friday 3 May, and the second week (6-10 May) will look at outstanding articles, along with the draft resolution for the World Health Assembly at the end of May. The INB Bureau has also undertaken to provide daily briefing to relevant stakeholders on progress. ‘Take it or leave it’ After the previous session at which member states expressed frustration with one another and the INB Bureau, the INB co-chairs have taken a gamble with the process this time – and member states may not play along. The multitude of bracketed contested text has been purged from the new draft, and the co-chairs want the meeting to focus on saying “yes”, rather than being bogged down by disagreements. The meeting will go through the 23-page draft paragraph by paragraph, and member states that don’t agree with the text will be invited to have informal sessions, the co-chairs told a recent stakeholder briefing. But the draft will be considered as the default text where there is no consensus, which the co-chairs described as a “take it or leave it” approach. “The Bureau is of the opinion that the text as presented in the proposal for a WHO Pandemic Agreement is consensus ready,” it explained in a briefing document sent to stakeholders on Friday (26 April). “It was drafted on the basis of our many rounds of negotiations. The co-chairs will open the different articles and will ask the member states if the article is ready for approval. If not, delegations will be invited to explain what their issue with the article is. “Where possible the co-chairs will immediately propose a way forward. If the issue at hand is more fundamental, either a small informal meeting between a few member states can be proposed, or – if more member states want to be involved – a working group session can be proposed.” These working groups would be led by a member of the Bureau and the plan would be found them to return to the drafting group with a solution. At the recent stakeholder briefing, the European Union indicated that not all the text was consensus-based while Bangladesh, a key player in the Group of Equity negotiating bloc, criticised the approach of grabbing “low-hanging fruit for the sake of consensus”. 🇧🇩Bangladesh doubted finishing by May 2024, criticized agreeing to “low-hanging fruit for the sake of consensus,” proposed one IGWG on all remaining topics (not separate), and opposed parallel discussions during #INB9. 🇬🇧The UK asked about civil society engagement (thank you!). pic.twitter.com/TXcGsFnCkl — Nina Schwalbe (@nschwalbe) April 19, 2024 Africa asserts unity Meanwhile, African leaders urged continental unity and pragmatism at a high-level meeting on the pandemic negotiations convened on Saturday by the Africa Centre for Disease Control and Prevention (Africa CDC). Dr Monique Nsanzabaganwa, Deputy Chairperson of the African Union, urged pragmatism and realism at the meeting, attended by health ministers, diplomats and UN agency officials. Dr Monique Nsanzabaganwa, Deputy Chairperson of the African Union “At the time of COVID, multilateralism collapsed completely and then Africa was shut [out of] accessing all the things we needed at the time, the PPE and the vaccines,” she said, adding that the pandemic negotiations were an attempt to revive multilateralism. “In some situations, we don’t have a choice because we need to continue being pragmatic as we look for all conditions that can allow us some equity and some flexibilities and conducive conditions for us to do what we’ll have to do for ourselves,” she added. Africa CDC Director General Dr Jean Kaseya told the meeting, which was also briefed by INB co-chair Precious Matsoso, that “what matters most is for the continent to speak with one voice”. He stressed that Africa’s priorities, as contained in its New Public Order, are “to boost manufacturing capacities, expanded manufacturing capabilities, tech transfer, resilient supply chains, and robust regulatory frameworks”. At the high-level strategic meeting for #INB Negotiations today, I underlined Africa's #NewPublicHealthOrder priorities which are to boost manufacturing capacities, expanded manufacturing capabilities, tech transfer, resilient supply chains, and robust regulatory frameworks.… pic.twitter.com/XUoK6Oa0Ro — Jean Kaseya (@JeanKaseya2) April 27, 2024 Kaseya said member states had three options: to reject the agreement, to accept it, or to bring “strategic thinking” to the Geneva negotiations, which was “not yes or no”. Whatever happened, he urged that the continent speak with “one voice” during the “tough” upcoming negotiations. A communique released after the meeting identified Africa’s three bottom lines, which related to equity, pandemic prevention, preparedness and response (PPPR) and predictable, sustainable governing and financing. However, Africa CDC withdrew the communique a few hours later and claimed another would be following shortly . However, no replacement had been sent by late Sunday night, indicating some disagreement between parties about how to express the outcome of the meeting – not exactly an auspicious start for negotiations. One of Africa’s bottom lines has been in relation to PABS, where continental leaders have insisted that they need to be compensated for sharing information about pathogens. The current draft agreement proposes that details of a mutually beneficial PABS system – one of the biggest areas of disagreement – will only be finalised by mid-2026. However, the continent stressed its leaders were ready to engage actively in finalising the agreement. Ethiopia’s Ambassador to Geneva, Tsegab Kebebew Daka, told a recent event in Geneva that “the differences in the text are not huge”. “They are mainly differences of ideas and they’re not that many. So we can come to an agreement,” Daka, a key negotiator for the Africa group, told the event at the Geneva Graduate Institute’s Global Health Centre. While Daka acknowledged that there were still sticking points, he appealed to member states to take a “holistic view on the entire pandemic agreement” rather than dwelling on “specific articles where we have differences” – thereby endorsing the Bureau’s approach. WHO Group is ‘Very Close’ But Fails to Agree on Changes to International Health Regulations 26/04/2024 Kerry Cullinan An exhausted looking WGIHR co-chair Ashley Bloomfield reports back on the process The World Health Organization’s (WHO) working group has failed to meet its deadline of Friday (26 April) for amending the rules governing global disease outbreaks – the International Health Regulations (IHR) – and will reconvene. This emerged late afternoon on Friday (26 April) at a briefing after the week-long Working Group of Amendments to the IHR (WGIHR), when drawn co-chair Dr Ashley Bloomfield announced that the group would reconvene on 16 and 17 May for a final two days’ negotiation. “The mood in the room has been outstanding, and we have worked really hard to make amazing progress. We’re not quite cracking the bottles of champagne and sparkling grape juice, but we were getting very close and I have every sense that you are all committed to finishing the job,” said Bloomfield. WHO Deputy Director General Dr Mike Ryan commended the group, saying he was “very confident” that the IHR would be “a clearer, better instrument for your efforts, something that we can apply better on your behalf and on behalf of the people that you serve”. The WGIHR has asked member states to submit written inputs, particularly on the articles that the meeting failed to reach agreement on or did not discuss, by 6 May and it will reconvene for a further two days after that. The Articles that still need agreement relate to technology transfer, financing and governance. However, many of the WGIHR members are also part of the pandemic agreement talks, which start on Monday 29 April under the intergovernmental negotiating body (INB). The programme of work for the INB envisages 12-hour days, so there will be no space for IHR talks until after 10 May. However, the two processes are closer linked and the definitions adopted by the IHR, including all the phases that led up to the WHP Director General declaring a public health emergency of international concern (PHEIC), will be used in the pandemic agreement. The World Health Assembly, which is due to ratify the amendments, begins on 27 May, so time is very tight. The WGIHR will submit an updated proposed text to member states by 10 May. While No Human-to-Human Transmission Yet, Scientists Are Concerned About Rapid Spread of Avian Flu 26/04/2024 Zuzanna Stawiska The ongoing global spread of “bird flu” infections to mammals including humans is a significant public health concern While no cases of human-to-human transmission have been recorded in the current H5N1 avian outbreak, scientists are concerned about its transmission speed in mammals and whether this might result in a mutated pathogen that can infect people more easily. “H5N1 is (an) influenza infection, predominantly started in poultry and ducks and has spread effectively over the course of the last one or two years to become a global zoonotic – animal – pandemic,” said Dr Jeremy Farrar, the World Health Organization’s (WHO) Chief Scientist. “The great concern, of course, is that in doing so and infecting ducks and chickens – but now increasingly mammals – that that virus now evolves and develops the ability to infect humans. And then critically, the ability to go from human-to-human transmission,” Farrar told a media briefing in Geneva last week. At the WHO’s global media briefing on Wednesday, WHO epidemiologist Dr Maria Van Kerkhove that “we have not seen human-to-human transmission in the recent cases, and I think that’s really important because there’s a lot of news right now on influenza”. Spread in US dairy herds H5N1 has been detected in cattle in 33 dairy herds in eight US states, according to the latest US Centers for Disease Control and Prevention (CDC) report on 24 April. Remnants of the virus have also been detected in raw milk. US CDC described “this degree of spread outside of birds & poultry is unprecedented and concerning” and the US Department of Agriculture has restricted interstate cow transport to limit the spread of the disease. One human infection has been reported in a Texas, cattle farm worker in late March. Genomic sequencing from this patient found that each individual gene segment was “closely related to viruses detected in dairy cattle” in Texas, according to US CDC. “While minor changes were identified in the virus sequence from the patient specimen compared to the viral sequences from cattle, both cattle and human sequences maintain primarily avian genetic characteristics and, for the most part, lack changes that would make them better adapted to infect mammals,” it noted. “There are no markers known to be associated with influenza antiviral resistance found in the virus sequences from the patient’s specimen and the virus is very closely related to two existing candidate vaccine viruses that are already available to manufacturers, and which could be used to make vaccine if needed,” added. Overall, the genetic analysis “supports CDC’s conclusion that the human health risk currently remains low”. US public officials said that Tamiflu, an antiviral effective for treating influenza, is stockpiled for a potential emergency, NPR reported. Some candidate vaccines for H5N1 are also in development and there are some options for enhancing present supply. US states where H5N1 has been detected in cattle Historically, human cases of the H5N1 virus are so far very rare, with only 889 cases reported to the WHO since 2003, all involving people who came in contact with infected animals. But virus mortality reaches 52%, which is “extraordinary high”, said Farrar, who urged close monitoring and investigation of the outbreaks in US cattle by public health authorities “because it may evolve into transmitting in different ways”. “Do the milking structures of cows create aerosols? Is it the environment which they’re living in? Is it the transport system that is spreading this around the country?” he asked. “This is a huge concern and I think we have to … make sure that if H5N1 did come across to humans with human-to-human transmission that we were in a position to immediately respond with access equitably to vaccines, therapeutics and diagnostics.” Different strains, different severity Though avian influenza viruses naturally occur in wild water birds, some variants are also known to develop the ability to infect other animals. The virus has multiple variants of differing severity and transmission possibilities. A case of human infection with the much milder strain of avian influenza virus (H9N2) was confirmed in Viet Nam on 9 April by the International Health Regulations (IHR) National Focal Point, as WHO reported. The same virus strain was also detected in three patients in China,according to the Centre for Health Protection of Hong Kong. H9N2 usually results in mild infections of the upper respiratory tract, mostly affecting children. It is a low pathogenic avian influenza, usually showing only mild disease in chickens and other poultry, according to the US CDC. Systems in place to respond Maria van Kerkhove “We are concerned about this particular virus because we know influenza has the potential to cause epidemics,” said Van Kerkhove. “That’s why we have a global system in place to monitor detect, to rapidly do risk assessments to look at viruses that could potentially be used in vaccines as we go forward.” However, she expressed confidence that risks of an outbreak in human populations remain low and that existing WHO surveillance systems competent to monitor any developments. ”We have a global influenza surveillance and response system that’s been in place for 70 years. And within this systems, there are strong surveillance components, made up of labs around the world, made up of many partner agencies,” she assured the media briefing. Dr Michael Ryan, WHO’s Executive Director of the Health Emergencies Programme, backed Van Kerkhove: “We have a system that can measure and we have countermeasures ready to go should anything happen and that’s all we can do in public health.” “We can’t stop living because viruses threaten us. What we can do is be ready to respond,” he said,. The Pandemic Influenza Preparedness Framework “has been in place again for 20 years and has provided a framework for collaboration between WHO labs and industry for the sharing of material, for the sharing of vaccines”, added Ryan. Image Credits: Charlotte Kesl/ World Bank. ILO: Excessive Heat Linked to Climate Change Affects 70% of Workers 26/04/2024 Disha Shetty Outdoor workers are at a high potential health risk as climate change worsens heat. Over 70% of the world’s workforce faces potential health risks due to climate change, according to the latest report by the International Labour Organization (ILO) released earlier this week. Nearly 1.6 billion outdoor workers are also at risk from high levels of air pollution. “More than 70% of our workers are exposed to excessive heat at least one point in their working lives. That’s 2.4 billion workers globally out of a global workforce of 3.4 billion,” said Manal Azzi, Senior Specialist on Occupational Safety and Health (ILO) at the report launch at the United Nations in Geneva. The report, Ensuring safety and health at work in a changing climate, states that climate change is already having a serious impact on the safety and health of workers in all regions of the world. The share of global workers impacted by climate change hazards has increased by about from 65% in 2020 to 70% in 2024, the report said. Workers in the world’s most impoverished regions face heightened risks from scorching heatwaves, prolonged droughts, raging wildfires, and devastating hurricanes, according to the ILO. Did you know? 🌍🔥 Over 2.4 billion workers face excessive heat due to #ClimateChange. ⏳It's a race against time for safety and health. Learn more at our global event tomorrow: https://t.co/i3SlGiyisO#SafeDay2024 pic.twitter.com/LnofX5hKif — International Labour Organization (@ilo) April 24, 2024 Range of climate-linked health risks The report notes that numerous health conditions in workers have been linked to climate change, including cancer, cardiovascular disease, respiratory illnesses, kidney dysfunction and mental health conditions. The impact includes the 1.6 billion workers exposed to UV radiation, with more than 18,960 work-related deaths annually from non-melanoma skin cancer. “More than 22 million workers are suffering from sicknesses and injuries related to exposure to excessive heat and these can range from injuries in transport, in traffic accidents due to bad night of sleep because it was excessively hot, to construction accidents, injuries, slips and falls related to the exposure to heat,” Azzi said. Many deaths are also directly related to the impact of climate change. “Nearly 20,000 workers are dying yearly because of these injuries in the workplace related to rising temperatures and to exposure to excessive heat, indoor and outdoor heat, and losing millions – over two million disability-adjusted years – are lost because of injuries and deaths related to heat,” said Azzi, who is the ILO’s specialist on occupational safety and health. A traditional brick factory in Tozeur, southern Tunisia. In Africa and South Asia brick making and waste burning are major sources of air pollution. High levels of air pollution causing harm The report also said that nearly 1.6 billion outdoor workers are at risk of health impacts due to worsening air pollution, particularly those working in the transport sector and firefighters. Around 860,000 work-related deaths have been attributed to air pollution for outdoor workers annually. The report noted that modified weather patterns due to climate change have influenced levels of outdoor air pollutants, such as ground-level ozone, fine (PM2.5) and course (PM10) particulate matter, nitrogen dioxide (NO2), and sulphur dioxide (SO2). Rise in vector-borne diseases With increasing temperatures and higher humidity, more pesticides are also being used in the agriculture sector. According to the report, there are more than 870 million workers in agriculture that are likely to be exposed to pesticides, with more than 300,000 deaths attributed to pesticide poisoning annually. Azzi notes that “15,000 people die due to parasitic and vector-borne diseases exposed to in the workplace”. “Obviously, these include a lot of diseases like dengue, rabies and various diseases that are increasing in regions that we never used to see them before. Malaria has even increased and we’re seeing it’s shown in countries that it never used to be before.” The ILO has planned a meeting in 2025 with government, employer and worker representatives to provide policy guidance on climate hazards. Image Credits: Unsplash, WHO/Diego Rodriguez. Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan HIV medicine dolutegravir. The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of the World Health Organization (WHO). Dolutegravir has fewer side effects and a lower risk of developing resistance. UNAIDS has described the move as an “important breakthrough in public health measures” that breaks “the monopoly”, and could mean that the price of the life-saving medicine is reduced by as much as 80%. “When the power to produce health technologies is held by a few companies, the result all too often is that countries can’t afford the high prices and people who need newer products cannot access them,” said Luisa Cabal, UNAIDS Regional Director for Latin America and the Caribbean. “This decision provides the government with the legal conditions to manufacture or purchase more affordable versions of this essential first-line antiretroviral treatment for all people living with HIV in Colombia, including Venezuelan migrants”, said Ms Cabal. “We are confident that this decision will have an impact across the whole region and beyond, as many middle-income countries are struggling to access generic markets of key health products to prevent and treat HIV infection.” Prohibitive costs This move has also been welcomed by Médecins Sans Frontières (MSF), Public Citizen and Global Humanitarian Progress Corporation Colombia. ⚡️⚡️⚡️Breaking News: Colombia issues its first compulsory license (CL) for the HIV drug dolutegravir bringing the price down from US$1,224 per patient per year by ViiV to $44 through generics. This proves the power of generic competition!!! https://t.co/yPSpAFzJyJ — Shailly Gupta (@Shaillytweeting) April 25, 2024 “Colombia’s decision to issue a compulsory license for dolutegravir is great news because, until now, we have not been able to introduce dolutegravir in our medical operations, as the costs have been prohibitive,” said Dr Carmenza Gálvez, MSF’s medical coordinator for Colombia and Panama. Although generic versions of dolutegravir are available internationally for a fraction of ViiV’s price through voluntary licenses with the Medicines Patent Pool (MPP), ViiV excluded Colombia and many middle-income countries from being able to benefit from its license with MPP, allowing ViiV to maintain its monopoly and continue to charge high prices in Colombia and other countries excluded from the license. The Global Fund buys generic dolutegravir for $22.80 per patient per year, while Pan-American Health Organization (PAHO) can procure it for $44 – but Colombia cannot access these prices. According to the Colombian government, the estimated cost of dolutegravir sold by ViiV under the brand name, Tivicay, is around $1,224 per patient per year in 2023. If Colombia can procure the generics for $44, it will be able to treat 27 people for what it is paying for one person at present. According to UNAIDS, Colombia hosts the largest number of Venezuelan migrants in the world (2.9 million as of October 2022), and “recent studies have shown a 0.9% HIV prevalence among this migrant population, almost double the 0.5% HIV prevalence among the country’s adult population”. Compulsory licensing is a provision in the World Trade Organization (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement). It enables governments to supply its citizens with generic versions of patented treatments either through domestic production or imports, ensuring health products’ prices are affordable. The 2001 WTO Declaration on the TRIPS agreement and public health reaffirmed the rights of member states to make use of all flexibilities in the TRIPS agreement to protect public health, including compulsory licenses. More recently, in the 2021 Political Declaration on HIV/AIDS, countries committed to make use of TRIPS flexibilities, specifically geared to promoting access to medicines. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Group is ‘Very Close’ But Fails to Agree on Changes to International Health Regulations 26/04/2024 Kerry Cullinan An exhausted looking WGIHR co-chair Ashley Bloomfield reports back on the process The World Health Organization’s (WHO) working group has failed to meet its deadline of Friday (26 April) for amending the rules governing global disease outbreaks – the International Health Regulations (IHR) – and will reconvene. This emerged late afternoon on Friday (26 April) at a briefing after the week-long Working Group of Amendments to the IHR (WGIHR), when drawn co-chair Dr Ashley Bloomfield announced that the group would reconvene on 16 and 17 May for a final two days’ negotiation. “The mood in the room has been outstanding, and we have worked really hard to make amazing progress. We’re not quite cracking the bottles of champagne and sparkling grape juice, but we were getting very close and I have every sense that you are all committed to finishing the job,” said Bloomfield. WHO Deputy Director General Dr Mike Ryan commended the group, saying he was “very confident” that the IHR would be “a clearer, better instrument for your efforts, something that we can apply better on your behalf and on behalf of the people that you serve”. The WGIHR has asked member states to submit written inputs, particularly on the articles that the meeting failed to reach agreement on or did not discuss, by 6 May and it will reconvene for a further two days after that. The Articles that still need agreement relate to technology transfer, financing and governance. However, many of the WGIHR members are also part of the pandemic agreement talks, which start on Monday 29 April under the intergovernmental negotiating body (INB). The programme of work for the INB envisages 12-hour days, so there will be no space for IHR talks until after 10 May. However, the two processes are closer linked and the definitions adopted by the IHR, including all the phases that led up to the WHP Director General declaring a public health emergency of international concern (PHEIC), will be used in the pandemic agreement. The World Health Assembly, which is due to ratify the amendments, begins on 27 May, so time is very tight. The WGIHR will submit an updated proposed text to member states by 10 May. While No Human-to-Human Transmission Yet, Scientists Are Concerned About Rapid Spread of Avian Flu 26/04/2024 Zuzanna Stawiska The ongoing global spread of “bird flu” infections to mammals including humans is a significant public health concern While no cases of human-to-human transmission have been recorded in the current H5N1 avian outbreak, scientists are concerned about its transmission speed in mammals and whether this might result in a mutated pathogen that can infect people more easily. “H5N1 is (an) influenza infection, predominantly started in poultry and ducks and has spread effectively over the course of the last one or two years to become a global zoonotic – animal – pandemic,” said Dr Jeremy Farrar, the World Health Organization’s (WHO) Chief Scientist. “The great concern, of course, is that in doing so and infecting ducks and chickens – but now increasingly mammals – that that virus now evolves and develops the ability to infect humans. And then critically, the ability to go from human-to-human transmission,” Farrar told a media briefing in Geneva last week. At the WHO’s global media briefing on Wednesday, WHO epidemiologist Dr Maria Van Kerkhove that “we have not seen human-to-human transmission in the recent cases, and I think that’s really important because there’s a lot of news right now on influenza”. Spread in US dairy herds H5N1 has been detected in cattle in 33 dairy herds in eight US states, according to the latest US Centers for Disease Control and Prevention (CDC) report on 24 April. Remnants of the virus have also been detected in raw milk. US CDC described “this degree of spread outside of birds & poultry is unprecedented and concerning” and the US Department of Agriculture has restricted interstate cow transport to limit the spread of the disease. One human infection has been reported in a Texas, cattle farm worker in late March. Genomic sequencing from this patient found that each individual gene segment was “closely related to viruses detected in dairy cattle” in Texas, according to US CDC. “While minor changes were identified in the virus sequence from the patient specimen compared to the viral sequences from cattle, both cattle and human sequences maintain primarily avian genetic characteristics and, for the most part, lack changes that would make them better adapted to infect mammals,” it noted. “There are no markers known to be associated with influenza antiviral resistance found in the virus sequences from the patient’s specimen and the virus is very closely related to two existing candidate vaccine viruses that are already available to manufacturers, and which could be used to make vaccine if needed,” added. Overall, the genetic analysis “supports CDC’s conclusion that the human health risk currently remains low”. US public officials said that Tamiflu, an antiviral effective for treating influenza, is stockpiled for a potential emergency, NPR reported. Some candidate vaccines for H5N1 are also in development and there are some options for enhancing present supply. US states where H5N1 has been detected in cattle Historically, human cases of the H5N1 virus are so far very rare, with only 889 cases reported to the WHO since 2003, all involving people who came in contact with infected animals. But virus mortality reaches 52%, which is “extraordinary high”, said Farrar, who urged close monitoring and investigation of the outbreaks in US cattle by public health authorities “because it may evolve into transmitting in different ways”. “Do the milking structures of cows create aerosols? Is it the environment which they’re living in? Is it the transport system that is spreading this around the country?” he asked. “This is a huge concern and I think we have to … make sure that if H5N1 did come across to humans with human-to-human transmission that we were in a position to immediately respond with access equitably to vaccines, therapeutics and diagnostics.” Different strains, different severity Though avian influenza viruses naturally occur in wild water birds, some variants are also known to develop the ability to infect other animals. The virus has multiple variants of differing severity and transmission possibilities. A case of human infection with the much milder strain of avian influenza virus (H9N2) was confirmed in Viet Nam on 9 April by the International Health Regulations (IHR) National Focal Point, as WHO reported. The same virus strain was also detected in three patients in China,according to the Centre for Health Protection of Hong Kong. H9N2 usually results in mild infections of the upper respiratory tract, mostly affecting children. It is a low pathogenic avian influenza, usually showing only mild disease in chickens and other poultry, according to the US CDC. Systems in place to respond Maria van Kerkhove “We are concerned about this particular virus because we know influenza has the potential to cause epidemics,” said Van Kerkhove. “That’s why we have a global system in place to monitor detect, to rapidly do risk assessments to look at viruses that could potentially be used in vaccines as we go forward.” However, she expressed confidence that risks of an outbreak in human populations remain low and that existing WHO surveillance systems competent to monitor any developments. ”We have a global influenza surveillance and response system that’s been in place for 70 years. And within this systems, there are strong surveillance components, made up of labs around the world, made up of many partner agencies,” she assured the media briefing. Dr Michael Ryan, WHO’s Executive Director of the Health Emergencies Programme, backed Van Kerkhove: “We have a system that can measure and we have countermeasures ready to go should anything happen and that’s all we can do in public health.” “We can’t stop living because viruses threaten us. What we can do is be ready to respond,” he said,. The Pandemic Influenza Preparedness Framework “has been in place again for 20 years and has provided a framework for collaboration between WHO labs and industry for the sharing of material, for the sharing of vaccines”, added Ryan. Image Credits: Charlotte Kesl/ World Bank. ILO: Excessive Heat Linked to Climate Change Affects 70% of Workers 26/04/2024 Disha Shetty Outdoor workers are at a high potential health risk as climate change worsens heat. Over 70% of the world’s workforce faces potential health risks due to climate change, according to the latest report by the International Labour Organization (ILO) released earlier this week. Nearly 1.6 billion outdoor workers are also at risk from high levels of air pollution. “More than 70% of our workers are exposed to excessive heat at least one point in their working lives. That’s 2.4 billion workers globally out of a global workforce of 3.4 billion,” said Manal Azzi, Senior Specialist on Occupational Safety and Health (ILO) at the report launch at the United Nations in Geneva. The report, Ensuring safety and health at work in a changing climate, states that climate change is already having a serious impact on the safety and health of workers in all regions of the world. The share of global workers impacted by climate change hazards has increased by about from 65% in 2020 to 70% in 2024, the report said. Workers in the world’s most impoverished regions face heightened risks from scorching heatwaves, prolonged droughts, raging wildfires, and devastating hurricanes, according to the ILO. Did you know? 🌍🔥 Over 2.4 billion workers face excessive heat due to #ClimateChange. ⏳It's a race against time for safety and health. Learn more at our global event tomorrow: https://t.co/i3SlGiyisO#SafeDay2024 pic.twitter.com/LnofX5hKif — International Labour Organization (@ilo) April 24, 2024 Range of climate-linked health risks The report notes that numerous health conditions in workers have been linked to climate change, including cancer, cardiovascular disease, respiratory illnesses, kidney dysfunction and mental health conditions. The impact includes the 1.6 billion workers exposed to UV radiation, with more than 18,960 work-related deaths annually from non-melanoma skin cancer. “More than 22 million workers are suffering from sicknesses and injuries related to exposure to excessive heat and these can range from injuries in transport, in traffic accidents due to bad night of sleep because it was excessively hot, to construction accidents, injuries, slips and falls related to the exposure to heat,” Azzi said. Many deaths are also directly related to the impact of climate change. “Nearly 20,000 workers are dying yearly because of these injuries in the workplace related to rising temperatures and to exposure to excessive heat, indoor and outdoor heat, and losing millions – over two million disability-adjusted years – are lost because of injuries and deaths related to heat,” said Azzi, who is the ILO’s specialist on occupational safety and health. A traditional brick factory in Tozeur, southern Tunisia. In Africa and South Asia brick making and waste burning are major sources of air pollution. High levels of air pollution causing harm The report also said that nearly 1.6 billion outdoor workers are at risk of health impacts due to worsening air pollution, particularly those working in the transport sector and firefighters. Around 860,000 work-related deaths have been attributed to air pollution for outdoor workers annually. The report noted that modified weather patterns due to climate change have influenced levels of outdoor air pollutants, such as ground-level ozone, fine (PM2.5) and course (PM10) particulate matter, nitrogen dioxide (NO2), and sulphur dioxide (SO2). Rise in vector-borne diseases With increasing temperatures and higher humidity, more pesticides are also being used in the agriculture sector. According to the report, there are more than 870 million workers in agriculture that are likely to be exposed to pesticides, with more than 300,000 deaths attributed to pesticide poisoning annually. Azzi notes that “15,000 people die due to parasitic and vector-borne diseases exposed to in the workplace”. “Obviously, these include a lot of diseases like dengue, rabies and various diseases that are increasing in regions that we never used to see them before. Malaria has even increased and we’re seeing it’s shown in countries that it never used to be before.” The ILO has planned a meeting in 2025 with government, employer and worker representatives to provide policy guidance on climate hazards. Image Credits: Unsplash, WHO/Diego Rodriguez. Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan HIV medicine dolutegravir. The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of the World Health Organization (WHO). Dolutegravir has fewer side effects and a lower risk of developing resistance. UNAIDS has described the move as an “important breakthrough in public health measures” that breaks “the monopoly”, and could mean that the price of the life-saving medicine is reduced by as much as 80%. “When the power to produce health technologies is held by a few companies, the result all too often is that countries can’t afford the high prices and people who need newer products cannot access them,” said Luisa Cabal, UNAIDS Regional Director for Latin America and the Caribbean. “This decision provides the government with the legal conditions to manufacture or purchase more affordable versions of this essential first-line antiretroviral treatment for all people living with HIV in Colombia, including Venezuelan migrants”, said Ms Cabal. “We are confident that this decision will have an impact across the whole region and beyond, as many middle-income countries are struggling to access generic markets of key health products to prevent and treat HIV infection.” Prohibitive costs This move has also been welcomed by Médecins Sans Frontières (MSF), Public Citizen and Global Humanitarian Progress Corporation Colombia. ⚡️⚡️⚡️Breaking News: Colombia issues its first compulsory license (CL) for the HIV drug dolutegravir bringing the price down from US$1,224 per patient per year by ViiV to $44 through generics. This proves the power of generic competition!!! https://t.co/yPSpAFzJyJ — Shailly Gupta (@Shaillytweeting) April 25, 2024 “Colombia’s decision to issue a compulsory license for dolutegravir is great news because, until now, we have not been able to introduce dolutegravir in our medical operations, as the costs have been prohibitive,” said Dr Carmenza Gálvez, MSF’s medical coordinator for Colombia and Panama. Although generic versions of dolutegravir are available internationally for a fraction of ViiV’s price through voluntary licenses with the Medicines Patent Pool (MPP), ViiV excluded Colombia and many middle-income countries from being able to benefit from its license with MPP, allowing ViiV to maintain its monopoly and continue to charge high prices in Colombia and other countries excluded from the license. The Global Fund buys generic dolutegravir for $22.80 per patient per year, while Pan-American Health Organization (PAHO) can procure it for $44 – but Colombia cannot access these prices. According to the Colombian government, the estimated cost of dolutegravir sold by ViiV under the brand name, Tivicay, is around $1,224 per patient per year in 2023. If Colombia can procure the generics for $44, it will be able to treat 27 people for what it is paying for one person at present. According to UNAIDS, Colombia hosts the largest number of Venezuelan migrants in the world (2.9 million as of October 2022), and “recent studies have shown a 0.9% HIV prevalence among this migrant population, almost double the 0.5% HIV prevalence among the country’s adult population”. Compulsory licensing is a provision in the World Trade Organization (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement). It enables governments to supply its citizens with generic versions of patented treatments either through domestic production or imports, ensuring health products’ prices are affordable. The 2001 WTO Declaration on the TRIPS agreement and public health reaffirmed the rights of member states to make use of all flexibilities in the TRIPS agreement to protect public health, including compulsory licenses. More recently, in the 2021 Political Declaration on HIV/AIDS, countries committed to make use of TRIPS flexibilities, specifically geared to promoting access to medicines. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
While No Human-to-Human Transmission Yet, Scientists Are Concerned About Rapid Spread of Avian Flu 26/04/2024 Zuzanna Stawiska The ongoing global spread of “bird flu” infections to mammals including humans is a significant public health concern While no cases of human-to-human transmission have been recorded in the current H5N1 avian outbreak, scientists are concerned about its transmission speed in mammals and whether this might result in a mutated pathogen that can infect people more easily. “H5N1 is (an) influenza infection, predominantly started in poultry and ducks and has spread effectively over the course of the last one or two years to become a global zoonotic – animal – pandemic,” said Dr Jeremy Farrar, the World Health Organization’s (WHO) Chief Scientist. “The great concern, of course, is that in doing so and infecting ducks and chickens – but now increasingly mammals – that that virus now evolves and develops the ability to infect humans. And then critically, the ability to go from human-to-human transmission,” Farrar told a media briefing in Geneva last week. At the WHO’s global media briefing on Wednesday, WHO epidemiologist Dr Maria Van Kerkhove that “we have not seen human-to-human transmission in the recent cases, and I think that’s really important because there’s a lot of news right now on influenza”. Spread in US dairy herds H5N1 has been detected in cattle in 33 dairy herds in eight US states, according to the latest US Centers for Disease Control and Prevention (CDC) report on 24 April. Remnants of the virus have also been detected in raw milk. US CDC described “this degree of spread outside of birds & poultry is unprecedented and concerning” and the US Department of Agriculture has restricted interstate cow transport to limit the spread of the disease. One human infection has been reported in a Texas, cattle farm worker in late March. Genomic sequencing from this patient found that each individual gene segment was “closely related to viruses detected in dairy cattle” in Texas, according to US CDC. “While minor changes were identified in the virus sequence from the patient specimen compared to the viral sequences from cattle, both cattle and human sequences maintain primarily avian genetic characteristics and, for the most part, lack changes that would make them better adapted to infect mammals,” it noted. “There are no markers known to be associated with influenza antiviral resistance found in the virus sequences from the patient’s specimen and the virus is very closely related to two existing candidate vaccine viruses that are already available to manufacturers, and which could be used to make vaccine if needed,” added. Overall, the genetic analysis “supports CDC’s conclusion that the human health risk currently remains low”. US public officials said that Tamiflu, an antiviral effective for treating influenza, is stockpiled for a potential emergency, NPR reported. Some candidate vaccines for H5N1 are also in development and there are some options for enhancing present supply. US states where H5N1 has been detected in cattle Historically, human cases of the H5N1 virus are so far very rare, with only 889 cases reported to the WHO since 2003, all involving people who came in contact with infected animals. But virus mortality reaches 52%, which is “extraordinary high”, said Farrar, who urged close monitoring and investigation of the outbreaks in US cattle by public health authorities “because it may evolve into transmitting in different ways”. “Do the milking structures of cows create aerosols? Is it the environment which they’re living in? Is it the transport system that is spreading this around the country?” he asked. “This is a huge concern and I think we have to … make sure that if H5N1 did come across to humans with human-to-human transmission that we were in a position to immediately respond with access equitably to vaccines, therapeutics and diagnostics.” Different strains, different severity Though avian influenza viruses naturally occur in wild water birds, some variants are also known to develop the ability to infect other animals. The virus has multiple variants of differing severity and transmission possibilities. A case of human infection with the much milder strain of avian influenza virus (H9N2) was confirmed in Viet Nam on 9 April by the International Health Regulations (IHR) National Focal Point, as WHO reported. The same virus strain was also detected in three patients in China,according to the Centre for Health Protection of Hong Kong. H9N2 usually results in mild infections of the upper respiratory tract, mostly affecting children. It is a low pathogenic avian influenza, usually showing only mild disease in chickens and other poultry, according to the US CDC. Systems in place to respond Maria van Kerkhove “We are concerned about this particular virus because we know influenza has the potential to cause epidemics,” said Van Kerkhove. “That’s why we have a global system in place to monitor detect, to rapidly do risk assessments to look at viruses that could potentially be used in vaccines as we go forward.” However, she expressed confidence that risks of an outbreak in human populations remain low and that existing WHO surveillance systems competent to monitor any developments. ”We have a global influenza surveillance and response system that’s been in place for 70 years. And within this systems, there are strong surveillance components, made up of labs around the world, made up of many partner agencies,” she assured the media briefing. Dr Michael Ryan, WHO’s Executive Director of the Health Emergencies Programme, backed Van Kerkhove: “We have a system that can measure and we have countermeasures ready to go should anything happen and that’s all we can do in public health.” “We can’t stop living because viruses threaten us. What we can do is be ready to respond,” he said,. The Pandemic Influenza Preparedness Framework “has been in place again for 20 years and has provided a framework for collaboration between WHO labs and industry for the sharing of material, for the sharing of vaccines”, added Ryan. Image Credits: Charlotte Kesl/ World Bank. ILO: Excessive Heat Linked to Climate Change Affects 70% of Workers 26/04/2024 Disha Shetty Outdoor workers are at a high potential health risk as climate change worsens heat. Over 70% of the world’s workforce faces potential health risks due to climate change, according to the latest report by the International Labour Organization (ILO) released earlier this week. Nearly 1.6 billion outdoor workers are also at risk from high levels of air pollution. “More than 70% of our workers are exposed to excessive heat at least one point in their working lives. That’s 2.4 billion workers globally out of a global workforce of 3.4 billion,” said Manal Azzi, Senior Specialist on Occupational Safety and Health (ILO) at the report launch at the United Nations in Geneva. The report, Ensuring safety and health at work in a changing climate, states that climate change is already having a serious impact on the safety and health of workers in all regions of the world. The share of global workers impacted by climate change hazards has increased by about from 65% in 2020 to 70% in 2024, the report said. Workers in the world’s most impoverished regions face heightened risks from scorching heatwaves, prolonged droughts, raging wildfires, and devastating hurricanes, according to the ILO. Did you know? 🌍🔥 Over 2.4 billion workers face excessive heat due to #ClimateChange. ⏳It's a race against time for safety and health. Learn more at our global event tomorrow: https://t.co/i3SlGiyisO#SafeDay2024 pic.twitter.com/LnofX5hKif — International Labour Organization (@ilo) April 24, 2024 Range of climate-linked health risks The report notes that numerous health conditions in workers have been linked to climate change, including cancer, cardiovascular disease, respiratory illnesses, kidney dysfunction and mental health conditions. The impact includes the 1.6 billion workers exposed to UV radiation, with more than 18,960 work-related deaths annually from non-melanoma skin cancer. “More than 22 million workers are suffering from sicknesses and injuries related to exposure to excessive heat and these can range from injuries in transport, in traffic accidents due to bad night of sleep because it was excessively hot, to construction accidents, injuries, slips and falls related to the exposure to heat,” Azzi said. Many deaths are also directly related to the impact of climate change. “Nearly 20,000 workers are dying yearly because of these injuries in the workplace related to rising temperatures and to exposure to excessive heat, indoor and outdoor heat, and losing millions – over two million disability-adjusted years – are lost because of injuries and deaths related to heat,” said Azzi, who is the ILO’s specialist on occupational safety and health. A traditional brick factory in Tozeur, southern Tunisia. In Africa and South Asia brick making and waste burning are major sources of air pollution. High levels of air pollution causing harm The report also said that nearly 1.6 billion outdoor workers are at risk of health impacts due to worsening air pollution, particularly those working in the transport sector and firefighters. Around 860,000 work-related deaths have been attributed to air pollution for outdoor workers annually. The report noted that modified weather patterns due to climate change have influenced levels of outdoor air pollutants, such as ground-level ozone, fine (PM2.5) and course (PM10) particulate matter, nitrogen dioxide (NO2), and sulphur dioxide (SO2). Rise in vector-borne diseases With increasing temperatures and higher humidity, more pesticides are also being used in the agriculture sector. According to the report, there are more than 870 million workers in agriculture that are likely to be exposed to pesticides, with more than 300,000 deaths attributed to pesticide poisoning annually. Azzi notes that “15,000 people die due to parasitic and vector-borne diseases exposed to in the workplace”. “Obviously, these include a lot of diseases like dengue, rabies and various diseases that are increasing in regions that we never used to see them before. Malaria has even increased and we’re seeing it’s shown in countries that it never used to be before.” The ILO has planned a meeting in 2025 with government, employer and worker representatives to provide policy guidance on climate hazards. Image Credits: Unsplash, WHO/Diego Rodriguez. Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan HIV medicine dolutegravir. The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of the World Health Organization (WHO). Dolutegravir has fewer side effects and a lower risk of developing resistance. UNAIDS has described the move as an “important breakthrough in public health measures” that breaks “the monopoly”, and could mean that the price of the life-saving medicine is reduced by as much as 80%. “When the power to produce health technologies is held by a few companies, the result all too often is that countries can’t afford the high prices and people who need newer products cannot access them,” said Luisa Cabal, UNAIDS Regional Director for Latin America and the Caribbean. “This decision provides the government with the legal conditions to manufacture or purchase more affordable versions of this essential first-line antiretroviral treatment for all people living with HIV in Colombia, including Venezuelan migrants”, said Ms Cabal. “We are confident that this decision will have an impact across the whole region and beyond, as many middle-income countries are struggling to access generic markets of key health products to prevent and treat HIV infection.” Prohibitive costs This move has also been welcomed by Médecins Sans Frontières (MSF), Public Citizen and Global Humanitarian Progress Corporation Colombia. ⚡️⚡️⚡️Breaking News: Colombia issues its first compulsory license (CL) for the HIV drug dolutegravir bringing the price down from US$1,224 per patient per year by ViiV to $44 through generics. This proves the power of generic competition!!! https://t.co/yPSpAFzJyJ — Shailly Gupta (@Shaillytweeting) April 25, 2024 “Colombia’s decision to issue a compulsory license for dolutegravir is great news because, until now, we have not been able to introduce dolutegravir in our medical operations, as the costs have been prohibitive,” said Dr Carmenza Gálvez, MSF’s medical coordinator for Colombia and Panama. Although generic versions of dolutegravir are available internationally for a fraction of ViiV’s price through voluntary licenses with the Medicines Patent Pool (MPP), ViiV excluded Colombia and many middle-income countries from being able to benefit from its license with MPP, allowing ViiV to maintain its monopoly and continue to charge high prices in Colombia and other countries excluded from the license. The Global Fund buys generic dolutegravir for $22.80 per patient per year, while Pan-American Health Organization (PAHO) can procure it for $44 – but Colombia cannot access these prices. According to the Colombian government, the estimated cost of dolutegravir sold by ViiV under the brand name, Tivicay, is around $1,224 per patient per year in 2023. If Colombia can procure the generics for $44, it will be able to treat 27 people for what it is paying for one person at present. According to UNAIDS, Colombia hosts the largest number of Venezuelan migrants in the world (2.9 million as of October 2022), and “recent studies have shown a 0.9% HIV prevalence among this migrant population, almost double the 0.5% HIV prevalence among the country’s adult population”. Compulsory licensing is a provision in the World Trade Organization (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement). It enables governments to supply its citizens with generic versions of patented treatments either through domestic production or imports, ensuring health products’ prices are affordable. The 2001 WTO Declaration on the TRIPS agreement and public health reaffirmed the rights of member states to make use of all flexibilities in the TRIPS agreement to protect public health, including compulsory licenses. More recently, in the 2021 Political Declaration on HIV/AIDS, countries committed to make use of TRIPS flexibilities, specifically geared to promoting access to medicines. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
ILO: Excessive Heat Linked to Climate Change Affects 70% of Workers 26/04/2024 Disha Shetty Outdoor workers are at a high potential health risk as climate change worsens heat. Over 70% of the world’s workforce faces potential health risks due to climate change, according to the latest report by the International Labour Organization (ILO) released earlier this week. Nearly 1.6 billion outdoor workers are also at risk from high levels of air pollution. “More than 70% of our workers are exposed to excessive heat at least one point in their working lives. That’s 2.4 billion workers globally out of a global workforce of 3.4 billion,” said Manal Azzi, Senior Specialist on Occupational Safety and Health (ILO) at the report launch at the United Nations in Geneva. The report, Ensuring safety and health at work in a changing climate, states that climate change is already having a serious impact on the safety and health of workers in all regions of the world. The share of global workers impacted by climate change hazards has increased by about from 65% in 2020 to 70% in 2024, the report said. Workers in the world’s most impoverished regions face heightened risks from scorching heatwaves, prolonged droughts, raging wildfires, and devastating hurricanes, according to the ILO. Did you know? 🌍🔥 Over 2.4 billion workers face excessive heat due to #ClimateChange. ⏳It's a race against time for safety and health. Learn more at our global event tomorrow: https://t.co/i3SlGiyisO#SafeDay2024 pic.twitter.com/LnofX5hKif — International Labour Organization (@ilo) April 24, 2024 Range of climate-linked health risks The report notes that numerous health conditions in workers have been linked to climate change, including cancer, cardiovascular disease, respiratory illnesses, kidney dysfunction and mental health conditions. The impact includes the 1.6 billion workers exposed to UV radiation, with more than 18,960 work-related deaths annually from non-melanoma skin cancer. “More than 22 million workers are suffering from sicknesses and injuries related to exposure to excessive heat and these can range from injuries in transport, in traffic accidents due to bad night of sleep because it was excessively hot, to construction accidents, injuries, slips and falls related to the exposure to heat,” Azzi said. Many deaths are also directly related to the impact of climate change. “Nearly 20,000 workers are dying yearly because of these injuries in the workplace related to rising temperatures and to exposure to excessive heat, indoor and outdoor heat, and losing millions – over two million disability-adjusted years – are lost because of injuries and deaths related to heat,” said Azzi, who is the ILO’s specialist on occupational safety and health. A traditional brick factory in Tozeur, southern Tunisia. In Africa and South Asia brick making and waste burning are major sources of air pollution. High levels of air pollution causing harm The report also said that nearly 1.6 billion outdoor workers are at risk of health impacts due to worsening air pollution, particularly those working in the transport sector and firefighters. Around 860,000 work-related deaths have been attributed to air pollution for outdoor workers annually. The report noted that modified weather patterns due to climate change have influenced levels of outdoor air pollutants, such as ground-level ozone, fine (PM2.5) and course (PM10) particulate matter, nitrogen dioxide (NO2), and sulphur dioxide (SO2). Rise in vector-borne diseases With increasing temperatures and higher humidity, more pesticides are also being used in the agriculture sector. According to the report, there are more than 870 million workers in agriculture that are likely to be exposed to pesticides, with more than 300,000 deaths attributed to pesticide poisoning annually. Azzi notes that “15,000 people die due to parasitic and vector-borne diseases exposed to in the workplace”. “Obviously, these include a lot of diseases like dengue, rabies and various diseases that are increasing in regions that we never used to see them before. Malaria has even increased and we’re seeing it’s shown in countries that it never used to be before.” The ILO has planned a meeting in 2025 with government, employer and worker representatives to provide policy guidance on climate hazards. Image Credits: Unsplash, WHO/Diego Rodriguez. Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan HIV medicine dolutegravir. The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of the World Health Organization (WHO). Dolutegravir has fewer side effects and a lower risk of developing resistance. UNAIDS has described the move as an “important breakthrough in public health measures” that breaks “the monopoly”, and could mean that the price of the life-saving medicine is reduced by as much as 80%. “When the power to produce health technologies is held by a few companies, the result all too often is that countries can’t afford the high prices and people who need newer products cannot access them,” said Luisa Cabal, UNAIDS Regional Director for Latin America and the Caribbean. “This decision provides the government with the legal conditions to manufacture or purchase more affordable versions of this essential first-line antiretroviral treatment for all people living with HIV in Colombia, including Venezuelan migrants”, said Ms Cabal. “We are confident that this decision will have an impact across the whole region and beyond, as many middle-income countries are struggling to access generic markets of key health products to prevent and treat HIV infection.” Prohibitive costs This move has also been welcomed by Médecins Sans Frontières (MSF), Public Citizen and Global Humanitarian Progress Corporation Colombia. ⚡️⚡️⚡️Breaking News: Colombia issues its first compulsory license (CL) for the HIV drug dolutegravir bringing the price down from US$1,224 per patient per year by ViiV to $44 through generics. This proves the power of generic competition!!! https://t.co/yPSpAFzJyJ — Shailly Gupta (@Shaillytweeting) April 25, 2024 “Colombia’s decision to issue a compulsory license for dolutegravir is great news because, until now, we have not been able to introduce dolutegravir in our medical operations, as the costs have been prohibitive,” said Dr Carmenza Gálvez, MSF’s medical coordinator for Colombia and Panama. Although generic versions of dolutegravir are available internationally for a fraction of ViiV’s price through voluntary licenses with the Medicines Patent Pool (MPP), ViiV excluded Colombia and many middle-income countries from being able to benefit from its license with MPP, allowing ViiV to maintain its monopoly and continue to charge high prices in Colombia and other countries excluded from the license. The Global Fund buys generic dolutegravir for $22.80 per patient per year, while Pan-American Health Organization (PAHO) can procure it for $44 – but Colombia cannot access these prices. According to the Colombian government, the estimated cost of dolutegravir sold by ViiV under the brand name, Tivicay, is around $1,224 per patient per year in 2023. If Colombia can procure the generics for $44, it will be able to treat 27 people for what it is paying for one person at present. According to UNAIDS, Colombia hosts the largest number of Venezuelan migrants in the world (2.9 million as of October 2022), and “recent studies have shown a 0.9% HIV prevalence among this migrant population, almost double the 0.5% HIV prevalence among the country’s adult population”. Compulsory licensing is a provision in the World Trade Organization (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement). It enables governments to supply its citizens with generic versions of patented treatments either through domestic production or imports, ensuring health products’ prices are affordable. The 2001 WTO Declaration on the TRIPS agreement and public health reaffirmed the rights of member states to make use of all flexibilities in the TRIPS agreement to protect public health, including compulsory licenses. More recently, in the 2021 Political Declaration on HIV/AIDS, countries committed to make use of TRIPS flexibilities, specifically geared to promoting access to medicines. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan HIV medicine dolutegravir. The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of the World Health Organization (WHO). Dolutegravir has fewer side effects and a lower risk of developing resistance. UNAIDS has described the move as an “important breakthrough in public health measures” that breaks “the monopoly”, and could mean that the price of the life-saving medicine is reduced by as much as 80%. “When the power to produce health technologies is held by a few companies, the result all too often is that countries can’t afford the high prices and people who need newer products cannot access them,” said Luisa Cabal, UNAIDS Regional Director for Latin America and the Caribbean. “This decision provides the government with the legal conditions to manufacture or purchase more affordable versions of this essential first-line antiretroviral treatment for all people living with HIV in Colombia, including Venezuelan migrants”, said Ms Cabal. “We are confident that this decision will have an impact across the whole region and beyond, as many middle-income countries are struggling to access generic markets of key health products to prevent and treat HIV infection.” Prohibitive costs This move has also been welcomed by Médecins Sans Frontières (MSF), Public Citizen and Global Humanitarian Progress Corporation Colombia. ⚡️⚡️⚡️Breaking News: Colombia issues its first compulsory license (CL) for the HIV drug dolutegravir bringing the price down from US$1,224 per patient per year by ViiV to $44 through generics. This proves the power of generic competition!!! https://t.co/yPSpAFzJyJ — Shailly Gupta (@Shaillytweeting) April 25, 2024 “Colombia’s decision to issue a compulsory license for dolutegravir is great news because, until now, we have not been able to introduce dolutegravir in our medical operations, as the costs have been prohibitive,” said Dr Carmenza Gálvez, MSF’s medical coordinator for Colombia and Panama. Although generic versions of dolutegravir are available internationally for a fraction of ViiV’s price through voluntary licenses with the Medicines Patent Pool (MPP), ViiV excluded Colombia and many middle-income countries from being able to benefit from its license with MPP, allowing ViiV to maintain its monopoly and continue to charge high prices in Colombia and other countries excluded from the license. The Global Fund buys generic dolutegravir for $22.80 per patient per year, while Pan-American Health Organization (PAHO) can procure it for $44 – but Colombia cannot access these prices. According to the Colombian government, the estimated cost of dolutegravir sold by ViiV under the brand name, Tivicay, is around $1,224 per patient per year in 2023. If Colombia can procure the generics for $44, it will be able to treat 27 people for what it is paying for one person at present. According to UNAIDS, Colombia hosts the largest number of Venezuelan migrants in the world (2.9 million as of October 2022), and “recent studies have shown a 0.9% HIV prevalence among this migrant population, almost double the 0.5% HIV prevalence among the country’s adult population”. Compulsory licensing is a provision in the World Trade Organization (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement). It enables governments to supply its citizens with generic versions of patented treatments either through domestic production or imports, ensuring health products’ prices are affordable. The 2001 WTO Declaration on the TRIPS agreement and public health reaffirmed the rights of member states to make use of all flexibilities in the TRIPS agreement to protect public health, including compulsory licenses. More recently, in the 2021 Political Declaration on HIV/AIDS, countries committed to make use of TRIPS flexibilities, specifically geared to promoting access to medicines. Posts navigation Older postsNewer posts